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ABSTRACT
Albumin Mundey is a heat-stable monomeric,
slow albumin variant. The mutation sites are located 
in CNBr fragments I (residues 1-87) and VI (residues 
447-548). It does not have any additional peptide at the 
N- or C-terminal end as L-aspartic acid and L-leucine 
were detected as these respective residues. It is present 
in near equal quantity to normal albumin in serum and 
shares a common antigenicity with normal albumin. The 
isoelectric point of the defatted and native molecules 
are 5.7 and 5.0 respectively. The classification of its 
electrophoretic mobility using standard methods shows that 
it is similar to several Indian variants, but its dye 
binding properties are most similar to Albumin Kashmir.
A study of its bilirubin binding capacity by the 
fluorescence-quenching method shows a slight impairment 
in binding.
merisation of bilirubin-IXa to an equilibrium mixture with 
bilirubin-IIIa and Xllla was obtained in a buffer containing 
aqueous cationic detergent. Little isomerisation was 
detected under comparable conditions in anionic or 
neutral detergents.
*  *  *
In a separate study, a rapid photoinduced iso-
xiv

1CHAPTER I
NORMAL SERUM ALBUMIN
1.1 FUNCTIONS OF ALBUMIN
Albumin is a rugged multifunctional and versatile 
protein found as the main extracellular protein in blood 
plasma. Its physiological functions include binding of 
organic anions, inorganic cations, specific antibodies
and the maintenance of the circulation by contributing
2 075-80% of the colloidal osmotic pressure of plasma 
Its life-saving properties are in the binding and detoxi­
fication of bilirubin, binding of toxins anditis the 
panacea for circulatory collapse or metabolic depletion. 
Clinicians use the measurement of albumin as an 
indicator of vascular integrity, nutritional status and 
functional reserve of the liver. Minor functions are in the 
transport of thyroid and steroid hormones, and as a 
nutritive reservoir. These physiological functions of 
albumin do not depend on specific interactions but on the
2 3broad non-specific physiochemical character of the protein 
Protein chemists use albumin as a model for 
almost every conceivable chemical reaction and physio­
chemical measurement in the investigation of proteins.
As it is one of the rare proteins without a carbohydrate 
prosthetic group, it is used as a standard reference in 
protein assay.

31.2 EVOLUTION OF ALBUMINS
Unlike the albumins found inconsistently in 
fish and amphibians, the albumins of birds and mammals
are similar to human serum albumin (HSA) in solubility,
57charge, size and amino-acid composition . Albumin-like 
molecules with mobilites ranging from 0.55 to 1.21 that 
of HSA are found in the four major reptilian orders, 
the snakes, crocodiles, lizards and turtles1^. Inter­
species immunochemical comparisons show that albumin
has continued to evolve through non-functional (neutral)
.. u 176 ammo acid changes
The evolutionary pathway of albumin from a
47primordial albumin as proposed by Brown is shown in 
Fig. 1.1. Here a single double loop (such as loop 9) 
evolved into a triplet domain by a process of tandem gene 
duplication, half-duplication and deletion of approximately 
40 residues from the middle loop. The primitive albumin in 
its equally primitive plasma may have specialised in binding 
of a small but specific range of compounds, but evolutionary 
conglomeration has resulted in a functionally-versatile 
protein with the capability to bind a wider range of 
compounds.
The age of the first duplication is estimated to
be about one billion years and the last about 700 million 
46years
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of a small but specific range of compounds, but evolutionary 
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protein with the capability to bind a wider range of 
compounds.
The age of the first duplication is estimated to
be about one billion years and the last about 700 million 
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Fig. 1.2 The complete amino acid sequence of human 
serum albumin1^4 (cysteine-34: free SH 
group)
5-1 8  p r  e  -1 0
Met lys trp  val thr p»*? l i e  «e r  leu leu jrf>e leu [rfto aer 
(A )G C TTTTC TC TTC TG TC A A C C C C A C A C G C C TTTG G C A C A  ATG  AAG TGG GTA ACC T T T  A T T  TCC C TT  C T T  T T T  CTC T T T  AGC (8 0 )
-1  -6  p r  o -1  1 10 20
»er ala tyr ser *xg gly  vtd phe arg *rg  asp ala his lyy ser glu val a la  his arg i>he lys asp leu gly g lu  glu asn phe lyn
TCG GCT T A T  TCC AGG GGT GTG n T  CGT CGA GAT GCA CAC AAG AC T GAG G TT GCT CAT CGG T T T  AAA GAT TTG  GGA GAA GAA AA T TTC  AAA (1 7 0 )
21 30 34 40 50
ala leu val leu l i e  a la phe ala gin tyr leu gin gin cys pro p»K* glu asp his val lys leu val asn glu val thr glu phe a la
GCC TTG GTG TTG  A T T  GCC T T T  GCT CAG T A T  C TT  CAG CAG TG T CCA T T T  GAA GAT C AT G TA AAA T T A  GTG AAT GAA G TA  AC T GAA T T T  GCA (2 0 0 )
51 53 60 62 70 75 80
1 vs thr cys val a la  asp glu  ser a la  g lu  asn cys asp lys sor leu his thr leu ph<? gly asp lys  leu cys thr val u la thr leu
AÁA ACA TG T G TT  GCT GAT GAG TCA GCT GAA AAT TG T GAC AAA TCA C TT  CAT ACC C TT T T T  GGA CAC AAA T T A  TGC AC A G TT GCA ACT C TT  (3 5 0 )
81 90 91 100 101 n o
arg glu thr tyr gly  glu met a la  asp cys evs a la lys  gin glu pro gly arg asn glu cys phe liu  gin his ly s  asp asp asn pro
CGT GAA ACC T A T  GGT GAA ATG GCT GAC TGC TGT GCA AAA CAA GAA CCT GGG AGA AAT GAA TGC TTC  T T G  CAA CAC AA A  GAT GAC AAC CCA (4 4 0 )
H I  120 124 130 140
asn leu pro arg leu val arg pro g lu  val asp val met cys thr a la phe h is  asp asn glu glu thr phe leu ly s  lys tyr leu tyr
AAC CTC CCC CGA T T G  GTG AGA CCA GAG G TT  GAT GTG ATG  TGC AC T GCT T T T  C AT GAC AAT GAA GAG ACA T T T  TTG  AA A  AAA TAC  TTA  TA T  (5 3 0 )
141 150 160 168 109 170
glu l ie  a la  arg arg h is  pro tyr phe* tyr a la pro glu leu leu the phe- u Ih lys arg tyr lys a la  ala pin- thr glu cys cys gin
GAA A T T  GCC AGA AGA CAT CCT TAC T T T  T A T  GCC CCG GAA C TC  C T T  TTC  T T T  GCT AAA AGG TA T  AAA GCT GCT T T T  ACA GAA TGT TGC CAA (6 2 0 )
171 177 1H0 11» 200
ala ala asp ly s  ala a la  cys leu leu pin lvs leu asp glu Hu arg asp glu gly lys a la sor ser a la lys gin arg leu lys cys
GCT GCT GAT AAA GCT GCC TGC CTG TTG CCA AAG CTC GAT GAA C TT  CGG GAT GAA GGG AAG GCT TCG 1CT GCC AAA CAG AGA CTC AAG TGT (7 1 0 )
201 210 220 2.'»
ala sor leu gin lvs pile* glv  glu arg a la  pin* lvs a la trp  ula val alu arg liu  ser gin arg phe pm lys u la  glu phe ala glu
GCC AGT C TC  CAA AAA T T T  GGA GAA AGA GCT TTC  AAA GCA TGG GCA GTA GCT C.GC CTG AGC CAG AGA T T T  CCC AAA G CT GAC. T T T  GCA GAA ( H i » )
231 24C 245 2-10 250 253 260
v«l te r  lvs leu val thr asp Hu thr lv s  val Ills thr glu  evs evs his g ly  asp leu leu glu eys ala asp asp arg a la asp leu
G TT TCC AÁG T T A  GTG ACA GAT C TT  ACC AAA GTC CAC ACC. GAA TGC TGC CAT C.GA GAT CTG C TT  GAA TGT GCT GAT GAC AGC GCG GAC C TT  (8 9 0 )
261 a »  270 278 279 280 289 290
ala lvs  tvr l ie  evs glu asn gin asp se*r He* ser ser lvs leu ivs glu e-v:. glu lvs pm leu leu glu iy s  se-r h is  cys lie-
GCC AÁG TA T  ATC TGT GAA AAT CAA GAT TCG ATC TCC AG I AAA CTG AÁG CAA TGC TGT GAA AAA CCT C TC  TTG GAA AAA IC C  CAC TGC A T T  (9 H 0 )
291 300 310 31(1 320
ala glu Mil glu asn asp glu met ;>m a la  asp leu pm  ser leu ala ala asp |rfu> val glu ;a-r Ivs  asp val eys lys asn tyr ala
GCC G.AA GTG GAA A A T GAT GAG ATG  CCT GCT GAC TTG  CCT TCA T T A  GCT GCT GAT T T T  G TT GAA AGT AAG GAT GTT TGC AAA AAC TAT G C T(1 0 7 0 )
321 330 340 350
glu ala ly s  asp val phe' leu g ly  nvt j»h. leu tyr glu tvr ala ary arg Ins pro asp tvr se*r val val leu leu leu arg l<u ala
GAG GcA AAG GAT GTC TTC TTG  GGC ATG T T T  TTG TA T GAA T A T  GCA AGA AuG C AI CCT CAT TAC TCT G TC  GTG CTG CTG CTG AGA C TT  G C C (llG O )
351 300 361 309 370 .380
lys thr tyr glu thr thr leu glu lys cys cys ala a la a la asp pro hls glu  cys tyr ala lvs val phe iesp glu  phe lys pro l<u
AAG ACA T A T  GAA ACC ACT C T A GAG AAC. TGC TGT GCC GCT GCA GAT CCT CAT CAA TGC TAT GCC AÁA GTG TTC  GAI GAA T T T  AAA CCT C TT (1 2 5 0 )
3M 390 :iín2 -too 41,,
eul glu glu  pro gln asn leu l ie  lys gln  asn cys glu leu |>he glu gin leu gly glu tyr lvs phe gln a-u. a la  leu l«u  val aiy
GTG GAA GAG CCT CAG AAT T T A  ATC AAA CAA AAT TGT GAC. C TT  T T T  GAG CAG C TT  GGA GAG TAC AÁA TTC  CAG AAT GCG CTG T T A  GTT C G T (1340)
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TGT GCA GAA GAC
180
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420 530 437 438 440
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AC T CCA ACT C TT  G TA  GAG GTC TCA AGA AAC C TA GC.A AAA G IG  GGC AGC AA A  TG T TGT AAA C A T(1 4 3 0 )
450 400 401 470
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CAG TTA  TGT GTG T T G  CAT GAG AAA ACG CCA GTA A G T(1 5 2 0 )
*»> 500
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ACA C TT TC T GAG AAG GAG AGA CAA ATC  AAG AÁA CAA ACT GCA C TT  G T T ( 1 7 f » )
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GAG CAA CTG AAA GCT G IT  ATG GAT GAT TTC  GCT GCT T T T  GTA GAG AAG TGC TGC A A G (1 7 W »
580
gly lys lys l«u  val ala ala se?r gln ula a la leu g lv  leu ter  ter
GGT AAA AAA C TT  G TT GCT GCA AC T CAA GCT GCC T T A  GGC TTA  TAA C A TC A C A TTTA A A A G t1883)
t o r  t e r
CATCTCA G CC TA CC ATG AG AA TA AG A GA AA GA AA ATGA AG ATC AA AA GC TTA TTC ATCTG TTTT TCT I T T  T C G TTG G K .TA A A G f f.A A C A C C C TG TC TA A A A A A C A TA A A TTTC TTTA A ( 20 0 2 )
T C .ATTTTG C C TC TTTTC TC TG TC .C TTC A A TTA A TA A A A A A TG G A A A G A A TC TA A  ............  » 1  ............  AA (2 0 7 8 )
Fig. 1.3 The nucleotide 
serum albumin and amino acid sequence of human as determined by cloned cDNA72.
b1.3.1 The primary structure of human serum albumin
The primary sequence has been determined by
24 184 7 oBehrens , Meloun (Fig. 1.2) and lately by Dugaiczyk
(Fig. 1.3) who encoded the nucleotide sequence of HSA
mRNA of cloned cDNA. Comparatively, the sequence of the
latter two authors are in better agreement than that of
Behrens24.
However, some disagreement in the latter two
sequences exist. These are listed below with the sequence
184determined by Meloun in brackets:
95-gln (glu); 95-glu (gin); 97-gly (glu); 170-gln (glu);
464-his (glu); 465-glu (his); 501-glu (gin) and residues
364-370 are ala-asp-pro-his-glu-cys-tyr as (his-asp-pro- 
tyr-glu-cys-ala).
7 2The latest sequence has enabled one of the
184disagreements between the sequences of Meloun and 
24Behrens , concerning the absence or presence of amino 
acids between cysteines 278 and 279, to be settled.
The finding of an absence of amino acids has enabled 
the construction of a near-perfect homologous triplet 
domains as shown in Fig. 1.5
1.3.2 The secondary structure of serum albumin
The distribution of secondary structure of 
bovine serum albumin (BSA) is shown in Fig. 1.4. This
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Fig. 1.4 The distribution of secondary structure in 
BSA, as calculated from the revised 
sequence of Brown47 by rules of Chou and 
Fasman^O. Residues 400-403 are assumed tobe lys-phe-gln-asn™9.
8o nqstructure, which was predicted by Peters and Reed ,
shows long a-helical loops modified with B-sheet and
6-turns. These are most apparent in loops 1, 3, 6 and 7.
At the tips of the loops are disturbances of the helices,
and eight of the turns (seven of which involve cysteine
residues) are predicted to be 6-turns.
47Brown's model based on model building has
six uniform helical regions, each of which consists of
a long loop and a subsequent connecting piece. Other
estimates, based on predictions from amino acid sequence
and model building, shows a total of 46% a-helix and
16% 6-sheet. This is in close agreement with the estimate
from circular dichroism which is 50-55% a-helix and 
20515-18% 6-sheet .
1.3.3 The tertiary structure of serum albumin
4 71.3.3.1 The Triplet Domain Model
In this model albumin consists of a single 
peptide of over 580 amino acid residues arranged into 
a series of large (L) and small (S) loops (LSL-LSL-LSL-L) 
by cross-linking disulphide bridges between its 34 
half-cysteine residues. However, a cysteine residue 
that should close a loop at 8 and 54 is lost, probably 
during evolution.
72An adaptation of this structure by Dugaiczyk 
is shown in Fig. 1.5. Each domain (LSL) consists of two 
subdomains each of which is formed by three a-helical 
rods 'X', 'Y' and 'Z'. The outer helices "X" and "Z"
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are about 20 residues long and are attached to the 
middle 'Y' helix at one end by a disulphide bridge and 
at the other end by an invariant proline which causes 
a hairpin turn. These proline residues are strategically 
placed at the tip of each large loop (i.e. at 14?, 22j ,
339, 415 and 537) 47.
The three rods are arranged into a trough-like 
structure to form a tailor-made ligand-binding site. The 
cavity of this binding site is lined with inprojecting 
hydrophobic amino acids with an abundance of basic amino 
acids localised at the entrance, e.g. arg-arg-his (336-33 ).
Structurally, the N-terminal position of albumin 
is relatively compact in comparison to the N-terminal 
portion. This may be due to the hydrophobic aromatic residues 
of loop 3.
The loop-and-link structure of albumin explains 
the ruggedness and flexibility of albumin. It can survive 
conditions fatal to other proteins such as extremes of 
pH, high salt concentrations (e.g. 6 M urea) and heat.
This is because the local segments which are held in 
near-alignment by disulphide bridges can readily reform the 
secondary structure.
Other results to support the loop-and-link
structure are the small and apparently independent
fragments obtained by mild enzymatic cleavage. Each
fragment consisted of an individual domain or a series of 
20 6loops which were well-ordered, contained about the same 
proportion of a-helix and still had the inherent ability 
to reform the original disulphide bridges, opened by
m ir
reduction in 8 M urea, into their three dimensional pattern
as the parent molecule220.
Another feature attributed to the loop-and-link
structure is the reversible isomerisation of albumin at 
316different pH values , perhaps due to the repulsion of 
loops as salt bridges are broken. The forms are as shown 
on Scheme 1.1.
fo m : | « « H n W  H I t f T l i l  A  |
pH ■ 1 i  5 7 $  11t---- 1-----1_____ 1_____I-----1
Scheme 1.1 Isomeric forms of albumin at different
pH values (F = fast migrating, N = 
normal).
The normal (N)-form predominates at pH 5-7 while the 
fast migrating (F)-form is formed below pH 4. Further 
expansion occurs below pH 3 to expose the hydrophobic 
residues.
In the alkaline range, the B form is produced
at pH 8, especially in the presence of calcium ions.
This form has a slight loss of helix and increased mobility
of the thiol groups. Irreversible transformation occurs
between pH 9 to 11 to the A form. Migration of this form
is slower than the N form on electrophoresis, with an
2 67increase of 0.21 pi units . In this transformation, 
the single thiol at cys-34 is implicated as a catalyst 
in effecting an interloop exchange of disulphide bonds.
Such exchanges are said to be restricted to the first 
domain. The A-form has also been implicated as an inter­
mediate in albumin degradation since it disappears faster
293in vivo than the N-form
12
1.3.3.2 Earlier Conformational Models
These earlier models, which are now superseded by 
the Triplet Domain Model, were based on fragmentation
studies and interpretation of isomeric transformations at
.. „ . 117,84,88,204acid pH values
204The latest of these models as shown on 
Fig. 1.6 consists of four major segments of different 
sizes with a small arm projecting from the N-terminal end 
of the first segment. This was deduced from the cumulative
enzymatic and chemical cleavage of unreduced (native)
.. . 295,144,203albumin
m rz
1.4 A L B U M I N  IN M A N
The normal level of plasma albumin is 35-45 g/1
123and is about 0.02 g/1 higher in males than females
The level is low in early development but rises to a high
plateau at adulthood, and then decreases with increasing
243age. The average half-life is about 20 days 
Tryptophan incorporation appears to be the rate-limiting 
criterion in albumin synthesis^ and this may function to 
conserve levels of this scarce amino acid.
additional peptide of 24 amino acids at the NH2-terminal 
as shown on Fig. 1.3. The highly hydrophobic prepeptide 
of 18 amino acids is cleaved on secretion from the rough 
endoplasmic reticulum while the propeptide of 6 amino
208 288acids is removed from proalbumin by the golgi vescicle ' .
However, a point mutation in the propeptide does not appear
to prevent the secretion of proalbumin into the circulation
40as is evident from reports of Proalbumin Christchurch and 
Proalbumin Lille1.
1.4.1 Chemical properties
The albumin molecule is the most anionic of the major
271plasma protein with a net charge of -19 at pH 7.4 . This
high charge is due to an excess of carboxylic acids which
is unequally balanced by lower levels of other amino acids,
e.g. glycine, alanine, lysine, histidine and especially
tryptophan. It has 102 carboxyl groups (pK 4.1), 15
imidazoles (pK 6.3), 1 a-amino group (pK 7.8), 56 e-amino
groups (pK 9.5), 17 phenolic groups (pK 10.2) and 23 guanidines
(pK > 12). All the imidazole groups are accessible to
hydrogen or hydroxyl ions in the pH range 2-12. About 50%
of the carboxyls can be titrated in the normal (N) form
8 6with an intrinsic pK of about 4.3 .
Spectral perturbation by bulky solvent
molecules shows that 5-6 of the 17 tyrosine residues appear
121to lie at the surface at pH 7 . The single tryptophan
in HSA and one of the surface tyrosines are located in an
193exposed location near the single sulphydryl group
14
Numerous values for the isoelectric point of 
albumin, containing 2-3 moles of fatty acids are reported,
microheterogenous population of protein impurities, mixed 
disulphides, bound ligands, polymers, possible configurational 
and isomeric species, possible 'molecular ageing1 and rare
a-globulins and enzymes (such as an esterase which migrates 
slightly ahead of albumin). Mixed disulphides are formed 
from the reaction of albumins with the free sulphydryl 
group at cys-34 (mercaptalbumins) with cystine or cysteine
os found in higher- oxidation states such as sulphonic acii1?^  
Bound ligands are bilirubin, fatty acids, and 
can include nearly the whole range of pharmacopeia such 
as salicylates, sulphonamides, barbiturates, aureoraycdn., 
penicillins and Warfarin.
'Molecular ageing' can be due to modification of 
amino acid residues without breakage of peptide bonds, 
such as acetylation of e-amino group by aspirin, or major
128 75such as ple 4.7 and ple 4.87 . The ple of albumin
75 1 2 fidevoid of fatty acids and other warts are 5.6 and 5.2
1.4.2 Heterogeneity of serum albumin
Isolated albumin is usually contaminated by a
209genetic variants . Even the composition of purified HSA
244preparations can contain 0.03% N-acetylhexosamine ,
0.02% trace metals170 and 0.8% fatty acids107 which,
58with vigorous defatting,can be decreased to 0.004% .
Common protein impurities in crude preparations are
Wt 14
lb
conformational changes . Dimerisation increases with
8 2storage and fresh preparations contain about 5% dimers .
Albumin isomers are a well-known source of
210heterogeneity. Peterson and Foster exploited their
solubility differences to separate the F- and N-forms.
The low-solubility of the F-and high solubility of the
N-form at decreasing pH (5-3) is the main criterion of
84the solubility test of Foster . A tertiary configurational 
change can be produced by 3-5 M urea involving either 
electrostatic or hydrogen bonds1
1.5 BINDING SITES ON ALBUMIN
1.5.1 Introduction
313
All the domains are dissimilar in hydrophobicity, 
net charge, ligand binding sites, and are functionally 
specialised.
The sites to which the multitude of substances
2 09known to bind to albumin can be classified as :
(A) Hydrophobic, non-covalent sites for
(i) primary long chain fatty acids,
(ii) bilirubin and certain drugs,
(iii) indole and certain other drugs.
(B) Covalent attachment for organic ligands
including the thiol group.
(C) Chelation sites for divalent metals.
Fig. 1.7 shows the principle ligand binding sites on
albumin.
16
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Fig. 1.7 Principle ligand binding sites on HSA.
Albumin is said to have allosteric properties
where the assembly of 9 semi-autonomous loops can transmit
information of conformational changes induced by binding
of some ligands from one site of the molecule to discrete
97parts of the polypeptide chain
1.5.2 The binding of bilirubin
1.5.2.1 Introduction
Albumin carries this breakdown product of haem 
to the liver for subsequent excretion. Failure in this 
secretory process can lead to uptake in the basal ganglia 
of the brain in jaundiced babies leading to kernicterus. 
The resulting neurotoxicity can lead to hearing loss, 
motor retardation and in extreme cases, death.
1.5.2.2 Binding Sites and Affinities
The studies of Beaven20 and Jacobsen133 on the
17
number of bilirubin binding sites and binding affinities 
are conflicting.
20Beaven showed that three binding sites exist 
at low ionic strengths but at high ionic strengths, there 
are only two binding sites. The dissociation constants
- 7(kD) at low ionic strengths are 1.4-2 x 10 M, 3.3-10 x
10-6 M, and 3.3 x 10-5 M.
133Jacobsen's model has one site of high affinity
— 9 — f(kD = 7 x 10 M) and two of lower affinities (kD = 2 x 10 M)
1.5.2.3 Location of Binding Sites
The location of the high affinity site is on loop 4
(residues 1 2 4 - 2 9 7 ) and the second site is on residues
102 129 446-547 . However, Hutchinson and Mutopo used
photoactivated covalent binding of [3H]-bilirubin to
locate the binding site and their results showed that the
majority of the label (62%) were in residues 1-24 and the
127remainder on residues 125-297. Hsia found that the
three bilirubin binding sites are specific, stereospecific
and allosteric. Binding to the primary site altered the
stereospecificity of at least one of the secondary sites.
2 26Using chemical modification methods Roosdorp
showed that the primary bilirubin site contains a vital
lysine residue but an earlier study implied that arginine,
histidine and tyrosine were involved in binding at different 
132sites on albumin
When bilirubin and BSA react, two first order 
configurational changes take place after a primary complex 
is formed in a fast bimolecular step. A dynamic 
equilibrium is then set up between the primary, secondary
xa
14 8and possibly, the final product . About 20-25 protons
dissociate from bilirubin between pH 6 and 9 in this 
134xnteraction , which has effectual similarities to that 
of temperature and calcium concentration on albumin"^
Biliverdin lX-a only binding at the primary site 
of HSA (kA = 1 . 3 + 2 x 1 0 6 M 1, defatted albumin;
1.3 + 3 x 10  ^M *, pooled adult sera)^.
1.5.2.4 Influence of Other Ligands
The binding of bilirubin is indifferent to the 
binding of nonesterified fatty acids even when 4-6 moles 
of fatty acids are bound per mole albumin to sites other 
than the bilirubin binding site1^. Bile salts, hematin, 
sulphonamides, acetamides, salicylates, pyridoxal 5-phosphate,
warfarin and numerous azo dyes compete for and decrease
204the effective binding capacity of bilirubin . In an 
interspecies test, hematin was found to bind only to 
human and monkey albumin^1, probably by attachment to 
histidine residues1^7. The binding affinities to its 
specific sites on HSA were increased by addition of two moles
laurate (C.^ ) Per m°le albumin, possibly by heterotropic
t . •*. 43 cooperatlvity
1.5.3 Binding of fatty acids
1.5.3.1 Introduction
Serum albumin serves as a sequestor of mainly 
unsaturated Cl6 and C1g free fatty acids (FFA) such as 
oleate, stearate, linoleate, archidonate (C2Q) and 
palmitoleic in the circulation This increases the
concentration of fatty acids near the cell surface thus
facilitating uptake by the cells. Under most conditions,
the plasma FFA is only 2-4% of the total fatty acids
present. These are then absorbed by adipose tissue for
storage as triglycerides or released during shortage in 
120the circulation . The average half-life of a plasma
• 9 2FFA is only 1-2 mins, and they have a high turnover rate .
Albumin can bind noncovalently up to 2 moles
of FFA without appreciably reducing its ability to bind
257a chemically different compound and their presence 
is essential to the stability of the tertiary structure128
Addition of fatty acid anions facilitate the realignment of 
the secondary structure during reoxidation of fully reduced
7albumin . Conformational changes which accompany the binding
of these anions are detected by spectral changes at
... 1962 9 5 nm
1.5.3.2 Binding Models
Hydrophobic pockets in the clefts between the
2 Sdomains can provide ideal binding sites for fatty acids
Each of the three domains could contain a structurally similar
site in addition to two to four sites located inbetween 
257two adjacent clefts . The group of localised basic
changes at the entrance to the cleft attracts the
carboxylate group of the fatty acid while its hydrocarbon
209shaft is corsetted into the hydrophobic pocket
Spector2*^  formulated a Scatchard model containing
three primary and three secondary sites while Goodman's 
107model had two primary and three secondary sites. In 
addition to these there are between 20 to 60 weak sites.
20
However, this Scatchard model does not accurately 
estimate the total number of binding sites and the binding 
constants obtained were non-specific. A new model based 
on Scatchard and equilibrium analysis showed that there
are six strong binding sites and about 30 weak sites in tests
. 2 S7using myristate (C14) and palmitate (Clg) .
1.5.3.3 Binding Affinities
The binding affinities of albumin decrease with
decrease of the fatty acid chain length1^7, that is,
14:0 < 16:0 < 18 : 1 .  Insertion of one eis-double
bond increases the strength of binding but insertion of a
second double bond decreases binding below that of the
2 5 6corresponding saturated fatty acid , presumably due 
to the stereochemical factor.
1.5.3.4 Binding Sites
The primary binding site for palmitate is in the
C-terminal domain loops 7-9 but chiefly near or in loop 7
( res. 377-582) 2^. Spector and Fletcher^"*7 suggested that
one or more of the stronger binding sites are located near
the hydrophobic cleft between the first and second
cylindrical domain. This deduction was based on the
259observation of Spector and John in that the tryptophan
fluorescence of both BSA and HSA were progressively
quenched when up to 5 moles of FFA are added. This could
be due to a conformational change in the geographical region
256of tryptophan produced by binding of FFA at remote sites 
The primary binding site for medium chain fatty 
acid is located between fragments (124-297) and (298-585).
The secondary binding site is in the same general region
21
as the primary site. Competition for binding of N-acetyl-L- 
tryptophan occurs at the primary site164.
1.5.4 Binding of metals
1.5.4.1 Introduction
Albumin acts as a scavenger of heavy metal ions 
and thus prevents them from damaging the mitochondria^66.
1.5.4.2 Copper and Nickel
The nonceruloplasmin Cu(II) and Ni(II) ions of 
plasma are bound at a highly specific site on the N-terminal 
tripeptide. In HSA, this is NH2-asp-ala-his. A tight chelate 
complex is formed by the first three nitrogen atoms of the 
peptide chain and one of the nitrogen atoms of his-3 to
create a square planar ring into which a Cu(II) ion can
2 o Sfit snugly and the larger Ni(II) ion more clumsily .
A square planar or square pyramidal co-ordination
geometry was detected about the Ni(II) ion. Its binding
affinities are less than for the Cu(II) ion and the log
(association constant) values for the binary and ternary
105complexes are 9.57 and 16.23 respectively
His-3 is the key amino acid since the albumin of
the pig and dog, which has a tyrosine in place of his-3,
does not complex Cu(II) or Ni(II) ions in this manner.
The identity of the first two amino acids are unimportant
for chelation as shown by bovine and rat albumin.
The secondary Cu(II) ion binds at the single
sylphydryl group to form a dimer analogous to the mercury
49dimer, albumin-S-Cu-S-albumin
12
1.5.4.3 Other Metals
Monovalent Ag(I) ions bind with high affinity 
but cannot cause dimer formation. The binding of metal 
ions other than Cu, Ni and Hg are of lower affinity, more 
electrostatic in nature, and react similarly as other 
proteins with metals^1. Binding of metal ions increases 
with pH and is minimal below the isoelectric point of albumin.
1.5.5 The binding of drugs and other ligands
1.5.5.1 Introduction
Drugs are an important and diverse group of
substances that bind to albumin. Although diverse in
chemical character, the tightly bound drug usually
contains a strongly electronegative centre or is an 
247organic acid . These are bound to HSA on strongly 
basic sites by electrostatic attractions.
The binding affinity of a drug is significantly 
influenced by the pharmacokinetics of the drug. When 
it is tightly bound (kA > 10^ M 1) to HSA, more than 95% 
of the drug will be concentrated in the blood and inter­
stitial fluid leading to an immediate decrease in
139pharmacological value of the drug However, in most
cases, competitive binding by other substances will displace 
250the bound drug . The therapeutic concentration of a
drug is such that the molar ratio of a drug:albumin
seldom exceeds 1. There is little or no competition
between FFA and other drugs for binding sites so long as the
.107FFA concentration remains below 1 mM The blood plasma
concentration of FFA is relatively low, between 0.3 
and 1.2 mM257.
Drugs are known to bind at specific pre-existing
sites of different specificity on the albumin molecule.
However, the versatility of albumin may also include
conformational induction to form specific sites. There
is evidence to support the mutual cooperative effects
between binding sites and the independent binding of
drugs, but it is difficult to distinguish between simple
9 7direct competition and cooperative effects .
1.5.5.2 Location of Binding Sites
The specific location of the binding site of a 
particular drug can be elucidated by affinity labelling, 
followed by enzymatic or chemical cleavage; and/or 
by the binding interaction (e.g. inhibition, or competitive 
displacement) between a variety of compounds. The majority 
of drug binding sites are located in loops 3 and 4 of the 
albumin molecule2 .^
Binding at specific sites or interaction with
a certain moiety on the albumin is exemplified below. In
most cases, basic residues inherent in the albumin sequence
interacts with the electronegative moiety in drugs.
Substitution of the strongly electronegative centre of the
drug or chemical modification of the basic residues on
44albumin results in loss of binding properties
Warfarin (1) binds at a single, high affinity, 
site (kA = 2.5 x lO'* M \  pH 7.4) at pH 6.9 and is higher 
in the basic conformation of albumin than the neutral.
The high affinity constant is increased by calcium ions
23
concentration of FFA is relatively low, between 0.3 
and 1.2 mM^^.
Drugs are known to bind at specific pre-existing
sites of different specificity on the albumin molecule.
However, the versatility of albumin may also include
conformational induction to form specific sites. There
is evidence to support the mutual cooperative effects
between binding sites and the independent binding of
drugs, but it is difficult to distinguish between simple
97direct competition and cooperative effects
1.5.5.2 Location of Binding Sites
The specific location of the binding site of a
particular drug can be elucidated by affinity labelling,
followed by enzymatic or chemical cleavage; and/or
by the binding interaction (e.g. inhibition, or competitive
displacement) between a variety of compounds. The majority
of drug binding sites are located in loops 3 and 4 of the 
24albumin molecule
Binding at specific sites or interaction with
a certain moiety on the albumin is exemplified below. In
most cases, basic residues inherent in the albumin sequence
interacts with the electronegative moiety in drugs.
Substitution of the strongly electronegative centre of the
drug or chemical modification of the basic residues on
4 4albumin results in loss of binding properties
Warfarin (1) binds at a single, high affinity, 
site (kA = 2.5 x 10"’ M pH 7.4) at pH 6.9 and is higher 
in the basic conformation of albumin than the neutral.
The high affinity constant is increased by calcium ions

25
pyridoxal 5'-phosphate (4) which forms a Schiff base'Xj
Q
with lys-223 of BSA ; 2,4-dinitrofluorobenzene (5)
and 2,4,6-trinitrobenzene sulphonate (6) link covalently 
to lys-222 of BSA282;
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cyclohexanedione is said to bind arg-145, arg-218 and 
248arg-222 in HSA and the highly electronegative atom
at C-7 of benzodiazepine binds at a vital arginine
. , 247residue
L-tryptophan binds exclusively to albumin. There
are one high affinity and two secondary sites on HSA and 
2 4 9BSA and binding is not influenced by non-esterified fatty
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Binding of albumin to prostaglandin H2, the 
endoperoxidase intermediate of prostaglandin syntheses168
has been implicated in the inhibition of prostaglandin
(8-anilinonaphthalene-l-sulphonate) ( 11) binds at 5 sites
appear to be on residues 1-386. N-acetyl-L-tryptophan
1.5.6.1 Introduction
The binding of dyes to albumin is used in physio- 
chemical, medical and analytical techniques. Dye binding 
induces configurational changes and they can protect the 
albumin molecule against enzymatic hydrolysis and 
dénaturation1^8.
232biosyntheses in vitro
Dodecyl sulphate binds at 8-9 sites with an 
average kA of 1.2 x lO^ *-881 and the fluorescent probe ANS
294in the hydrophobic regions of albumin . The sites
I -A N IU N O N A P T H A L E N E -8 -  
S U L P H O N A T E
9 8competitively displaces one of the bound ANS molecules
1.5.6 The binding of dyes
The tetrabromo-derivatives, bromocresol green 
(16), bromophenol blue86 (13), bromosulphonaphthalein16
225
28
and phenol sulphonaphthalein (Phenol Red)224, bind with an
average affinity constant of about 10nf.' The other
naphthalene sulphonates, e.g. Congo Red (3^ 8), Tryphan Blue,
Evan Blue and azobenzoates (e.g. Methyl Red) are tightly
bound"*2. Schneider24'*’ showed that the rate of access to
the organic ligand site is entropy controlled.
1.5.6.2 Dyes used in Estimation of Albumin
The three most commonly used dyes in albumin
1 9 1assay are HABA [(2-4'-hydroxyazobenzene)benzoic acid]
(15), methyl orange142 and bromocresol green70 (16).
14 2Since methyl orange gives dubious results in nephritis , 
and the binding of HABA is temperature-sensitive and 
affected by bilirubin and certain other drugs (e.g. 
heparin, salicylates), bromocresol green is now used in 
clinical estimations of albumin.
29 6Bromocresol green also binds to a- and 6-globulins 
and in BSA the binding of numerous dye molecules is shown to be 
loose with only a few specific binding sites. The binding 
of the numerous dye molecules is proportional to the size 
of fragment as shown on Fig. 1.8.
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Fig. 1.8
Binding of bromocresol green 
to isolated fragments of BSA 
(figures are percent of colour 
change observed with an 
equimolar amount of BSA)206.
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and phenol sulphonaphthalein (Phenol Red)224, bind with an 
average affinity constant of about 10nu' The other 
naphthalene sulphonates, e.g. Congo Red (Hi), Tryphan Blue, 
Evan Blue and azobenzoates (e.g. Methyl Red) are tightly 
bound^2. Schneider241 showed that the rate of access to 
the organic ligand site is entropy controlled.
1.5.6.2 Dyes used in Estimation of Albumin
The three most commonly used dyes in albumin
I Q Iassay are HABA [(2-4'-hydroxyazobenzene)benzoic acid]
(15), methyl orange142 and bromocresol green‘d  (1^ 6).
. 142Since methyl orange gives dubious results in nephritis ,
and the binding of HABA is temperature-sensitive and
affected by bilirubin and certain other drugs (e.g.
heparin, salicylates), bromocresol green is now used in
clinical estimations of albumin.
m e t h y l  o r a n g e
(12)
Bromocresol green also binds to a- and ß-globulins296
and in BSA the binding of numerous dye molecules is shown to be 
loose with only a few specific binding sites. The binding
of the numerous dye molecules 
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Binding of bromocresol green 
to isolated fragments of BSA 
(figures are percent of colour 
change observed with an 
equimolar amount of BSA)206.
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albumin, in between 6-30 seconds. Globulins are only bound
from 10 to 15 mins. Also, since this albumin-dye complex
absorbs at 615 nm, interference by bilirubin and haemoglobin
can be avoided.
222Rice used ANS (^ 1) to determine albumin 
concentration since the fluorescence obtained is highly 
specific and sensitive.
1.5.7 The binding of antigen
1.5.7.1 Introduction
Antigenic sites on albumin are binding loci 
whereby the antibody is regarded as the macromolecule 
and albumin as the ligand.
1.5.7.2 Characterisation of Jthe Antigenic Site 
Characterisation of the antigenic binding site usually
involves the isolation of intact antigenic site on fragments 
cleaved by enzymatic or chemical scissors. The ensuing 
detection may be by combining the fragment to the 
antibody and therefore preventing it reacting with its 
normal antigen. However, because of the heterogenous 
population of antibodies produced by immunisation and the 
multitude of different binding sites on the antigen, the 
fragment will bind the antibodies specific for the site 
it represents, but the rest of the antibody directed 
against other sites, will still be able to form a precipitate.
For use in analytical estimations, Gustafsson112
that bromocresol green binds almost instantaneously to
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1.5.7.3 Binding Sites
Horse albumin has 8 antigenic sites and the molar
ratio of albumin to antibody is 4. There are 2 binding
sites on each IgG molecule11 .^ Lapresle1 ®^ showed that
in HSA there are at least three different antigenic
determinants. This result was obtained in fragments cleaved
by cathepsin at pH 3.5, pepsin pH 1.4, and chymotrypsin at
27pH 4.5. Loop 9 of HSA has two strong binding sites in the 
208C-terminal region
Double immunodiffusion of bovine albumin and its 
various fragments against rabbit anti-albumin showed a 
progressive loss of determinants in fragments of decreasing 
size obtained from either the N- or C-terminal ends. The
two halves of bovine albumin can recombine to regenerate 
27a complete antigen
1.5.7.4 Specificity of Binding
The specificity of the antigenic site on albumin
is a subiect for debate. Lapresle1 ^ '1^  found the
antigenic sitesto be specific and distinct. On the contrary,
Atassi1  ^ and Habeeb11’’ found homologous, repeating
antigenic sites. A recent report by Doyen^1 appears as
a compromise. Cross reactivity between antigenic sites
are found such that an antibody specific for an antigenic
site can cross-react with a site on another part of the
46molecule. Since albumin contains 18% homology , a certain 
degree of duplication can be expected. The specificity of 
the isolated antibodies were shown to react with the 
fragment used for their isolation (homologous) but also 
with other fragments (heterologous). However,a relatively 
high concentration of antibody was needed to cross-react
31
with heterologous antigenic sites. This is in agreement
209with predictions of Peters and Reed
Carboxylate groups are essential at the antigenic 
site of albumin. Mild esterification inhibits the precipi­
tation of albumin with specific antisera but esterified 
albumin can still form soluble antigen-antibody complex
so that at least one site may not include a carboxylate 
262s^roup
1.6 ALLOALBUMINEMIA
1.6.1 Introduction
Alloalbuminemia can be defined as the rare 
occurrence of either two forms of albumin (bisalbuminemia), 
or one variant form of albumin, in the serum. In 
bisalbuminemia, the mobility of the variant albumin on 
electrophoresis is either slightly advanced or retarded 
with respect to the normal allotype. Single variant 
albumins are usually difficult to detect unless a 
comparative parallel run with the normal allotype is made 
on electrophoresis. This difference in mobility of 
allotypes is attributed to the difference in total charges of 
the albumin molecule.
Bisalbuminemia (synonyms: paraalbuminemia, 
alloalbuminemia, dialbuminemia, isoalbuminemia, double- 
and split-albuminemia) can be classified into two categories.
I Congenital hereditary bisalbuminemia
(i) Structural bisalbuminemia arising from
32
point mutation(s) in the primary amino 
acid sequence.
(ii) Albumin dimers arising from noncovalent 
and/or disulphide interactions between 
two structurally similar albumins.
II Non-hereditary transient bisalbuminemia 
Arising from attachment of small organic 
ligands to normal albumin or as a consequence 
of pancreatic disease.
1.6.2 Congenital hereditary bisalbuminemia
The occurrence of double albumin bands is a
congenital condition, transmitted by heterozygotic
individuals, whereas in the case of a homozygotic carrier
only the variant allotype is represented. This genetic
transmission is by a non-sex linked, autosomal, codominant
mechanism where the phenotypic expressions of both alleles are
equal. The quantitative ratio of the normal:variant
albumin and the sex ratio of the affected individuals
are nearly always near equality and these characteristics
support the codominancy theory of the albumin gene.
The gene symbol for the normal albumin, albumin A 
A Nor (A1) is Al (accepted notation) = A1 , the slow allotype
S F(A2, B) is Al and the fast allotypes is Al . Therefore,
A Sheterozygotes for the slow and fast variants are Al /Al 
and AlA/AlF and homozygotes are A1S/A1S and AlF/AlF 
respectively. Heterozygotes for two different variants 
have never been reported.
Variants are named for ethnic, geographical, 
or laboratory origin, their gene symbols being abbreviations 
of their names. Exceptions to this rule are albumin B, 
reserved for the most common allotype found in Europeans 
initially detected by Earle^, and several Italian cases 
named for the location of the laboratory and place of 
origin of the proband, using Italian car number plates 
for their gene symbol.
1.6.2.1 Mechanisms of Mutation
The variant albumin arises from mis-sense point 
mutations where one or several amino acids are substituted 
at given sites in the primary amino acid sequence of 
albumin. The substitution may be a transition (pyrimidine- 
pyrimidine or purine-purine substitution) formed as a 
result of inversion of a particular cistron segment, or a
transversion (purine-pyrimidine substitution) in the
„„.263DNA
An example of a transition (guanine to adenine 
substitution) is the replacement of glutamic acid -570 
(coded by GAA or GAG) by lysine (coded by AAA, AAG) in 
albumin B10 .^ Another example of a transition (guanine 
to adenine substitution) is Proalbumin Lille1 where 
arginine (CGU, CGC, CGA, CGC) is replaced by histidine
99(CAU, CAC). The unnamed variant of Gentou and Plazonnet 
exemplifies both transition and transversion substitutions. 
In this case, lysine (AAA, AAG) replaces glutamic acid 
(GAA, GAG) in a transition and alanine (GCU, GCC, GCA,
GCG) replaces proline (CCU, CCC, CCA and CCG) in a 
transversion. Most of the determined amino acid mutations
34
in albumin variants, except for Albumin Naskapi (Section
1.6.2.9.3), are unaffected by the revised HSA primary
72sequence of Dugaiczyk (Fig. 1.3).
1.6.2.2 The Albumin Gene
237The albumin locus is highly variable in man , where
197it can produce a line of allotypes and is extremely close
124to the Gc locus [Hirschfield's group specific
a-glycoproteins with phenotypes Gc 1-1, Gc 2-2 and Gc 1-2
140on the same autosomal chromosome , with a map distance
of 1.5% between them. The linkage probability was calculated 
251by Smith to be 0.9788. The close proximity of these two 
loci are borne out by the recombination values for a 
number of affected families bearing different albumin 
variants.
Lau et a^.1^0 showed group specific segregation
of Albumins B and Gainsville with Gc-2 and that albumin
Naskapi frequently segregates with Gc -1 but rarely with
Gc 2-2 Some strongly cathodic variants occur with all
297three common Gc phenotypes
1.6.2.3 Alloalbuminemia in Man and other Animals 
1.6.2.3.1 Animals
The autosomal and codominant character of 
the albumin alleles can be demonstrated by controlled
genetic studies in animals, especially hybrids. These
F Sstudies show that three phenotypes of Al and A1 are
F Spossible, that is the heterozygote is Al /Al and
,  ^ A1F /AlF j a1S /a1S 37,179,268homozygotes are Al /Al and Al /Al '
In horses and sheep , the three
dominant alleles are A, B and C. Tne appropriate cross-
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progeny produce the predicted homozygous (AA, BB, and CC) 
and heterozygous (AB, AC, BC) phenotypes.
The 0 alleles control highly diminished albumin 
production so that pigs with phenotype 00 are analbuminémie 
and phenotypes AO and BO have only half the normal albumin 
levels150. Albumin polymorphism also occurs in some 
breeds of cattle253, horses62, and toads114.
1.6.2.3.2 Man
In man, the first observation of double albumin 
240bands was by dcheurlen in the serum of a Swiss-German
diabetic patient. However, it was later that the hereditary
aspect of hétérozygotie alloalbuminemia was observed by 
189 147Nennstiel and Becht and Knedel , who coined the term
'double-albuminemia' and designated the two albumins 'A.1
7 3and 'A2'. Simultaneously, Earle found a similar albumin
anomaly, which he termed 'A' and 'B', in 25 individuals
of a pedigree of 58 persons. Dimeric variants were first 
91reported by Fraser . These initial reports of a rare
and unusual anomaly generated much medical interest
because of the extreme rarity of these genotypes in
Caucasians. However, this general opinion was to change
by the exposure of a polymorphic variant, Albumin Naskapi,
182by Melartin and Blumberg in 1966, amongst the Algonkian- 
speaking people of North America. This variant is yet 
to be found in Caucasians, Negroes or South American 
tribes. From this and other studies, alloalbuminemia 
appears to be more interesting anthropologically rather 
than medically.
Another medical expectation was the extreme
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lethality of the homozygous gene (e.g. AlNa/AlNa) and
a double dose of this rare gene was expected to result in
2dire clinical consequences. Adams expected it to occur
as a result of consanguineous union. On the contrary,
all if not most homozygotes are healthy.
1.6.2.4 Hypotheses on Alloalbuminemia
Since alloalbuminemia is not associated with any
apparent diseases or symptoms, one wonders why nature
has safeguarded the survival of this gene. Could it also
be possible that the aberrant albumin is evidence of an
evolutionary progression of a protein that is redefining
its properties in an increasingly chemical world? For
instance, several named variants have binding properties
distinguishable from the normal allotype and mutation
rates are high in culturally isolated societies that are
adjusting to the modern world.
8 8In 1967 Franglen suggested that two albumins
are present in normal individuals and both are electro-
phoretically similar. However, in bisalbuminemia, an
aberrant albumin leads to the formation of an electro-
phoretically different variant. On a similar theme,
Gitlin and Gitlin1^1 suggested that 'normal' albumin
is actually polymorphic. In this case the aberrant
'normal' albumin has substitutions between neutral amino
2 8acids. Bergstand and Czar suggested that slow albumin
was due to continue production of a normal foetal protein
(a-feto protein?), and these are limited by the maternal 
108immune system , but this suggestion was shown to be 
unlikely due to an increasing understanding of the subject.
Evidence to support these postulates is the
abnormal binding of thyroxine by A1 A in a bisalbuminanemic 
23 6patient . However, it can be argued that thyroxine is
not an obligate ligand and is bound to albumin in times
of saturation in the plasma. Yamamoto315 obtained almost
equal binding (17.0 + 31.5 pg T^/g albumin) of both
normal and slow variants.
Mutations in albumin have been found to occur
especially frequently in Amerindian population and indeed 
18 7Neel estimated the mutation rates of South American 
Indian tribes to be eight times that assumed for other 
populations as attested by their high rates of chromosome 
breakage, mercury intolerance and high susceptibility to 
diseases.
The design of a new variant albumin may be to
decrease its binding capacity for their culturally
accepted but harmful drugs, e.g. hallucinogens and
narcotics (these drugs may be mutagens) and to increase
its adaptability to withstand modern day diseases,
chemicals and so ensure their survival and reproducibility.
1.6.2.5 Methods of Classification
The majority of albumin variants are detected in
hospitals and by the multi-disciplinary protein-typing of
certain racial groups or tribes by electrophoretic
procedures. However, electrophoretic procedures cannot
detect all protein variants at the amino acid level.
The number of alleles undetectable by electrophoresis is
246calculated to be proportional to population size 
The pH of electrophoresis is important. Although most
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routine hospital electrophoresis is at about pH 8.6, 
fast variants are more clearly resolved at pH 5.4242 
and identical allormorphs to albumin A either cannot or are 
extremely difficult to detect by simple conventional 
electrophoresis, but not by peptide mapping.
1.6.2.5.1 Standard Method of Classification
There are two standard methods of classifica­
tion .
297I Vertical starch gels system of Weitkamp
The buffer systems are acetate-EDTA (pH 5.0), 
tris-lithium-succinate-citrate (pH 6.0) and 
tris-EDTA-borate (pH 6.9). These pH values 
were chosen for maximum discrimination between 
slow and fast variants. The relative mobility 
of the variants are different over this pH 
range as shown on Table 1.1.
t a h l e  i.l  Relative mobility o f  25 "■monomeric" albumin 
v a r ia n t s  in  th r e e  s ta r c h  g e t  e le c t r o p h o r e t ic  s y s t e m s a
JJuJ’e r  s y s t e m
V a r ia n t p H  5 .0 p H  6 .0 p H  6 .9
1. R S I l •> 6
2 .  P o l l i b a u c r 1 -> 4
3 .  B d c m  1 2 1 4
4 .  U 3 3 1
5 .  K o m a 3 1 3
6 .  G a i n e s v i l l e 3 3 4
7 .  P a r i s  ( G o m b a k ) 4 3 5
8 K a s h m i r  ( A f g h a n i s t a n )  5 2 l
9 .  O i s u 6 4
10 .  S a n t a  A n a 7 4 3
II  s o  US 7 5 3
12 .  C a r t a g e 7 3 5
13 .  X a v a n t e S 6 7
14 .  P u s h t o o n S 4 6
15 .  C a v e m i t e 9 5 6
16 .  M e x i c o 9 4 5
17 .  U i n b a 9 6 7
18.  Y a n o m a m a - 2 1 0 6 6
N o r m a l  a l b u m i n 1 0 6 7
19 .  M e d a n 11 6 8
2 0 .  M a k u 12 7 1 0
2 1 .  N e w  G u i n e a  ( R e a d i n g )  13 9 9
2 2 .  M a k i r i t a r c - 3 13 8 9
2 3 .  N a s k a p i 14 10 1 0
2 4 .  G e n t 15 11 1 0
2 5 .  K y o t o 16 I I 10
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The variants with mobilities closest to normal 
albumin (no. 13-21) are found in non-European 
populations especially Indians. Wider 
separation is seen in European variants.
II
Actual reversals in mobility occur, for example, 
albumin Maku migrates faster than Naskapi in
the pH 5.0 system but not as far in the pH 6.9
. 301system
Test schedule by Tarnoky introduced at the 
Royal Berkshire Hospital^ 4
This involves tabulating the relative electro­
phoretic mobility of the variants on a 0-100 
scale (0 = cathodic trailing edge and 100 = 
leading edge of albumin A) by the electrophoretic 
following systems.
(i) Whatman 3 MM paper in barbitone buffer 
(pH 8.6, 0.05 M) .
(ii) Cellulose acetate (Shandon Celagram cellulose 
acetate strips) in barbitone oxoid buffer 
(pH 8.6, 0.1 M).
(iii) Helena Titan III zip zone cellulose acetate
plates in barbitone buffer (pH 8.8, 0.05 M).
277(iv) Disc-polyacrylamide (7%) in a discontinuous 
buffer system (pH 8.3 -*• 8.9 -*• 8.3).
(v) Agar (1%) in barbitone buffer (pH 8.6,
0.05 M)13°.
(vi) Agarose (1%) containing sucrose (5%) in 
barbitone buffer (pH 8.6, 0.065 M)
[Corning ACI electrophoresis system].
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The comparative ability of the variants to bind 
ligands were tested by incubating serum with the six 
dye solutions (approximately 250 yg/ml serum): bromophenol 
blue (13) , Ponceau S (14)/ 2,4-(hydroxyazobenzene)benzoic 
acid (HABA) (15)/ bromocresol green (16)/ bilirubin (17)/ and 
Congo Red (^ 8) at 37°C for 10 min. before electrophoresis 
on all six media. All except HABA were added to an excess 
of albumin.
b r o m o p h e n o l  b l u e
( 1 3 )%
( 2 - 4 ; H Y D R O X Y B E N Z E N E )B E N Z O IC  ACID
( 1 6 )'Sj
HOOC----CHj CH2— COOH
BILIRUBIN
CONGO RED
S O 3 N Q SO3NQ
1.6.2.5.2 Critique of Ligand Binding Methods
The binding of fatty acids and dyes to albumin 
A are described in Sections 1.5.3 and 1.5.6. In these tests 
the pre-existing and inherently-bound ligands are not 
leached out to ensure true quantification of these test 
ligands, for example, sera obtained from patients may 
have drugs already bound to them and these may bind at or 
block the binding of these test ligands. Sera also 
nearly always contain a proportion of bilirubin bound to 
albumin. This binding is tight with kD in the region 
of 7 x 10 9 M 133 (Section 1.5.2.2).
variants is well-used in proving non-identity of newly 
detected variants, this analysis is affected by the 
reversible binding of ligands during electrophoresis.
Although differential binding of ligands to albumin
During electrophoresis, ligands may remain bound to 
albumin because their binding affinities are greater than the 
field strength at the electrodes. After an interim period, 
ligands become detached because of their faster electrophoretic 
mobility and can migrate as a separate band. If quantification 
of a strongly anionic ligand were taken, the fast band of 
a fast variant and the normal band of a slow variant would 
appear to bind more ligands. This can be offset by finding 
the optimum length of electrophoresis in a stated field 
strength.
Reversible binding of bromophenol blue occurs 
during isoelectric focusing of this variant Albumin Munday.
The dye, added as a marker to follow the migration process, 
becomes detached when the albumins are focused and travel 
as one band to the anode.
Although not implying the same situation,
albumin A in numerous slow variants,such as Albumins Vellore
and Kashmir,bind more bromophenol blue than the slow 
122allotypes ; but the fast allotypes, e.g. Albumin Reading
279  ^ 278bind more bromophenol blue . Tarnoky proposed that, in 
general, fast variants bound more bromophenol blue than the 
slower variants but Wieme^07 showed that this observation 
can be dispelled by the inclusion of bromophenol blue into 
the electrophoretic media to compensate for its reversible 
binding during electrophoresis.
On the other hand, undefatted albumin ensures 
a stable tertiary structure. This outweighs the advantages 
of an unstable albumin molecule, depleted of stabilising 
fatty acid anions (Section 1.5.3.1), with possible deformed
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,275
binding sites. The IFCC criterion for standardisation
of albumin preparation is 1-2 moles of fatty acid per
mole of albumin with a polymer content of less than 1%'
Non-esterified fatty acids do not interfere with
bilirubin binding (as used in this classification) even
when a physiologically large number of fatty acids (4-6 moles)
132are bound to a mole of albumin
Even if dyes were to compete for fatty acid binding
only one or two of the high affinity sites are 'permanently'
occupied leaving the remaining high affinity and weak sites 
, 257available . The detection of differential binding of 
dyes used in standard quantification of albumin by variant 
albumins has led to their reassessment of their values.
1.6.2.6 Other Methods of Classification 
1.6.2.6.1 Binding of Ligands
I Panel of Ligands Cavalli-Sforza"^ devised
a method of screening serum or plasma for 
variants based on a panel of 63 radioactive 
ligands which include vitamins, hormones, 
drugs, amino acids, purine, pyrimidines, 
sugars and lipids. Binding was then deduced 
from PAGE-autoradiography.
131Binding of Thyroxine Binding of [ I]-thyroxine 
by variant albumins is mainly quantified by 
autoradiography or scintillation counting. 
Stability of Alloalbumin to
II
1 . 6 .2 .6 . 2  
I The sera is frozen toFreezing and Thawing1^
-20°C and rapidly thawed at 37°C ten times. Its 
electrophoretic mobility is then compared to the 
control sera.
* i ' I: -4 *<#: 1 5 I
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II High Temperature11 This involves heating sera
to 56°C for 30 min. and 2 hr. Schultz and 
243Hereman found an alloalbumin unstable to 
storage at room temperature. The slow Spanish 
variant, Albumin Luarca, appears to be dimeric 
rather than separate unique proteins since it 
merges into albumin A on freezing, thawing and 
storage at room temperature and the proportion of 
variant albumin is decreased by 9% (i.e. from 
44% to 35%)1^1. This might imply that this 
'slow' variant is formed by the increased binding 
of cations which are then detached by repeated 
freezing and thawing.
1.6.2.6.3 Molecular Weight
The monomeric or dimeric nature of variant can 
be easily elucidated by gradient-PAGE. This method supersedes 
ultracentrifugation methods.
1.6.2.6.4 Immunochemical Character
The immunochemical character of the variant 
albumin can be detected by its reaction against specific 
anti-albumin A and/or reaction of albumin A against specific 
anti-albumin variant. However, this has never been analysed 
employing the very sensitive, unique monoclonal antibodies.
Most varients are concluded to be immuno- 
chemically identical to albumin A because of several 
contributing features: the repetitive homology of the 
albumin molecule leading to numerous near identical binding 
sites (Section 1.5.7.4 ) ; secondly, the site and character 
of the mutant amino acid may not be involved or contribute
45
drastically to antigenic charcter and thirdly, binding 
at only a few sites may be sufficient to form the 
antibody-antigen precipitate. Even if the mutations were 
involved in antigenic specificity, the methods may be 
insufficiently sensitive to detect any microscopic 
differences in the variants, so that they appear to be 
immunochemically similar.
Albumin Chiari (BS/VR) was classed as immunochemically
similar to albumin A by the reaction of normal and variant
albumin against anti-normal albumin and anti-bisalbuminemia 
4antibodies .
223 172Robbin and Margni have, however, found
2 23inconclusive differences in antigenic specificity. Robbin 
reported two immunoprécipitation areas formed by cross­
reaction with diluted (1:30) variant sera. They attributed 
this to a second precipitation with excess antibodies 
without ruling out slight immunochemical differences with 
albumin A.
.172 .Margni immunised rabbits against separated
fractions (I and II) of the albumins. They found that
anti-albumin-I antibodies bound albumin-II, but anti-albumin-II
reacted with albumin-I bound albumin-II only slightly.
This phenomenon may be explained by a depletion of antigen
binding sites for albumin-II.
1.6.2.6.5 Isoelectric Point
Analytical isoelectric focusing could be useful
in the classification of variants but isoelectric points
are very rarely determined. Some of the objections include
8 5the possible binding of ampholytes carriers by albumin
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and even normal albumin has several published isoelectric 
points (Section 1.4.1 ). However, like any empirical study, 
the standardisation of this technique should enable precise 
comparisons to be made.
39Bradwelland Hornbeck used pH-gradient elution 
on the strongly anionic ion-exchanger, QAE Sephadex, to 
determine the isoelectric part of slow and fast albumins. 
However, reproducible pH elution profiles are very difficult 
to generate and some variants are sufficiently similar to 
albumin A to hinder separation, let alone to determine its 
isoelectric point.
1.6.2.6.6 Proportion of Normal to Variant Albumin
Most monomeric variants occur in a 1:1 ratio 
to normal albumin. Some reported exceptions are:
Name of Variant Normal:Variant Reference
Genoa /Catania 9:1 214
Cuneo/Belluno 8:2 289
RIH 6.4:3.6 56
Stirling 6.6 ^5.9:3.3 ->-4.1 67
Vancouver 3.5:6.5 93
B 6.2:3.8 66
Most dimers constitute less than half of the toal albumin, 
e.g. albumin Warao is 30% of total albumin11.
1.6.2.6.7 Mutation Point(s)
„ 274Tarnoky proposed that the mutation points 
will be the ultimate method of classification. The
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and even normal albumin has several published isoelectric 
points (Section 1.4.1 ). However, like any empirical study, 
the standardisation of this technique should enable precise 
comparisons to be made.
39Bradwell and Hornbeck used pH-gradient elution 
on the strongly anionic ion-exchanger, QAE Sephadex, to 
determine the isoelectric part of slow and fast albumins. 
However, reproducible pH elution profiles are very difficult 
to generate and some variants are sufficiently similar to 
albumin A to hinder separation, let alone to determine its 
isoelectric point.
1.6.2.6.6 Proportion of Normal to Variant Albumin
Most monomeric variants occur in a 1:1 ratio 
to normal albumin. Some reported exceptions are:
Name of Variant Normal:Variant Reference
Genoa /Catania 9:1 214
Cuneo/Belluno 8:2 289
RIH 6.4:3.6 56
Stirling 6.6 -*• 5.9:3.3 -*■ 4 .1 67
Vancouver 3.5:6.5 93
B 6.2:3.8 66
Most dimers constitute less than half of the toal albumin, 
e.g. albumin Warao is 30% of total albumin11.
1.6.2.6.7 Mutation Point(s)
_ 274Tarnoky proposed that the mutation points 
will be the ultimate method of classification. The
location of mutations of only a few variants have so far 
been determined.
1.6.2.7 The Population Distribution of Variants
Albumin variants discovered by mass investigations
or by hospital screenings have been categorised according
238to their gene frequencies and geographical distributions
279or according to population frequencies
However, this categorisation cannot be a true 
representation of the total occurrence of these rare 
variants because of the dependence on availability of 
resources such as equipment and finances. One need only 
compare the situations found in the well-developed 
Western World where facilities are readily available to 
that of selected mass-screening of small indigenous tribes 
and the limited screening in the poor Third World countries 
where financial priorities are given to more urgent needs 
for survival.
So far about 80 variants are named of which about 
28 types can be distinguished. The distribution of some 
known variants (Table 1.2) shows a fairly orderly 
distribution. These can be divided into three groups.
The first group are private variants restricted to one
299particular family, e.g. Albumin Cayemite . The second
group encompasses rare variants found in two or more vastly
279different ethnic cultures, e.g. Albumins Reading and 
304New Guinea , or are distributed widely regionally, e.g.
73 297albumin B ' . The last group are polymorphic variants
restricted only to the ethnic group or to some neighbouring
182 90groups, e.g. Albumins Naskapi and Mexico
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Table 1.2 The population distribution of some albumin 
alleles - Adapted from Weitkamp^03
Race Variant Population
Caucasoid Pollibauer 
B (SO/CZ)
Roma
Gainesville 
Paris (Gombak)
SO/BS
Cartoga
Reading (New Guinea)
Gent (MI/fast) 
"Dimer"
Negroid Cayemite 
Uinba
New Guinea (Reading) 
"Dimer"
Mongoloid Gombak (Paris)
Kashmir (Afghanistan)
Pushtoon
Mexico
Medan
Maku
Makiritare-3
Naskapi
Makiritare
Austrian descent (Holland)
Swiss, Norwegian, Danish, 
Swedish, German, English, 
Italian
Italian
English, Irish descent (USA)
French
Italian
Spanish (Costa Rica)
British, Greek, Swiss 
descent (USA)
Danish, Belgian, Italian
Welsh, Swedish
Negro (Haiti)
New Guinea, indigenes
New Guinea, indigenes
Negro (USA)
Indonesian
Pushtoon (Afghanistan)
Pushtoon (Afghanistan)
Indians of South Western 
USA and Mexico
Malayan aborogine
Yanomamo (Venezuela), 
Makiritare (Brazil)
Makiritare (Brazil)
North American Indian
Warao, Makiritare (Venezuela), 
Trio, Wajana (Surinam)
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Table 1.2 The population distribution of some albumin 
alleles - Adapted from Weitkamp-^ Uj
Race Variant Population
Caucasoid Pollibauer 
B (SO/CZ)
Roma
Gainesville 
Paris (Gombak)
SO/BS
Cartoga
Reading (New Guinea)
Gent (MI/fast) 
"Dimer"
Negroid Cayemite 
Uinba
New Guinea (Reading) 
"Dimer"
Mongoloid Gombak (Paris)
Kashmir (Afghanistan)
Pushtoon
Mexico
Medan
Maku
Makiritare-3
Naskapi
Makiritare
Austrian descent (Holland)
Swiss, Norwegian, Danish, 
Swedish, German, English, 
Italian
Italian
English, Irish descent (USA)
French
Italian
Spanish (Costa Rica)
British, Greek, Swiss 
descent (USA)
Danish, Belgian, Italian
Welsh, Swedish
Negro (Haiti)
New Guinea, indigenes
New Guinea, indigenes
Negro (USA)
Indonesian
Pushtoon (Afghanistan)
Pushtoon (Afghanistan)
Indians of South Western 
USA and Mexico
Malayan aborogine
Yanomamo (Venezuela), 
Makiritare (Brazil)
Makiritare (Brazil)
North American Indian
Warao, Makiritare (Venezuela), 
Trio, Wajana (Surinam)
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Race Variant Population
Yanomama Yanomano (Venezuela)
Unknown B Negroid extraction (USA)
Santa Ana Caucasoid or Mongoloid 
(Mexico)
Belem I 
Belem II 
Belem III
Trihybrid group of 
Caucasoid, Negroid and 
Mongoloid mixture (Brazil)
Albumin variants of Amerindian origin are
Albumins Naskapi, Mexico, Makiritare, Maku, Yanomama and
Makiritare (Warao). Another two variants, Santa Ana and Belem I,
303may be of Indian origin . The overall pattern shows poly­
morphism for albumin Naskapi in north North America (gene 
101
frequency 0.14 ), lower gene frequency for Albumin Mexico
183in south North America (gene frequency 0.03 ), and even
3 0 3lower gene frequency (0.014) for Albumin Makiritare (Warao)
It would be interesting to find the precise function of this
polymorphism although their finding might suggest a north
8 9 3 0 3to south migration from Asia '
The slow Albumin B (population frequency 1:
1,000-10,000) and fast Albumin Gent, are two of the most
303frequently found variants in Europeans . It is interesting
19 7that albumin B and its subtypes should be found so
frequently in Europeans of numerous diverse backgrounds
and it is difficult to imagine that it arose from a common
founder allele, or identical random mutation.
Some of the other variants in Europeans are
the only case of variant recorded in Poland (Gdansk),
186probably of Jewish origin an original, spontaneous
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mutation found in Austria , numerous cases in Italy and
their immigrants to USA217, about 14 Spanish130,131,161,104,2®®
and at least a dozen cases in Britain64'07'®7'202'270.
In Japan, the population frequency of
bisalbuminemia is higher (population frequency 1:400) in
Hiroshima and Nagasaki (mutations most probably catalysed
by radioactivity) compared to the general frequency of 1:6,000
of which about twenty-two cases are reported70,04'133,303.
Some variants found in the India subcontinent are
276 298AlbuminsKashmir (Afghanistan) and Pushtoon ' . Some
of these variants are described in the following sections 
and are subdivided into fast and slow monomeric variants 
and dimeric variants.
1.6.2.8 Slow Monomeric Albumins
1.6.2.8.1 Albumin B
Albumin B appears to be a broad classification
of the widely distributed variant found in Europeans with
297a population frequency of 1:1,000-10,000 . Heterozygotes
of this variant are found throughout Europe and their
migrants in Argentina and the USA30,73,160,312.
One of the earliest B albumins was found in
an American family of German descent and was named for
their surname ’Oliphant1. It was originally thought to
be a 'private' variant but was later found in 22 families,
and is an identical allomorph of Albumin Ann Arbor found
311in a family originating from Denmark and Albumin B
Albumin Gainesville, found in an American 
of Irish descent160 was classed as B' by Ott100. Its site 
of mutation is located between residues 1-122137.
125
Albumin Paris which migrates almost identically
1 9  9to the fast-moving albumin was subclassed as B" . A
homozygous albumin B, called Albumin B Schonaich, was
found in Stuttgart1 ®^.
About 25-30 slow type albumin B have been 
22 81discovered in France ' including a homozygote whose
174parents are relatives , two families in investigation of 
10,000 sera in England^, and one case in Norway^.
The majority of albumin B are found to be 
immunochemically identical to albumin A but a supposedly
structurally different albumin B was detected by immuno-
190precipitation but not by immunoelectrophoresis
The diminished anionic character of albumin B on
electrophoresis is due to replacement of glutamic acid-570
by basic lysine1^1' 1. Gitlin and Gitlin1 1^1 proposed that
since the C-terminal segment is unnecessary for the stability
of the tertiary structure, it is more vulnerable to mutation.
Study of the turnover rate and distribution of
131albumin A and B by in vitro labelling [ I]-normal and
125 29[ I]-slow albumins showed no significant differences
Albumin B had a similar affinity in bromophenol blue binding
but bound thyroxine more tightly than albumin A. Reversed
albumin A/globulin ratio was noticed on the slow variant of
Creason and Creason .
1.6.2.8.2 Albumins Kashmir and Afghanistan
Albumin Kashmir was originally found in a Moslem
277family living in London but originating from Kashmir 
Although it is one of many types of variants found in the 
Indian subcontinents, with a frequency of 1:500 among 1,500
Asian Indians, it has also been found in other populations
297in the Indo-Dravidian group . In studying bisalbuminemia 
J 94in Hawaian-Japanese it is argued that Indians are 
anthropologically classed as Caucasians and,therefore, this 
variant should not be qualified as a case of Asian albumin 
polymorphism.
This variant binds slightly more bromocresol
green (52%), has impaired binding of HABA, and binds more
bromophenol blue on filter paper (reversed on cellulose
277acetate) than albumin A
Albumin Afghanistan was found in 10 individuals 
of a 251 strong Pushtoon tribe that had originated from 
Afghanistan near Kashmir300. It is similar to Albumin 
Kashmir when tested by 3 pH starch gel systems of 
Weitkamp.
1.6.2.8.3 Albumin Mexico
The distribution of this polymorphic variant
is wide, from central Mexico (especially amongst the
Uto-Aztecan language group) to as far south as northern
Gautemala and the linguistically and culturally-related
Pima and the Papago and Zuni Indians of south western USA,
297who live contiguously to the Navajo and Apache . The 
Apache may have acquired this variant through raids in
254Pima and Spanish villages in the 17th and 18th Centuries
303It was also found in a trihybrid Brazilian population 
Both Albumin Naskapi and Mexico are found in the Navajo, 
Apache and Hopi in high frequencies. All homozygotes of 
these variants are healthy.
However, it has not been detected,so far,in
53
northern North American Indians, Eskimos, two Peruvian 
Indian tribes, Mayan, and a limited number of half castes.
Mexican sera which had been stored for five 
years in deep freeze migrated between albumins A and B on
1 O *5
electrophoresis at pH 8.6 . Two species of Albumin Mexico
named Albumin Mexico I and II, can be distinguished by 
comparisons of peptide maps.
The latter arise from at least a 550-glycine 
to aspartic acid substitution. This substitution of 
helix-indifferent aspartic acid by strong helix breaker,
glycine,in the a-helical region is sufficient to cause a gap
90of about 4 residues in the helix when predicted using the
59rules of Chou and Fasman . This mutation is also in
Domain III, the site of long chain fatty acid binding and
is also one of the primary binding sites for medium chain
fatty acids16  ^ (Section 1.5.3.4 ).
The variant binds haemoglobin and thyroxine 
181 308equally well but dyes and warfarin are bound less
readily than albumin A. The mean number of warfarin binding
sites per normal albumin molecule is 1.23 + 1.7 and the mean
association constant is 1.62 x 10^ M 1, but these values
are diminished to 1.40 + 0.18 and 1.26 x 10^ M 1 
A Merespectively in A1 /Al . The clinical implication of 
decreased binding is an increase in pharmacologically 
active free warfarin in the circulation leading to an 
altered pharmacological response.
1.6.2.8.4 Albumins Christchurch and Lille
Albumin Christchurch contains a propeptide sequence 
40,41of arg-gly-val-phe-arg-gln and Albumin Lille, arg-gly-
54
val-phe-his-arg1 instead of the normal human propeptide
72sequence arg-gly-val-phe-arg-arg
These circulating proalbumins are in the same 
proportion to albumin A and can be easily proven to be 
proalbumins by cleavage of the propeptide by mild tryptic 
treatment.
The existence of these circulating variant pro­
albumins gives an insight into the in vitro recognition 
factor in propeptide cleavage. Paired basic residues at 
the C-terminal of the propeptide appear to be a prerequisite 
for in vivo cleavage but the finding that the chicken propeptide 
only contains one arginine, but is nevertheless cleaved,
suggests instead the requirement of a non-specific tryptic- 
7 8like protease .
Impaired Cu(II)binding due to lack of high affinity
41binding site was found in Albumin Christchurch . A similar 
aspect in Albumin Lille, plus defective Ni(II)binding, can be 
expected in both variants (Section 1.5.4.2 ).
Albumin Christchurch binds stearate more strongly 
and myristate less strongly than albumin A. Both albumins 
bind palmitate, ANS and bromocresol green equally well.
When compared to control normal albumins, this variant and 
albumin A contain more myristate and sterate but less oleate 
and linoleate41.
1.6.2.8.5 Albumin Xavante
This variant, originally found in the Xavante 
Indians of the Brazilian Mato Grasso, is one of four (besides 
Yanomama, Yanomama-2 and Makiritare-3) variants so far found 
exclusively in American Indians'^2.
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val-phe-his-arg1 instead of the normal human propeptide
72sequence arg-gly-val-phe-arg-arg
These circulating proalbumins are in the same 
proportion to albumin A and can be easily proven to be 
proalbumins by cleavage of the propeptide by mild tryptic 
treatment.
The existence of these circulating variant pro­
albumins gives an insight into the in vitro recognition 
factor in propeptide cleavage. Paired basic residues at 
the C-terminal of the propeptide appear to be a prerequisite 
for in vivo cleavage but the finding that the chicken propeptide 
only contains one arginine, but is nevertheless cleaved, 
suggests instead the requirement of a non-specific tryptic- 
like protease^®.
Impaired Cu(II)binding due to lack of high affinity
41binding site was found in Albumin Christchurch . A similar 
aspect in Albumin Lille, plus defective Ni(II)binding, can be 
expected in both variants (Section 1.5.4.2 ).
Albumin Christchurch binds stearate more strongly 
and myristate less strongly than albumin A. Both albumins 
bind palmitate, ANS and bromocresol green equally well.
When compared to control normal albumins, this variant and 
albumin A contain more myristate and sterate but less oleate 
and linoleate41.
1.6.2.8.5 Albumin Xavante
This variant, originally found in the Xavante 
Indians of the Brazilian Mato Grasso, is one of four (besides 
Yanomama, Yanomama-2 and Makiritare-3) variants so far found 
exclusively in American Indians2 *^2.
The electrophoretic mobility of Xavante and Albumin 
Uinba are indistinguishable from normal albumin the pH 6.0 
and 6.9 buffer systems but can be identified from Albumin 
Pushtoon in the latter system.
1.6.2.8.6 Albumin Yanomama-2
This polymorphic variant was found in 47
individuals from three Yanomama villages in northern Brazil,
272which included one homozygote
Its electrophoretic mobility is similar to albumin A
in?at pH 5.0 and 6.0 but is only slightly different at pH 6.9
„ 303and is distinguishable from Albumin Maku
1.6.2.8.7 Albumin RS-1
This comes from East African and is Indo-European in
origin. It is similar to SO/BS on electrophoretic cellulose 
216acetate at pH 9.25 ; however they can be discriminated on
pH 5.0 and 6.0 starch gel systems. Unfortunately in this 
system, it is similar to albumin Pollibauer but can be
shown to be different in the pH 6.9 system where it is
302slightly faster
1.6.2.8.8 AlbuminsGombak and Paris
166Both albumins, originating from Malaysia and
303France are similar and are unstable in that they will 
merge into albumin A on prolonged storage. This may be 
because this variant is actually albumin A with charged 
ligands bound to it and these become detached during 
freezing.
1.6.2.8.9 Albumin Adana 
So far, this variant is found to be restricted
to the district of Adana in South Eastern Turkey, unlike 
Albumin Mersin which is frequently found amongst the
56
Eti Turks living in the same region. The reason may be 
that these two groups of Eti Turks are ethnically distinct 
and these albumin variants arise from inbreeding or genetic 
drift within local communities.
Albumin Adana can be distinguished from
albumin B by PAGE and the site of mutation is located
89between residues 549 and 585 .
1.6.2.8.10 Albumin Cayemite
This variant was found in a Negro mother and
son as a result of investigations in Savannah/Georgia USA
and Grand Cayemite Island/Haiti. Although two distinct
bands are manifested in all three pH systems, the best
299resolution was in acid pH
1.6.2.8.11 Albumin Cartoga
Eighteen individuals out of 1,400 sera in 
Cartoga/Costa Rica carried this anomaly. At pH 8.6, its 
electrophoretic mobility was similar to Albumin Santa Ana 
and inbetween Albumins Mexico and Gainesville. At acid pH 
(5.0 and 5.4) it is similar to Albumins Uinba, Mexico,
Cayemite and
1.6.2.8.12 Albumin Santa Ana
This variant was found in a Mexican family living in
California and is suspected to be Indian in origin. At
pH 5 and 6, its electrophoretic mobility is alike
152Albumins Cayemite and B but not Albumin Mexico
1.6.2.8.13 Albumin Pushtoon
This variant with a gene frequency of 1-2% 
was found during a multidisciplinary study in a Pushtoon 
village which had migrated from a region in Afghanistan.
It is separable from normal albumin on electrophoresis using the 
three pH systems, pH 5.0, 6.0 and 6.9 but not at pH 8.6300.
1.6.2.9 Fast Monomeric Albumins
1.6.2.9.1 Albumin Reading and New Guinea
Albumin Reading, of Welsh ancestry, was found
279in a 75 year old male and his two female near relatives
Like most fast variants, electrophoretic separation was
24?better at pH 5.4 than pH 8.6 . It is identical to
Albumin New Guinea which is found in a totally different and
separate population, in the pH 5.0 and 6.0 gel buffer system 
297of Weitkamp
The authors found that bromophenol blue bound 
only to Albumin Reading but not albumin A. Binding to the 
latter was achieved only at the same level at which globulins 
were also stained. Another dye, ANS (11) travelled with 
albumin on filter paper but on cellulose acetate electrophoresis 
the dye became detached probably due to differential affinities 
for the media. Albumin A bound more thyroxine than 
Albumin Reading.
Albumin New Guinea was found in about thirty
169 178 299individuals in New Guinea and surrounding island ' '
302Weitkamp quotes the gene frequency as 0.017.
1.6.2.9.2 Albumin Gent
This variant, previously named Albumin Fast or
Albumin Very Fast( was found in a family of seven. A
367further 17 individuals were later found
Similar to most fast variants, bromophenol blue
was bound with much higher affinity.
1.6.2.9.3 Albumins Naskapi and Mersin
182This variant is one of the three polymorphic 
variants, besides Albumins Mexico and Makiritare, to be 
of Amerindian origin.
The dispersion of this variant is from the 
Canadian and North American Indians [Naskapi, Montagnais, 
Sioux, Athabascan (Navajo, Apache) and Shoshonean (Hopi)] 
to Eskimos from Alaska and Labrador. Indians from the 
middle and south USA, South Americans nor Africans,
Asians, Oceonics and Caucasians have yet to be found with 
this variant. The discovery of this variant in so many 
tribes have proven anthropological links, for example, 
between the English-speaking, Anglican Naskapis and the 
French-speaking, Roman Catholic Montagnais, both of whom 
are Algonkian-speaking tribes. One plausible explanation 
for its polymorphism is inbreeding through several generations
The genetic distribution of Albumin Naskapi on 
Table 1.3 shows the heterozygotic frequency to be 8.48% and 
the homozygous frequency as 0.36%.
This variant segretates genetically with Gc-1 
140phenotypes and the site of mutation is located between 8
8 9residues 330 and 446 . This is on the B-turns of albumin
(Fig. 1.4) of Domain II, in between the high affinity binding 
sites of bilirubin (Section 1.5.2.3 ) and on one of
164secondary binding sites for medium chain fatty acids 
It is not known if bindingsof these ligands are impaired.
An identical allomorph is albumin Mersin found 
in high frequency amonst the Eti Turks of south eastern 
Turkey. The heterozygote frequency is 8.8% in Mersin
TABLE 1.3 The genetic distribution of albumin Naskapi
Tribe Number AlNa/Na AiA/Na AlA/A
Naskapi (Canada) 203 1 54 148
Montagnais (Canada) 128 2 19 207
Sioux (N. America) 160 0 2 158
Athabashan (USA & Canada) 230 1 11 218
Eskimos (Labrador) 124 0 3 121
Eskimos (Canada & USA) 262 0 4 258
Total 1,107 4 93 1,010
% of Total 100 0.36 8.48 91.23
Adapted from Blumberg .
and 9.7% in Tarsus. This discovery of its similarities to 
albumin Naskapi is anthropologically interesting because 
it strongly suggests the ancestry of these Indians to be
89from Mongoloid populations in Central and/or Eastern Asia
181Albumin Naskapi binds more bromophenol blue 
34and thyroxine more tighly than albumin A. Both albumins
55bind linolenic acid, linoleic acid and haemoglobin 
181equally well . Only albumin A binds riboflavin and 
warfarin55. Reaction of penicillin with heterozygous 
Albumin Naskapi produces four bands15.
1.6.2.9.4 Albumin Maku
This widely distributed variant is found in 
tribes living in the Southern borders of Venezuela and 
Brazil5111. The original sighting was in a captured Maku 
woman and her three near relatives living among the 
Yanomamo tribe of Southern Venezuela. It was later found
in two other individuals in adjacent north central Brazil 
(Makiritare-2) and in the trihybrid population of Northern 
Brazil (Belem III)303.
The migration of this variant is faster than 
Albumin Naskapi at shorter (5-6 hr.) length of electrophoresis, 
but this is reversed at longer (19 hr+) running times30 
probably because Albumin Naskapi is able to bind more 
charged ions during the longer running time to increase 
its relative mobility.
1.6.2.9.5 Albumin Syracuse
This was found in a family of Swiss German descent. 
Minimal separation was obtained on electrophoresis at
pH 8.6 but the variant separated well on cellulose acetate
. „ c .242at pH 5.4
1.6.2.10 Dimeric Albumins 
1.6.2.10.1 Warao
This dimer was found on two natives of British
Guyana11 and in five familial members of a Warao tribe living
12in the Orinoco delta . This tribe is thought to originate 
from the Andes and blood group-typing detected Karib or 
Arawak Indian phenotypes.
This dimer constitutes 30% of the total albumin 
content and can be separated easily into monomers by 
heating at 56°C for 30 min. Susceptibility to dimerisation 
may characterise this variant.
Its electrophoretic mobility is close to a^- 
globulin on cellulose acetate and close to the fast-moving 
a2~globulin in starch gel. It can be distinguished from 
European dimers in the pH 6.0, but not in the 5.0 and 
6.9 starch gel system of Weitkamp.
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1.6.2.10.2 Albumin Makiritare
This dimer is found amongst the Makiritare and 
the Piaroa tribes of Venezuela, and rhe Trio and Wajana 
of Surinam. The average gene frequency is 0.014, arising 
from a total of 41 affected individuals, out of 1,461 members
on oof the four tribes: Makiritare, Warao, Trio and Wajana .
This hereditary dominant variant is also thought to be
alike Albumin Warao found in the Warao of Venezuela and 
297Wapishana of Guyana
1.6.2.10.3 Albumin Yanomama
This variant originates from the Yanomamo
Indians living in South Venezuela and Northern Brazil. They
separate on electrophoresis at pH 5.0 and 6.9 showing a
298slight separation of monomers from dimers
1.6.2.10.4 Albumin dimers in Sweden, USA and Wales
Five carriers were found amongst some orthopaedic 
patients in a Swedish clinic although a connection between 
this hereditary anomoly with orthopaedics is unproven.
A large number of affected individuals were found in nine 
of the 24 relatives of a proband, including a brother who 
was homozygous.
The albumin dimer found in a healthy American 
Negro carrier and 6 members of his family of nine1^7
could be dissociated into monomers after reduction and
.v . .. 136alkylation
The electrophoretic mobility of the Welsh
dimer, which was the first reported case of hereditary 
91dimers is similar to a dimer found in the USA, except 
that they differed in binding of alkaline haematin and 
haemoglobin. There were six carriers in a family of
b 2
11 spanning three generations.
1.6.3 Non-hereditary transient bisalbuminemia
1.6.3.1 Introduction
Transient bisalbuminemia is a rarer phenomenon than 
hereditary bisalbuminemia with about 50 reported cases from 
1948 to 1979. It can be easily recognised as it appears in 
lesser quantities than normal albumin during acute illness 
as a fast (anodic) band adjacent to the normal allotype.
It usually disappears before complete recovery from illness 
is secured. The fast band can be induced by ligand binding 
or by pancreatic diseases.
Unlike hereditary bisalbuminemia, the drug- and
enzyme-induced forms are not usually clear distinct bands
. . . . 215m  vivo or in vitro, except within certain limits . Both
albumins are usually immunochemically similar and
investigation of familial albumin excludes the hereditary
factor.
The initial reports of transient persistant
double albumins were by Glatthaar11*5, Sandor22 ,^
42 > 274Brodenstein and Rau and is reviewed by Tarnoky and
Porta215.
1.6.3.2 By Pancreatic Diseases
A fast albumin component was observed in a
47 year old woman with subacute pancreatitis with
hyperamylasemia. The concentration of the fast component
was later recognised to be directly proportional to the
serum amylase level. It constituted less than 50% of
the total serum albumin, even when the serum amylase
245level was at 3,000 Somogyi level
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However, with the report of a aase of bisalbu-
minemia associated with chronic pancreatitis which was
indifferent to the level of amylase was reported, Lamotte- 
155Barillon suggested structural modification of albumin A 
by trypsin.
Pancreatic enzymes were later shown to cause 
formation of a more anodic component by limited proteolysis 
of albumin A in a clinical case of pancreatitis with 
hyperamylasemia. The same effect could be reproduced 
in vitro by the limited action of chymotrypsin with 
carboxypeptidase A and B and elastasis-carboxypeptidase
A and B on albumin A. Trypsin acts merely to activate
6 8the zymogens of the above enzymes .
The action of chymotrypsin or elastase followed 
by carboxypeptidase A and B was to remove a C-terminal 
fragment, therefore, accounting for a fast mobility 
albumin.
1.6.3.3 Binding of Ligands
Albumin A can be transformed into an electro- 
phoretically distinct rapid molecule by binding anionic 
ligands. This transformation may be a balance in favour 
of anions bound to rather than those that bind reversibly 
through weak associations.
Arvan1  ^noted that a small fraction containing 
penicillin G bound to albumin A was electrophoretically 
faster than albumin A because of the increased anionic 
character contributed by the carboxylic acids on the drug. 
They showed that heavy prescription of cephalothin and 
penicillin G (20 to 60 million units/day) but not
64
chlorophenicol nor streptomycin could induce this 
transformation. In vitro, cephalosporins can induce 
bisalbuminemia (Hutchinson, private communication).
Disproportionate ratios of albumins could be 
induced in vitro by adding increasing quantities of 
penicillin G (124 to 22,700 IU/ml serum), the concentration 
of fast form being proportional to quantities of drug.
Inactivation of penicillin by an equal quantity 
of penicillinase at 25°C did not induce formation of the 
fast form since an opened B-lactam ring was functionally 
useless as shown on Scheme 1.2.
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Scheme 1.2 Cleavage of penicillin G by penicillinase
This observation was used as confirmation of mechanism
5 3of penicillin binding by Bungaard (Section 1.5.5.2).
Guibaud11  ^related the cause of transient bisalbuminemia
to high dosage of B-lactam type antibiotics.
214Porta standardised the in vitro conditions 
for progressive induction of penicillin-albumin from 
albumin A by incubation 500-30,000 units of penicillin/ 
ml serum at 37°C for 3 hours. Equal albumin bands were 
formed at 10,000 units. The same effect could be obtained by
increasing the penicillin concentration but decreasing the 
212incubation time . As expected, normal bands
predominate at low penicillin levels but the fast albumin 
is formed at increasing penicillin levels. Penicillinase 
(bacterial B-lactamase) at 256-500 units/1,000 units of 
penicillin completely hindered formation of double bands.
Only two or three moles of penicillin were
8 3originally thought to be bound per mole of albumin but
the more sensitive and specific method, radioimmune assay,
uncovered 5-10 more penicillyl groups bound to the fast 
. 159component than the normal . Cleavage of the fast 
component by cathepsin D increased the concentration of 
penicillyl groups 50 fold, but pronase or subtilisin further 
increased this value by 100-200 fold.
Penicillin binding does not impair binding of
288 280 bromophenol blue to albumin . Tarnoky and Porta
showed that bisalbumins induced in vitro by penicillin
had less affinity for bromocresol green and bilirubin
than normal sera or hereditary variants. Reduced dye
binding capacity could be achieved by the action of
chymotrypsin or carboxypeptidase A and B.
1.6.4 Analalbuminemia
This is the near absence or complete absence 
of albumin in an individual, and its existence casts 
doubts on the vital requirement and obligate functions of 
albumin discussed in Section 1.1. It may be inherited
as an autosomal recessive gene and can be found in offspring
, . . 2 1of consanguineous unions
Other proteins, such as haptoglobins, a^-anti-
109trypsin, ceruloplasmin, c^-macroglobulins, Ig G , *
* , „ , . . • J , 65,69,109,291transferrin, B-lipoprotein and t ibnnogen
66
are present in elevated amount probably to substitute
the functions of albumin.
Christen and Franglen01 suggested the possibility
of two forms of analalbuminemia. The most probable
reasons are that albumin is absent or made in minute
quantities. Alternatively, the albumin may be produced in
say, a modified form which also has a tendency to form
complexes with other proteins, and so escape detection.
The latter possibility was not confirmed.
In analalbuminemia the half life of intravenously-
injected labelled albumin is prolonged to 120 days,
instead of the normal 20 days101. Undeveloped rough
endoplasmic reticulum contributes to the decreased rate of
albumin synthesis although a minimal amount of albumin
141is produced by a few healthy cells
Albumin levels are difficult to estimate at
such low levels but figures of 16-240 mg/1 are measured
21 195by sensitive immunologic methods ' compared to 
42 g/1 in a normal individual.
Despite such low albumin levels, most symptoms 
are mild. Colloidal pressure which is decreased to a 
third or half normal value is compensated by a slight 
decrease in blood pressure and low capillary pressure.
Most patients have elevated serum, cholesterol and 
phospholipid but normal triglyceride levels. Transport 
disorder is indicated by an increase in elimination of 
intravenously injected Congo Red and Evan Blue.
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CHAPTER II
2.1 INTRODUCTION
In 1980 a young Punjabi male was hospitalised 
for ulcerative colitis in Warwick Hospital. The cellulose 
acetate electrophoresis pattern of his serum proteins 
showed two distinct and separate forms of albumins 
(Fig. 2.1). The rare, extra albumin was of slower electro­
phoretic mobility than normal albumin, and appeared to be 
equal in concentration to normal albumin.
('■) 00
Fig. 2.1 Cellulose acetate electrophoresis pattern 
(i) Mundey's serum, (ii) normal serum.
A later investigation of the familial albumin 
established hereditary bisalbuminemia. The pedigrees in 
Mundey family with bisalbuminemia is shown on Fig. 2.2 
and the electrophoretic pattern of their serum on poly-
93
<f 5  S 5 i
(c) (d) ( I )  (f) (9)
Fig. 2.2 Genealogical tree of the Mundey family with 
bisalbuminemia.
0  = p o s i t i v e ,  0  = n e g a t i v e ,  8  = n o t  t e s t e d
T h e  a g e  o f  t h e  o f f s p r i n g  d e c r e a s e s  fro m  l e f t  t o  r i g h t .
T h e  s u b j e c t  i s  t h e  y o u n g e r  o f  t h e  two s o n s .
~ a b c d e f
+
Fig. 2.3 Analysis of the serum of the Mundey family 
on disc-PAGE^.
acrylamide gel is shown on Fig. 2.3. So far, this 
anomalous albumin is not associated with any known 
diseases, except incidentally. We propose to call this 
slow alloalbumin "Albumin Mundey" for their surname.
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slow alloalbumin "Albumin Mundey" for their surname.
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Fig. 2.3 Analysis of the serum of the Mundey family 
on disc-PAGE^.
acrylamide gel6 is shown on Fig. 2.3. So far, this 
anomalous albumin is not associated with any known 
diseases, except incidentally. We propose to call this 
slow alloalbumin "Albumin Mundey" for their surname.
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2.2 AIMS OF THIS PROJECT
Hereditary bisalbuminemia is the rare occurrence 
of amino acid mutation(s) in the primary sequence of normal 
albumin to produce a second albumin of either slower or 
faster electrophoretic mobility in the serum (Section 1.6.2).
The main objective of this research was to 
identify the mutant amino acids and to locate their 
ositions on the primary structure of Albumin Mundey.
2.3 EXPERIMENTAL STAGES
This research was performed in five successive 
stages. The first stage was the characterisation of 
Albumin Mundey using well-known methods of classification 
(Sectionsl.6.2.5 and 1.6.2.6). The information gathered 
at this important initial stage was used to distinguish
it from other well-established Indian variants, Albumins
16 3 8Kashmir , Hussain, Birmingham-3 and Vancouver0.
The second stage was the isolation of Albumin 
Mundey from normal albumin in an absolutely pure and 
homogenous state. This condition was stringent so 
that any unusual peptides observed in the comparison of 
the peptide maps of Albumin Mundey and the control 
(normal HSA) could be attributed solely to the mutant 
peptides.
The elements of the third stage, sequence 
determination, involved the fragmentation of Albumin Mundey 
into fairly large and accountable fragments. To achieve
(
95
this, the sites of cleavage were specifically aimed at the 
amino acids, rare in the primary sequence of HSA. These 
amino acid residues are the six methionines and the single 
tryptophan.
The fourth stage was the detection of the mutant 
peptides by peptide mapping. Using this technique the 
identities and locations of the peptides on albumin were 
identified.
The final stage was the identification of the 
mutant amino acids by finger printing methods. To achieve 
this, the mutant fragments were isolated and then cleaved 
further into smaller peptides or hydrolysed completely into 
a pool of amino acids.
These five successive stages are described in the 
following chapters.
CHAPTER III
STAGE 1: CHARACTERISATION OF ALBUMIN MUNDEY
3.1 INTRODUCTION
The characteristics of Albumin Mundey that were 
determined are listed.
(i) Electrophoretic mobility1  ^ and the quantitative 
ratio of albumins in serum on six electrophoretic 
media.
(ii) Ligand binding capacities1 *^ of albumins in serum as 
detected by the same six electrophoretic media,
(iii) Quantification of ligands bound to albumins as 
detected on cellulose acetate.
(iv) Proportion of Albumin Mundey to normal albumin in 
serum.
(v) Total protein concentration in serum.
Q(vi) Total albumin concentration in serum .
(vii) Thermal stability^'1®.
11 19(viii) Molecular weight ' determination, including
the possibility that it may be a dimeric variant 12
(ix) Detection of N- or C-terminal peptide
13
1,4
(x) Immunochemical character
(xi) Isoelectric point.
(xii) Genetic linkage to group specific component
(Gc-component).
Dr. A. L. Tarnoky at the Royal Berkshire 
Hospital kindly classified Albumin Mundey for us by
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determining factors in Section 3.1(i, ii, and xii). A 
comparison of its electrophoretic mobilities and ligand 
binding capacities was made with Albumins Kashmir 
(Section 1.6.2.8.2) and Hussain on the six electrophoretic
media. Data on two other albumin variants of Indian origin 
3 8Albumins Birmingham and Vancouver were also used for 
comparisons. Albumin Birmingham and this variant both 
have ancestral origins in the Punjab, India.
Chromatographically pure normal albumin was 
prepared as described in Chapter IV.
3.2 EXPERIMENTAL
3.2.1 Electrophoretic mobility1^
Table 3.1 summarises the electrophoretic conditions 
used to determine the electrophoretic mobility on six 
standard media.
3.2.2 Ligand-binding capacity1 1^
Serum (100 pi) was incubated with 50 yl of
0.05% solutions of bromophenol blue, Ponceau S, HABA, 
bromocresol green, bilirubin and Congo Red for 10 min. 
at 37°C. The molar ratio of albumin:dye was about 2:1
except for HABA where this ratio was 1:2. The albumin- 
ligand complexes were then separated on the six 
electrophoretic media. Qualitative estimation of the 
ligands bound or the positions of the unbound ligands
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were noted before staining. All, except the paper 
electrophoretogram, were stained in Ponceau S (0.2% w/v) 
in TCA (3% w/v). The paper chromatogram was stained in 
bromophenol blue (1% w/v) in ethanol (95%) . The position 
of the albumins were again noted after destaining.
3.2.3 Quantification of bound ligands on cellulose 
acetate
The ligands were bound to the albumins in Mundey's 
serum using the procedure in Section 3.2.2, except that 
the solution of HABA was at pH 6.2 and bromocresol green 
at pH 3.9. Electrophoresis on cellulose acetate was in 
barbital buffer (pH 8.6, 0.05 M) at 12 V/cm for 1 h. 20 min.
To quantify the ligand bound, the cellulose 
acetate strip was cut in half parallel to the direction of 
electrophoresis. One half was used to observe the relative 
quantity of ligand bound by albumins or the positions of 
the ligands before staining in Ponceau S. The albumin bands 
in the second half (located by the stained first half) 
were excised and the albumin-ligand complexes eluted from 
each excised band with equal volumes of ethanol (2 ml), 
except for the bilirubin-albumin complex which was eluted 
in chloroform (2 ml). The UV absorbances of the eluted 
bromophenol blue, Congo Red, bromocresol green and bilirubin 
was measured at 590, 488, 630 and 453 nm respectively.
3.2.4 Proportion of albumins in serum
The albumin bands separated by cellulose acetate
electrophoresis were initially located by a Ponceau S 
stained guide strip. The individual bands were excised 
and then the albumins eluted with NaOH (1 M, 2 ml). The 
eluates were then quantified by the UV absorbance at 
280 nm.
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3.2.5 Estimation of total protein in serum^
The total protein content was determined by 
the Biuret method. Chromatographically pure normal HSA was 
used to construct a standard curve.
Q3.2.6 Estimation of total albumins in serum
Serum (10 yl) was added to the dye solution 
(2 ml). This was followed by very rapid mixing and 
almost immediate measurement of the absorbance at 628 nm 
by UV spectrometry.
The dye solution consisted of bromocresol green 
(0.15 mmol) in succinate buffer (75 mmol) and Brij-35 
surfactant (4.0 ml, 300 g/1), pH 4.20. Water (10 yl) 
was substituted for the serum in the blank. Chromatographically 
pure HSA was used to construct a standard curve.
3.2.7 Thermal stability
The sera were subjected to heating at 37°C and 
then freezing at -20°C ten t i m e s a s  well as to heating 
at 56°C for 30 min. and 2 h^. The thermal stability was
101
then determined by observation of the mobility of Albumin 
Mundey against the control variant sera on cellulose 
acetate.
3.2.8 Molecular weight determination
3.2.8.1 By disc-SDS-PAGE
50 yg of double albumins were loaded per gel 
(7.0 x 0.6 cm i.d.) and electrophoresis carried out by 
SDS-PAGE19 (7.5%) in sodium phosphate (pH 7.2, 0.2 M) 
system containing SDS (0.2%) at 6 mA/gel. The molecular 
weight marker used was chromatographically pure normal HSA.
The molecular weight was also determined by 
disc-SDS-PAGE11 consisting of a stacking gel (4%) in 
Tr-Ls-HC1 (pH 8.8, 0.375 M) . Both gel buffers contained 
SDS (0.1%).
After electrophoresis the proteins were fixed
and SDS removed in isopropanol/acetic acid (25:1 v/v) .
Staining was in Coomassie Blue R-250 (0.1%) and destaining
was in methanol/acetic acid/water at 40°C (5:2:13 v/v/v)
14containing CuSO^ (0.5%) to decrease the blue background
123.2.8.2 By Gradient SDS-PAGE
The possibility that Albumin Mundey may be a 
dimeric variant was investigated by 'sieving' this protein 
on a gradient gel (5-22.5%) containing Trts-HCl (0.375 M, 
pH 8.8).
The stacking gel (4.75%) contained Tris-HCl 
(0.125 M, pH 6.8). Both gel buffers contained SDS (0.1%). 
Electrophoresis was at 125 V. The albumins were fixed in
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sulphosalicyclic acid (10%), stained in Coomassie Blue 
R-25 (0.1%) in destaining solution, methanol/acetic acid/ 
water (25:10:65 v/v/v) followed by destaining. Chromato- 
graphically pure normal HSA was used as a molecular weight 
marker.
3.2.9 Detection of N- or C-terminal peptide
The possibility that Albumin Mundey may have 
an N- or C-terminal peptide, whose ionic charge may 
account for its slow electrophoretic mobility, was 
investigated by reaction with mild trypsin under optimised 
conditions1'^ .
3.2.9.1 With Serum
Serum (10 pi) and TPCK-trypsin (5 pi, 0.1% w/v) 
in ammonium carbonate buffer (pH 8.0, 0.1 M) were incubated 
for 2 h at 37°C. Trypsin was not added to the control sera. 
The electrophoretic mobilities of these two samples were 
compared by cellulose acetate electrophoresis.
3.2.9.2 With Albumin Mundey
Pure Albumin Mundey (2% w/v) dissolved in 
ammonium carbonate buffer (pH 8.0, 0.1 M) was added to 
TPCK-trypsin solution (2 pi). The ratio of trypsin to 
protein was 0.2% (w/v). Incubation and detection 
procedures were as for whole serum. The control was 
Albumin Mundey without any added trypsin.
3.2.10 Immunochemical character
The immunochemical character of Albumin Mundey
(isolated and in serum) was determined by immunoprécipitation 
with goat antiserum monospecific for normal HSA. The binding 
capacity of the antigen was initially determined with serial 
dilutions of normal HSA.
3.2.10.1 Preparation of Agar Gel
A solution of agar (electrophoretic grade, 1% w/v, 
20 ml) in sodium phosphate buffer (pH 7.1, 0.25 M) and 
sodium azide (1% w/v) was poured into sterile petri dishes. 
Underrunning of sera and antisera was prevented by smearing 
the petri dish with a thin layer of grease and then layering 
a thin film of agar powder before the addition of the agar 
solution. Sample wells (0.5 cm diameter) were cut with 
a mechanical cutter and the contents removed by suction.
3.2.10.2 Determination of Antigenic Binding Capacity 
Antiserum (200 pi, 4.0 mg/ml) was mixed with
sodium phosphate buffer (100 ul, pH 7.2, 0.05 M) in the 
control sample well. Serial dilution of chromatographically 
pure normal HSA were added to the peripheral sample wells 
such that the antigen/antibody ratio was 1:1, 1:2 and 1:4 
(w/v). The total volume in each sample well was 300 pi 
solution. The best binding capacity was found to be an 
antigen/antibody ratio of 1:1 (w/w). The immunoprécipitation 
reaction was allowed to occur in a constant-moisture 
chamber for 24 h at 37°C. Once the precipitation lines 
were obtained, the bands were fixed in 20% methanol/ 
saline (1:1 v/v).
3.2.10.3 Immunoprécipitation of Albumin Mundey 
Albumin Mundey (0.4 mg) in sodium phosphate
(300 yl, pH 7.2, 0.05 M) was reacted against antiserum
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(200 yl) in the same phosphate buffer (100 yl). The 
control was chromatographically pure HSA (0.4 mg).
3.2.10.4 Immunoprecipitation of Double Albumins in Serum
Serum (10 yl) in sodium phosphate buffer (pH 7.2, 
0.05 M) was reacted against antiserum (200 yl) with pure 
normal HSA (0.4 mg) as control.
3.2.11 Determination of isoelectric point of Albumin Mundey
The isoelectric point of Albumin Mundey was 
determined by electrofocusing in thin-layer and rod 
polyacrylamide gel. An approximation of this value was 
initially obtained by electrofocusing in the wide pH range 
(pH 3-10) followed by analytical determinations in the 
narrow pH range (pH 4-6.5).
3.2.11.1 Analytical Electrofocusing in Thin-Layer 
Polyacrylamide Gel
Electrofocusing in thin-layer polyacrylamide gel 
(1 mM, T = 5%, C = 3%) was at 30 W constant power at 10°C 
for 2.5 h on LKB Multiphor 2117. The isoelectric points 
of albumins [defatted5 and native (not defatted)] were 
determined.
3.2.11.2 Preparation of Electrofocusing Gel
A glass plate (25 x 12.5 cm) was pretreated 
with silane A-174 to ensure adhesion of the gel to 
the plate during prolonged staining and destaining procedures. 
A plastic sheet (Gel Bond) was attached to the other plate to 
prevent adhesion of gel. The gels, containing Ampholyte 
(pH 3-10) or Pharmalyte (pH 4-6.5), were cast according 
to a combination of instructions on Pharmacia leaflet on
>
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isoelectric focusing and LKB application note 250. Leakage 
of the gel was prevented by sealing the edges of glass 
plate with agar.
3.2.11.3 Measurement of Generated pH Gradient 
Immediately after completion of electrofocusing,
the pH was measured with a surface pH electrode at 1 cm 
intervals at 10°C.
3.2.11.4 Detection of Albumins
The gel was electrofocused for a further 15 min.
after measurement of the pH gradient to restore sharpness
of band. The proteins were then fixed in sulphosalicyclic
acid (5% w/v) and TCA (10% w/v) for 1 h. Carrier ampholytes
were removed in destaining solution methanol/acetic acid/
distilled water (3:1:6 v/v) for 0.5 h and then stained in
14Coomassie Blue R-250
3.2.11.5 Analytical Electrofocusing in Gel Rods 
Electrofocusing of defatted'’ double albumins in
gel rods (0.25 x 8 cm) was carried out at constant current 
(1 mA/gel rod) for about 3 h at room temperature. The 
polyacrylamide gel (T = 5%, C = 3%) contained Pharmalyte 
pH interval 4-6.5. The pH gradient was determined by elution 
of carrier ampholytes from focused gel rod (blank) which 
did not contain any added protein.
3.2.11.6 Measurement of pH Gradient
The blank gel rod was sliced at 1.5 mm intervals 
immediately after completion of electrofocusing. Each 
slice was then sligtly homogenised in degassed distilled 
water (1 ml) and ampholytes eluted with mild mechanical 
agitation. After about 6 h, the pH of the solution was 
measured with a micro pH electrode.
106
Table 3.2 Comparison of the electrophoretic mobilities of Albumins Mundey, Kashmir, 
Hussain, Birmingham^ and Vancouver® on six standard media
Variant
Electrophoretic mobility* 
of albumins Albumin <%) Concentration (g/1)
Albumin Normal Slow Normal Slow Protein Albumin
Cellulose Mundey 100 90 50 50 76 46
(cellagram) Kashmir 100 90 48 52 92 46
Hussain 100 89 46 54 80 45
Birmingham 100 92 - - - -
Vancouver 100 89.5 - - - -
Helena Mundey 100 93 47 5 3 76 43
Acetate Kashmir' 100 91.5 49 51 92 43
Hussain 100 92 46 54 80 47
Birmingham - - - - - -
Vancouver 100 89.5 - - - -
Paper Mundey 100-87 85-74 _ _ 76 _
Kashmir - - - - 92 -
Hussain 100-89 87-77 - - 80 -
Birmingham 100 91 - - - -
Vancouver t * - - - -
Agar Mundey 100-93 92-82 49 51 76 43
Kashmir 100-92 91-81 47 53 92 42
Hussain 100-94 92-84 48 52 80 55
Birmingham 100 92 - - - -
Vancouver 100 92 - - - -
Agarose Mundey 100-94 91-85 51 49 76 52
Kashmir+ 100-93.5 90.5-84 51 49 92 52
Hussain 100-93 89-82 50 50 80 50
Birmingham 100 94 - - - -
Vancouver 100-90.5 89.5-81 - - - -
Polyacryl- Mundey 100-95 92-86 _ _ 76 .
Kashmir ■ “ - “ 92 -
Hussain 100-95 92-87 - - 80 -
Birmingham 100-94 85-92 - - - -
Vancouver 100-94 93-84.5 - - - -
‘Electrophoretic mobility expressed on a 0-100 scale 
0 = edge of cathodic serum protein 
100 = edge of normal albumin
Data was an average of two experiments 
*Albumins migrated as a single band
-Not Determined
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3.2.11.7 Detection of Protein
The proteins were fixed in sulphosalicyclic acid 
(5% w/v) and TCA (15% w/v) overnight and then stained by 
Fast Green (0.25% w/v) in destaining solution acetic acid/ 
ethanol/water (1:3:6 v/v/v). Destaining was at 40°C.
3.2 RESULTS AND DISCUSSION
The results of the electrophoretic test on 
Table 3.2 show that Albumin Mundey is a slow albumin 
variant. Its mobility is similar to Albumin Kashmir 
only on cellulose acetate, to Albumin Hussain on agar 
and polyacrylamide and to Albumins Birmingham and Vancouver 
on agar. Data on the electrophoretic mobility of Albumin 
Kashmir on paper and acrylamide were not available for 
a complete comparison.
These small differences in electrophoretic 
mobilities, due to the overall ionic charge on the albumin 
molecules, are of significance in distinguishing these 
nearly similar slow allormophs of normal HSA. A comparison 
of their proximity to normal albumin shows that Albumin 
Mundey is closest on Helena cellulose acetate and agarose 
while Albumin Birmingham is closest on cellulose acetate 
and paper. On polyacrylamide, Albumin Vancouver is nearest 
to normal albumin. It also shows that Helena cellulose 
acetate and agarose are the most sensitive media to 
differentiate between these variants, while agar was the 
least sensitive, since four of the five variants have 
identical electrophoretic mobility on this medium.
r.
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Table 3.3 Comparisons of the ligand binding capacities of Albumins Mundey, Kashmir 
Hussain, Birmingham^ and Vancouver® as detected on the standard media
Media AlbuminVariants
Ligands
Bromophenol
Blue
Ponceau
S HA BA
Bromocresol
Green Bilirubin
Congo
Red
Cellulose Mundey N > S A U N > S N = S 0
Acetate N > S A U N > S N = S 0(Cellagram)
Hussain N > S A U N > S N = S 0
Birmingham N > S Only N - N = S N = S -
Vancouver N > S * * N > S N = S *
Helena Mundey N > S N > S U N = S S > N 0
Cellulose N > S N > S u S * N S > N 0Acetate
Hussain N = S N > S u S > N S > N 0
Birmingham - - - - - -
Vancouver N > S * * Only S Only S ”
Paper Mundey N s S B u N > S U 0
Kashmir - - - - - -
Hussain N = S B u N = S U 0
Birmingham N > S - - N = S N = S -
Vancouver - - “ “ ” ■
Agar Mundey N > S A A Only N N = S N > S
Kashmir N > S A A Only N N = S N > S
Hussain N > S A U A U N > S
Birmingham N > S - - N > S N = S N = S
Vancouver N > S * * N > S N = S N > S
Agarose Mundey N > S A u N > S N = S N > S
Kashmir N > S A u N > S N = S N > S
Hussain N > S A u N > S N = S N > S
Birmingham - - - - - -
Vancouver N > S * * N > S N = S N = S
Polyacryl- Mundey N > S N > S u N > S N = S S > N
amide Kashmir N > S N > S u N > S N = S S > N
Hussain N > S N • S u U N • S S > N
Birmingham - - - - - -
Vancouver N = S * * Only N N = S S • N
A = Mobility of ligand (A)head of albumins after electrophoresis 
B = Mobility of ligand (B)ehind albumins after electrophoresis 
N = Normal albumin
0 = Dye at (Origin after electrophoresis
S = Slow albumin
U = Quantity of dye bound by albumins (U)ndetectable after
electrophoresis
* = Ligand not bound by albumins (data did not state positions of ligands)
Not determined
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Table 3.2 also shows the quantity of Albumin 
Mundey detectable on the different media. On cellulose 
acetate, it is equal in concentration to normal albumin. 
Slight increases in quantities (53% and 51%) were observed 
on the Helena and agar system respectively, but a slight 
decrease was observed on agarose (49%). These quantitative 
differences are too small to be of any significance and 
it can be concluded that these two albumins are in a 1:1 
proportion in serum. A similar result was arrived at by the 
elution of albumins on unstained cellulose acetate strips.
The results of the ligand binding test on 
Table 3.3 show that Albumin Mundey binds bromophenol blue, 
bromocresol green and bilirubin either equally well or with 
decreased binding capacity when compared to normal albumin 
on all six electrophoretic media. HABA and Ponceau S 
were generally not bound to the albumins or were 
undetectable by eye on all six media. Congo Red was only 
bound to Albumin Mundey on agar, agarose and polyacrylamide. 
The binding affinities of Albumin Mundey for these ligands 
are individually discussed below.
Bromophenol blue was bound by normal albumin 
in larger quantity than Albumin Mundey on all media except 
paper, where equivalent binding was obtained. Quantification 
of bromophenol blue bound by the albumins on cellulose acetate 
(Table 3.4) shows that Albumin Mundey bound 34% while 
normal albumin bound 66% of the total quantity of dye.
The binding of Ponceau S by this albumin was only 
detectable on Helena cellulose acetate and acrylamide 
where normal albumin bound more Ponceau S than Albumin Mundey.
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On the remaining media, this ligand moved as a separate 
band ahead of the albumin S, except on paper where the 
Ponceau S-free albumins were of faster mobility than this 
ligand.
It was impossible to estimate the quantity of 
HABA bound by these albumins on all six media because the 
HABA-albumin complex is either undetectable by eye or 
it moved as an advanced separate band on agar.
Bromocresol green was bound in lesser quantities 
by Albumin Mundey on all media except on Helena and agar.
On Helena cellulose acetate, both albumins bound bromocresol 
green equally well.
It is interesting to note that Albumin Mundey had 
no binding affinity for this ligand on agar, where it was 
bound only by normal albumin. However, quantification of 
eluted bromocresol green bound by albumins on cellulose 
acetate (Table 3.4) shows a decreased binding capacity of 
Albumin Mundey (42%) whereas the value for normal albumin 
is 58%.
The binding of bilirubin by Albumin Mundey and 
normal albumin were equivalent on cellulose acetate, 
agar, agarose and acrylamide. On paper, the binding was 
undetectable but Albumin Mundey bound more bilirubin on 
the Helena system.
Congo Red was not bound to the albumins, but remained 
at the origin on cellulose acetate, Helena and paper. On 
agar and acrylamide, the normal albumin had the greater 
binding capacity but this was reversed on acrylamide.
Table 3.4 Quantification of eluted ligands bound to 
albumins after cellulose acetate electro­
phoresis
Dye
% dye bound to
Normal albumin Albumin Mundey
Bromophenol Blue 66 34
Ponceau S A A
HABA U U
Bromocresol Green 58 42
Bilirubin 50 50
Congo Red 0 0
A = Mobility of dye ahead of albumins 
U = Quantity of due bound by albumins 
0 = Dye at origin
A critique on the ligand bind test was made in 
Section 1.6.2.5.2.
Comparisons of the ligand binding capacities of 
Albumin Mundey with the other Indian variants, Kashmir, 
Hussain, Birmingham and Vancouver (Table 3.3), show that 
the ligand binding capacity of Albumin Mundey is most 
identical to albumin Kashmir. To support this statement, 
their binding capacities are identical on all five media, 
except on paper. It was unfortunate that this data was 
unavailable for a complete comparison of the ligand 
binding capacity.
The binding capacities of Albumin Mundey for all 
ligands on cellulose acetate and agarose are indistinguishable 
from Albumins Kashmir and Hussain.
Albumin Hussain is similar to Albumin Mundey in the
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binding of Ponceau S, Congo Red, bilirubin and bromophenol 
blue on Helena cellulose acetate, paper, agar and agarose. 
The similarity to Albumin Birmingham is in the binding 
of bromophenol blue and bilirubin on cellulose acetate 
and agar. Albumin Vancouver binds bromophenol blue, 
bromocresol green and bilirubin identically to Albumin 
Mundey on cellulose acetate and agarose. Some similarities 
are also observed on agar in the binding of bromophenol blue 
and Congo Red.
These results are summarised on Table 3.5.
Table 3.5 Similarities in ligand binding capacities of 
Albumins Birmingham, Hussain, Kashmir and 
Vancouver to Albumin Mundey
L ig a n d
E l e c t r o p h o r e t i c  M e d ia
C e l l u l o s e
A c e t a t e
H e le n a P a p e r A g a r A g a r o s e
P o l y a c r y l ­
a m id e
B ro m o p h e n o l B lu e B , H , K , V K , V H B , H , K , V H , K ,  V H ,K
P o n c e a u  S •k H , K ★ ★ k H ,K
HABA + t t * , + t t
B r o m o c r e s o l G r e e n H , K , V K N one K H , K , V K
B i l i r u b i n B , H , K , V H ,K + B , K , V H , K , V K
C o n g o  R ed * ★ ★ H , K , V H , K H , K , V
B = Albumin Birmingham
H = Albumin Hussain
K = Albumin Kashmir
V = Albumin Vancouver
* = Ligand was not bound to albumins
+ = Quantity of bound ligand was undetectable
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These comparisons of mobility and ligand binding 
suggest that Albumin Mundey may be an identical variant 
to Albumin Kashmir. However, a firm conclusion could not 
be made even though their qualitative binding capacities 
(Table 3.3) may be identical on all test media. A quanti­
tative survey may reveal important differences in the amount 
of ligands bound by these two variants. Also, a comparison 
of their electrophoretic mobility (Table 3.2) does not 
correlate on all six media.
The total concentration of serum proteins of the 
healthy subject a year after hospitalisation was 92 g/1 
(Fig. 3.1). This was considerably higher than the value 
(76 g/1) measured during hospitalisation (Table 3.2).
The albumin concentration was 52 g/1 as measured
by improved analytical estimation of albumin using
bromocresol green (Fig. 3.2). This value was also
considerably increased from the average concentration of
46 g/1 obtained during hospitalisation (Table 3.2).
Both protein and albumin concentrations are known to
18decrease during illness but are restored to their 
normal value after recovery. Since the ratio of the 
albumins is 1:1 (Table 3.2), the concentration of both 
normal and abnormal albumins is about 26 g/1 respectively.
The electrophoretic mobility and concentration 
of Albumin Mundey was unchanged after repeated freezing, 
thawing and heating. This was proof of its thermal 
stability and that its slow electrophoretic mobility was 
not due to bound charged ligands that could be removed by 
these thermal processes, as found in some albumin variants 
discussed in Section 1.6.2.6.2.
ns
SDS-PAGE showed that Albumin Mundey was of 
similar relative molecular mass as normal albumin. The 
same conclusion was arrived at by gradient PAGE and this 
confirmed that Albumin Mundey is a monomeric variant.
Mild limited tryptic digestion of Albumin 
Mundey (isolated and in serum) showed an unchanged electro­
phoretic mobility when compared to the control Albumin 
Mundey. Under identical conditions, the propeptides of 
the slow variants, Albumins Christchurch and Lille were 
cleaved to reveal albumins of similar electrophoretic 
mobility to normal albumin.
Albumin Mundey shares a common antigenity with 
normal albumin. A single immunoprécipitation line was 
formed by the reaction of this variant against monospecific 
anti-normal HSA as shown on Fig. 3.3.
Fig. 3.3 Immunoprécipitation of albumins against anti­
normal HSA
S a m p le  w e l l :  (A) n o r m a l H S A , (B) A lb u m in  M u n d ey 
T h e  c e n t r a l  w e l l  c o n t a in e d  a n t i - n o r m a l  hum an a lb u m in  
a n t i s e r a .  (T h e  b u b b le s  w e re  fo rm e d  b e c a u s e  o f  t h e  
h e a t  o f  t h e  p h o t o g r a p h ic  p l a t e . )
U S
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The immunoprécipitation band of the double 
albumins in sera were slightly wider (figure not shown) 
than that of the single albumins as on Fig. 3.3. This 
band was twice as close to the central antisera well than 
the immunoprécipitation band of the control normal 
albumin. Although Albumin Mundey reacted with anti-normal 
antisera, this did not prove total immunochemical similarities 
to normal albumins. The reasons are discussed in Section
1.5.7. Reaction with specific monoclonal antibodies 
(Section 1.6.2.6.4) should be a more sensitive method to 
detect minute immunochemical differences.
On the electrofocusing gel shown on Fig. 3.4,
Albumin Mundey is identified as the second most anionic 
of the serum proteins.
1 2  3 4  6  6  7  8  9
Fig. 3.4 Isoelectric focusing of various proteins in 
the pH 3-10 range
S a m p le s :  ( 1 , 2 , 7 , 8 , 9 )  n o r m a l s e r u m ; ( 3 , 4 )  c h r o m a t o g r a p h ic a l ly
p u r e  u n s e p a r a t e d  A lb u m in  M undey a n d  n o r m a l a lb u m in ;
( 5 ,6 )  p r e c i p i t a t i o n  o f  M u n d e y 's  s e ru m  b y  amm onium s u lp h a t e  
( 0 - 4 5 % ) .
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Fig. 3.5 pH profile of thin-layer isoelectric focusing
gel focused in the pH 4-6.5 range.
Analytical thin-layer isoelectric focusing in 
the pH range 4-6.5 (Fig. 3.5) showed that the isoelectric 
point of the defatted and native Albumin Mundey to be
5.7 and 5.0 respectively. The charge difference between 
these two moieties and normal albumin (also defatted and 
native) was about 0.1 pH units. Isoelectric focusing in 
gel rods between the same range (Fig. 3.6) of defatted 
Albumin Mundey shows the isoelectric point to be 5.7.
Fig. 3.6 pH profile of gel rods focused in the pH 4-6.5 
range.
v,
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The result of these tests show that Albumin 
Mundey is a heat-stable monomeric variant present in 
an equal quantity to normal albumin in serum. It does 
not have any additional peptide at the N- or C-terminal 
ends of the albumin peptide chain and is genetically 
transmitted with Gc-2. Double immunoprécipitation with 
anti-normal human albumin antisera demonstrate immuno­
chemical similarities to normal albumin. Defatted Albumin 
Mundey is isoelectric at pH 5.7 but the native species is 
isoelectric at pH 5.0. The electrophoretic mobility of 
Albumin Mundey was identical to several Indian variants on 
different media. The dye binding test shows the greatest 
similarity in ligand binding capacity to Albumin Kashmir.
3.3 REFERENCES
1. Abdo, Y., Rousseaux, J. and Dautrevaux, M. 
(1981) F.E.B.S. Lett., 131, 286-288
2. Arends, T. Gallango, M. L., Layrisse, M., 
Wilber, J. and Heinen, H. P. (1969) Blood, 
33, 414-420
3. Bradwell, A., Deverill, I. and Jefferis, R. 
(1975) Vox. Sang., 28, 383-388
4. Brennan, S. 0. and Carrell, R. W. (1980)
Biochim. Biophys. Acta, 621, 83-88
5. Chen, R. F. (1967) J. Biol. Chem., 242, 173
6. Davis, B. J. (1964) Ann. N.Y. Acad. Sei., 121, 
404-427
7. Doumas, B. T. (1975) Clin. Chem., 21, 1159
I
119
8 .
9.
1 0 .
11.
1 2 .
13.
14.
15.
16.
17.
18.
19.
Frolich, J., Campbell, D. J., Curnow, J. V. and
Tarnoky, A. L. (1978) Clin. Chem., 24,
Gustafsson, J. E. C. (1976) Clin. Chem
616-622
Izquierdo, J. M., Sotorrio, P., Dowding, B. 
and Tarnoky, A. L. (1971) J. Clin. Pathol., 24, 
515-517
Laemmli, U. K. and Favre, M. (1973) J. Mol. Biol., 
80, 575-599
O'Farrell, P. H. (1975) J. Biol. Chem., 250, 
4007-4021
Ouchterlong, 6. (1954) Int. Arch. Allergy, 11,
3-4
Righetti, P. G. and Drysdale, J. W. (1974)
J. Chromatog., 98, 271
Tarnoky, A. L. and Dowding (1967) Clin. Biochem., 
1, 48-65
Tarnoky, A. L. and Dowding, B. (1969) Clin. Chim. 
Acta, 26, 455-458
Tarnoky, A. L., Dowding, B. and Lakin, A. C. (1970)
Nature, 225, 742
Tarnoky, A. L. (1981) Ann. Clin. Biochem., 18, 
61-63
Weber, K., Pringle, J. R., Osborn , M. (1969) 
Methods in Enzymology, Vol. XXVI, pp.3-27 
(Hirs, C. H. W. and Timasheff, S. G., editors) 
Academic Press, New York and London
120
CHAPTER IV
STAGE 2: SEPARATION OF ALBUMIN MUNDEY 
FROM NORMAL ALBUMIN
The physiochemical properties of Albumin Mundey 
are almost identical to those of normal albumin. This 
lack of distinction was the source of great difficulties 
in effecting their separation, indeed, it was once thought 
to be impossible. This chapter summarises the techniques 
tried (with disappointing results) over the span of one 
year.
The principles of the methods used in attempting 
separation, could only exploit the very subtle differences 
between the albumins. These differences are: (i) ionic 
charge (ion-exchange chromatography and polyacrylamide gel 
electrophoresis); (ii) isoelectric points (isoelectric 
focusing and chromatofocusing); and finally (iii) affinity 
chromatography based on their differential specific binding 
affinities for dyes of different chemical structures.
The methods used in this difficult and highly 
laborious separation are described below.
4 . 1 ION-EXCHANGE CHROMATOGRAPHY
Marginally different protein allomorphs, differing 
in as little as a single amino acid, are supposedly separable 
by this technique (Section 1.6.2.6.5).
However, an inherent problem in this technique
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s u b s t a n c e s  a r e  a b o u t  t o  e n t e r  t h e  io n  e x c h a n g e  b e d .  In  s t a g e  2  t h e  c o u n t e r - i o n s  h a v e  
b e e n  e x c h a n g e d  f o r  s a m p l e  s u b s t a n c e s .  A f t e r  t h is  a d s o r p t i o n  a  g r a d ie n t  is  a p p l ie d .  
D e s o r p t i o n  o f  o n e  s a m p l e  s p e c i e s  o c c u r s  a t  s t a g e  3 . T h i s  s u b s t a n c e  is  e x c h a n g e d  fo r  
c o u n t e r - i o n s  in  th e  e l u t i n g  b u f f e r  a n d  is  t h e r e f o r e  e lu t e d  f r o m  t h e  io n  e x c h a n g e r .  A t  
s t a g e  4  t h e  r e m a in in g  s a m p l e  s u b s t a n c e  is  e x c h a n g e d  f o r  g r a d ie n t  i o n s  a n d  e lu t e d ,  
a l t e r  w h i c h  r e g e n e r a t io n  m a y  b e  s t a r t e d .  T h e  g r a d ie n t  i o n s  a r e  e x c h a n g e d  lo r  
c o u n t e r - i o n s  in  s t a g e  5  a n d  t h e  io n  e x c h a n g e r  is  t h u s  r e g e n e r a t e d  a n d  r e a d y  l o r  re ­
u s e .
Fig. 4.1 Principles of ion-exchange chromatography
is that the amino acids of albumin (isolated and in serum) 
can easily undergo acid-to-base-transformations. There 
are many ways in which this can arise, including storage 
(private communication of Dr. S. G. Franklin to 
Dr. D. W. Hutchinson). The result is to further decrease, 
or even nullify, the already small ionic charge difference 
between the albumins. This can hinder their separation 
by this technique.
Another problem is the oxidation of sulphur in 
thioether linkage to the corresponding sulphoxide. This 
results in many different chromatographic forms of 
albumin with varying quantities of sulphoxide groups.
These forms deter the chromatographic separation of the 
albumins which should only comprise two pure forms; 
normal and abnormal. Thiodiglycol, an antioxidant, is
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usually incorporated into chromatographic buffers (0.1 to 
0.3% v/v) to keep the thioether sulphur in the reduced 
state. Other amino acid transformations that can occur 
in peptides are discussed in Section 6.1.
The variable parameters in ion-exchange 
chromatography used to attempt separation include 
chromatography at pH 5.22, 5.6, 5.7, 5.75, 6.8, 7.0,
7.5 and 8.8. These pH values were chosen to be 
intermediate and at increasing pH units above their 
isoelectric points of about 5.7 (Section 3.2). The 
last pH value of 8.8 was tried since separation by 
electrophoretic techniques was achieved at this pH.
These systems were coupled with a continuous, 
linear decreasing salt gradient. In the decreasing 
pH system1, the pH range was chosen such that the 
isoelectric points of the albumins coincided with the 
approximate centre of the pH gradient. These separations 
were generally performed on long thin chromatographic 
columns with only small quantities of albumins applied, 
to aid their separation. The continuous elution of 
the albumins from one such column to two other parallel 
columns, of similar dimensions, was also tried.
4.2 AFFINITY CHROMATOGRAPHY
Albumin Mundey differs from normal albumin in 
its specific binding affinities of certain ligands 
(Table 3.3). This property may be sufficiently 
discriminating so as to effect the rapid and quantitative 
separation of Albumin Mundey by affinity chromatography 
(Fig. 4.2).
■ B O H
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Adsorb sample substance(s)
Desorb bound substance(s)
Fig. 4.2 Principle of affinity chromatography
Albumin Mundey was screened against 65 affinity 
columns in the laboratory of Dr. P. G. Dean (University 
of Liverpool). Each affinity column consisted of a specific 
dye covalently attached to Sepharose CL6B. The amphipathic 
dye bromosulphophthalein (^ 9) was immobilised onto 
Sepharose CL4B and the chromatographic behaviour of 
normal albumin then tested on this column.
a 9>
4.3 ISOELECTRIC FOCUSING
In this technique, the separation of the albumin 
relied solely on the slight difference in their isoelectric
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points. Preparative isoelectric focusing in the pH 4-6.5 
range was tried in a granulated gel medium as well as in 
polyacrylamide. Fig. 4.3 illustrates the principles of 
the technique.
increasing pH (3-11)
Direction of migration
Fig. 4.3 Schematic drawing illustrating the principles 
of isoelectric focusing
4.4 CHROMATOFOCUSING
Chromatofocusing is isoelectric focusing on 
ion-exchanges without the application of an external 
potential13. In this technique, the chromatographic 
gel is initially equilibrated with the buffer of the 
higher pH value in the pH gradient. A gradient is then 
generated by the gradual titration of this in situ 
buffer with a second amphoteric buffer. The pH profile 
of the chromatographic column shows a gradual linear 
decrease in pH down the length.
The journey of a protein down this column is a 
continual cycle of attachment, followed by detachment from
f
12b
the gel and migration down the column, depending on the 
charge of the protein at that instant (Fig. 4.4).
Fig. 4.4 Behaviour of a protein in chromatofocusing
This charge is determined by a combination of its 
isoelectric point (pi) and the pH of the surrounding 
buffer. When the pH of the buffer is above the pi, the 
protein becomes negatively-charged and so binds to the 
cationic exchanger. When the changing pH drops below 
the pi of the protein, it becomes positively charged and 
is repelled by the exchanger. It then travels further 
down the column until the combination of buffer and pi 
causes it once again to be attached to the gel.
a difference in isoelectric points of only 0.1 pH units 
by chromatofocusing was attempted in the pH 6-4 range. 
Recycling of the relevant peak to obtain better distinction 
was also tried.
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An attempt to separate the two albumins, with
4.5 P R E P A R A T I V E  P AGE
J
This was the only successful method in which 
quantitative isolation of Albumin Mundey was achieved.
1 2 6
It is a rapid method (can be completed in a day) and does 
not require expensive chemicals or equipment. A bonus is 
that high yields of pure albumins can be obtained (over 
90%) .
The double albumins, obtained by ammonium sulphate
Oprecipitation and ion-exchange chromatography, were first
4 14separated on an anodic disc-PAGE system '
After electrophoresis they were rapidly stained with
7the fluorescent dye, l-anilinonaphthalene-8-sulphonic acid . 
This stain was chosen because albumins bound this dye 
instantly and the usual lengthy staining and destaining 
processes normally used in PAGE were avoided. Since protein 
bands become less distinct in the absence of an electric 
field, the use of this stain afforded the immediate 
visualisation of the albumins after electrophoresis.
Therefore it ensured that the two close albumin bands 
could be excised before they merged as one blurred, 
indistinct band.
To extract the albumins from the gel slice, 
reverse polarity electrophoresis was employed. The 
method of Otto and Snejdatkova1® was used with gel rods 
and on vertical slab gels, an adaptation of this method
Qby Mendel-Hartig was used. The eluted albumin contained 
tightly bound dye molecules (Section 1.5.5.2) which were 
removed by interaction with charcoal at low pH'1.
4.6 ANALYSIS OF THE ALBUMIN FRACTIONS
The albumin fractions produced by these prepara­
tive methods were analysed by cellulose acetate electrophore­
sis, disc-PAGE4'14 and ultrathin isoelectric focusing between
T
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pH 4-6.5^. The latter two methods were excellent in 
detecting the extent of separation of the albumins.
Cellulose acetate electrophoresis at pH 8.6 was 
initially used to detect separation of albumins immediately 
after a separation process, but the wide blurred albumin 
bands were observed on electrophoresis. This effect is 
due to the salts in the sample and electrolyte interacting 
with the albumins.
4.7 EXPERIMENTAL
4.7.1 By ion-exchange chromatography
The general method used involved the application 
of small quantities of salt-free double albumins (about 
10 mg) or serum (3 ml) on long thin chromatographic 
columns (100-150 length x 1.5 cm i.d.). The anion 
exchangers were DEAE-Sephadex, DEAE-Sephacel or QAE-Sephadex. 
The eluting buffers were sodium acetate, tris-HC1 or 
sodium phosphate at I = 0.1. The pH values of these buffers 
were pH 5.22, 5.60, 5.70, 5.75, 6.8, 7.0, 7.5 and 8.8.
After running the dissolved double albumins or 
serum into the gel, the flow rate of the buffer was 
decreased to almost zero. After 30 min., the columns 
were washed with buffer to remove unattached proteins.
The adsorbed proteins were eluted with a continuous 
linear NaCl gradient (0-0.5 M) in the same buffer.
Individual fractions from various points in the peaks were 
subjected to analysis by the technique mentioned in
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Section 4.6. After this, the albumins were desalted by 
dialysis against water and then lyophilised.
4.7.1.1 By Decreasing pH-gradient1
About 50 mg of double albumins were applied to a 
QAE-Sephadex column (24 x 4 cm i.d.) equilibrated with 
phosphate buffer (pH 5.9, 0.1 M). The adsorped albumins 
were then eluted by the application of a decreasing 
pH gradient (pH 5.9 to 5.5).
4.7.1.2 By Continuous Elution into Parallel Columns 
Double albumins (50 mg) were loaded onto a
QAE-Sephadex column (106 x 1.5 cm i.d.) equilibrated with 
tris-HC1 (pH 6.5, 0.2 M). The outlet of this column was 
connected by tubing to a second column of identical 
composition and dimensions. Connection to a third 
column was made in a similar fashion. The albumins 
were desorbed by application of a linear NaCl gradient 
(0-0.5 M).
4.7.2 Preparative electrofocusing in granulated gel
LKB application note 198.
4.7.2.1 Preparation of Electrofocusing Gel bed
The granulated gel bed was prepared by adding 
Ultrodex (4.0 g) slowly to Pharmalyte pH range 4-6.5 
(5.3 ml) in water (95 ml) to form a 4% (w/v) gel slurry. 
After pouring into the electrofocusing tray, the calculated 
quantity of water was evaporated from the slurry by means 
of a small fan placed about 80 cm directly above the tray. 
When the correct consistency was reached, the tray was
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transferred to the cooling plate of LKB Multiphor 2117.
Good thermal contact between the electrofocusing tray 
and the cooling plate was ensured by the application of a 
thin film of Triton X-100 (0.1% w/v). The pH gradient 
was established at 8 W for 0.75 h with H3P04 (1 M) as 
anode buffer and NaOH (1 M) as cathode buffer.
4.7.2.2 Electrofocusinq
The salt-free double albumins (120 mg) were • 
dissolved in 3 ml of Pharmalyte (pH 4-6.5) solution (0.5 ml 
in 10 ml water). The sample well was prepared by pressing a 
sample applicator at the approximate centre of the gel and 
removing its contents. A sample slurry was formed by 
mixing the removed sample gel with the solution of double 
albumins. This mixture was returned to the sample well.
After hydrostatic equilibration, electrofocusing was 
carried out at 10 W for 16 h at 10°C. After this, the gel 
was fractionated by a grid of 0.8 cm slit widths.
4.7.2.3 Detection and Elution of Protein
After electrofocusing, the albumins were detected by
12the contact print method of Radola . The pH profile of 
the gel was obtained by measuring at 0.8 cm intervals with 
a surface electrode. The gel from each grid was 
transferred into micro-chromatographic columns and the 
albumins eluted from each gel with equal volumes of water.
The absorbance of the eluate of each column at 280 nm 
was measured. The albumin-containing peaks were applied 
on Sephadex G-50 columns to remove the ampholyte carriers.
They were then concentrated in vacuo before analysis by 
ultra-thin isoelectric focusing.
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4.7.3 By preparative Isoelectric focusing in PAGE
The double albumins were subjected to electro- 
focusing in PAGE rods (0.6 x 7 cm) containing Pharmalyte 
pH 4-6.5/water (1:15 v/v) in polyacrylamide gel 
(T = 5%, C = 3%). The anodic buffer was DL-glutamic acid 
(0.01 M) and cathodic buffer L-histidine (0.01 M) .
Prefocusing of the gel to establish the pH 
gradient was at 1 mA/gel. Electrofocusing was at 1 mA/gel 
using myoglobin (pi = 5.6-8.0) as marker protein. After 
electrofocusing,the albumins in a gel were located by rapid 
staining in Fast green (0.25% w/v) in acetic acid/ethanol/ 
water (1:3:6 v/v/v) for 1 h, without prior fixation of 
albumins. The destained gel was then aligned with the 
unstained gels and the corresponding albumin bands excised 
using a clean degreased razor. The gel slices containing 
abnormal albumin were homogenised in water. The homogenate 
was magnetically stirred at 4°C for 12 h. The polyacrylamide 
was then precipitated by centrifugation on a bench top 
centrifuge. Small traces of polyacrylamide in the 
supernatant were removed by passage through a medium-pore 
sinter under suction. The carrier ampholyte from the 
resulting solid-free supernatant was removed by gel 
filtration on Sephadex G-75 followed by lyophilisation.
4.7.4 By chromatofocusing
All buffers and gels used in this technique 
were thoroughly degassed to prevent fluctuations in
Hi*
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the pH gradient. This effect, due to dissolved atmospheric 
CO2, occurs between pH 5.5 to 6.5. The anionic exchanger, 
PBE 94, in a water-jacketed column (26.5 x 1.5 cm) was 
equilibrated with the starting buffer, L-histidine-hydro- 
chloride (pH 6.2, 0.025 M). The column packing was 
checked by the migration of cytochrome C (4 mg, horse- 
heart type IIA).
The pH of the column was adjusted with the 
amphoteric eluting buffer, Polybuffer-hydrochloride 
(5 ml, 0.0094 mmol/pH unit/ml) prior to sample application 
to prevent exposure of the sample to vast pH differences. 
The mixture of the albumins (120 mg), which was dialysed 
against the starting buffer for 48 h at 4°C, was applied 
to the column. Elution was at a constant flow rate 
(30 ml/h ) using a peristatic pump. A pH gradient (pH 
6.2-4.0) was generated by the application of twelve 
column volumes (360 ml) of the eluent. Fractions (3 ml) 
were monitored at 280 nm and the pH of every fifth 
fraction recorded.
After concentration of the relevant albumin 
peaks, Polybuffer was removed from the individual 
albumin peak by gel filtration on Sephadex G-75 eluted 
with the start buffer. After concentration in vacuo 
at 30°C, the first albumin peak which should contain 
the slow alloalbumin was subjected to rechromatography 
under identical conditions to remove normal albumin 
contained in the sample.
Chromatofocusing of the double albumins (60 mg) 
in the narrow pH range (5-4) was also tried. The water- 
jacketed column (40 x 1 cm i.d.) was equilibrated with
■
degassed piperazine-HCl (pH 5.5, 0.025 M). The pH gradient 
was generated by titration with Polybuffer 74 (pH 4.0,
0.075 mmol/pH unit/ml Polybuffer) at a flow rate of 32.2 
ml/h.
4.7.5 By affinity chromatography
4.7.5.1 Dye-Affinity Chromatography1^
The dye-affinity column was synthesised as
follows.
Sepharose CL6B (50 ml) was suspended in an equal 
volumn of water warmed to 60°C. The dye (50 mg in 5 ml water) 
was added with vigorous stirring followed after 15 min. by 
addition of NaCl (5 g). The mixture was then heated to 80°C 
and solid Na2CO.j (1 g) was added, followed by incubation 
at the same temperature for 30 min. The dyed gel was then 
washed with hot water (80°C).
The affinity of the double albumins for the dyes 
was tested as follows.
The dye-affinity gel (1 ml) was washed with 
6 M urea/0.5 M NaOH (15 ml) and then equilibrated with the 
eluting buffer, sodium phosphate (20 ml, pH 8.0, 20 mM).
The purity of the colum was checked by measuring the 
absorbances of the eluate at 280 nm. The double albumins 
(1 mg) were applied and the column washed with ten column 
volumes of buffer. The absorbance of the eluted albumins 
at 280 nm was measured.
The albumins were then desorbed by five column 
volumes of sodium phosphate (pH 8.0, 20 mM) containing
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NaSCN (0.2 M) and KC1 (1 M). The absorbance of the 
fractions at 280 nm was measured. This step was 
repeated to desorb any remaining albumin. The control 
affinity column was Sepharose CL6B without any attached 
dyes.
4.7.5.2 By Bromosulphophthalein Affinity Chromatography6
Sepharose CL4B (20 ml) was washed copiously with 
water and then equilibrated in NaOH (4 ml, 5 M) for 10 
min. Bromosulphophthalein (3.04 g) and NaBH^ (160 mg) 
were added and the suspension refluxed with gentle stirring 
for 5 h at 80°C. The attached gel was then washed 
consecutively with NaOH (1 M), glycine (0.1 M)/KCl (1 M)
(pH 3), SDS (2%), urea (6 M), KSCN (2 M) in sodium 
phosphate (pH 7.4, 0.01 M), distilled water and finally 
phosphate buffer (pH 7.4, 0.01 M) containing EDTA (0.001 M) 
and NaCl (0.1 M).
Normal albumin was applied to this affinity 
column equilibrated with buffer [KCl (0.1 M), phosphate 
(0.01 M) and EDTA (0.001 M) pH 7.40]. After eluting the 
column with this buffer to remove unabsorbed albumins, 
a linear gradient of 0-1.2 M KSCN was used to elute the 
albumins.
4.7.6 By preparative PAGE under non-denaturating
conditions
4.7.6.1 Separation of Albumin
The double albumins obtained by ammonium
Osulphate precipitation and purification by ion-exchange
4 14chromatography were separated by disc-PAGE ' system.
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The separating gel was tris-(0.315 M)-HC1 (0.06 M) (pH 8.9) 
in polyacrylamide (T = 7.5%, C = 2.6%). The stacking gel 
was tris-(0.062 M)-HC1 (0.062M)(pH 8.3) in polyacrylamide 
(T = 4.5%. C = 2.5%). The electrolyte was tris- (0.05 M)- 
glycine (0.38 M) (pH 8.3). The separation can be achieved 
in gel rods (0.9 x 8 cm) or vertical slabs (17 x 16 x 1 cm).
Separation of mixed albumins (5 mg/gel rod) in 
ultrapure sucrose (10%, 200 pi) was achieved by electrophoresis 
at 2 mA/gel for 30 min. and then 3 mA/gel for 1.5 h.
*74.7.6.2 Staining Procedure
Immediately after electrophoresis, the gels were 
stained in l-anilino-8-naphthalene (0.003%, Mg2+ salt) in 
sodium phosphate buffer (pH 6.8, 0.1 M) for about 1-2 min.
The albumin bands were excised with a clean degreased razor 
under long wavelength u.v. (365 nm). Although it was 
usually unnecessary, the fluorescence could be enhanced 
by exposing the gel to cone. HC1 fumes or immersion in 
HC1 (3 M) for a few seconds.
4.7.6.3 Electrophoretic Elution of Albumins9'10
The slice of albumin containing gel was placed on 
top of a polyacrylamide support gel. This gel of similar 
composition to the separating gel was initially subjected to 
pre-electrophoresis at 2 mA/gel rod for 3 h. A buffer 
(400 pi, 0.025 M tris/0.015 M glycine and 30% glycerol] 
was layered above the tube. The other void areas above 
the gel and buffer were filled with NaCl (2 M). Elution 
of the protein from the gel was at reversed polarity at 
6 mA/gel rod for 3 h. The complete elution of albumin 
from the gel was checked by observing the gel slice for
any remaining fluorescence under UV light. After 
electrophoresis, the NaCl layers were carefully syringed 
off and the albumin-containing fractions dialysed against 
several changes of deionised water at 4°C. This fraction, 
after concentrating, when necessary, was subjected to the 
charcoal treatment of Chen^ to remove the tightly bound 
fluorescent dye and fatty acids. On slab gels, the gel 
slice was 'glued' to the support gel by the addition of 
unpolymerised acrylamide. After polymerisation, the 
electrophoretic elution of the albumin was carried out 
as described above.
4.7.7 Analysis of the albumin fractions
4.7.7.1 Ultrathin Isoelectric focusing^
An ultrathin (0.36 mm) isoelectric focusing 
polyacrylamide gel (T = 5%, C = 3%) in pH range 4-6.5 
was polymerised into a chamber consisting of a U-shaped 
gasket made of three films of Parafilm between a silanised 
glass plate and an untreated glass plate. The outer 
edges of the glass plates were sealed with agar to prevent 
leakage. During pouring of the deaerated polymerising 
solution, two paper clips were wedged in between the upper 
edges of the glass plate. These clips were removed during 
polymerisation. Isoelectric focusing, on LKB Multiphor, 
was performed in the conventional way: the anode solution 
was DL-glutamic acid (0.04 M) ; the cathode L-histidine 
(0.2 M). 5 pi of the albumin solution [albumin (0.5% w/v)
dissolved in sucrose (10%)] was applied into the sample
wells on the gel. Electrofocusing was at 400 V for 
30 min., 1000 V for 30 min. and 1500 V for 15 min. using 
a LKB 2197 power supply.
After focusing, the proteins were fixed in 50% 
sulphosalicyclic acid/10% TCA for 30 min. The Pharmalyte 
carriers were removed in destaining solutions, methanol/ 
acetic acid/water (3:1:6 v/v/v) for 30 min. Coomassie 
Erilliant Blue R-250 (0.2%) in destaining solution was 
used to stain the gel. Destaining was in the destaining 
solution. A permanent record of the gel was obtained by 
pressing a filter paper gently on the surface of the gel. 
After a few minutes, the paper was gradually pulled back with 
the gel attached to the paper. It was then dried on a 
makeshift frame.
4.7.7.2 Disc-PAGE
- 14The method of Tarnoky and Dowding was used.
4.7.7.3 Cellulose Acetate Electrophoresis 
Electrophoresis on cellulose acetate was carried
out in barbital buffer (pH 8.6, 0.05 M) at 12-25 v /cm  for 
50 min. (width-wise) or 120 min. (length-wise). Staining 
of the cellulose acetate strip was in Ponceau S (0.2% 
w/v) in TCA (3%) for 10 min. followed by three successive 
washes in acetic acid 5% (v/v).
4.8 RESULTS AND DISCUSSION
Ion exchange chromatography should resolve the 
double albumins into two peaks if separation into the 
normal and abnormal albumin had been achieved. These
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two peaks need not be completely separate. However, 
the chromatography of the double albumins on DEAE- and 
QAE-Sephadex columns at pH 5.2, 5.60, 5.70, 5.75,
6.8, 7.0 and 7.5 at different gel bed heights failed to 
separate the albumins.
The UV absorbance profile of the albumin fractions 
at 280 nm showed only a single peak, instead of the expected 
two. Analysis of fractions at either side of this single 
peak by thin layer isoelectric focusing at pH 4-6.5 
showed double albumin bands. Since all the precautions 
(i.e. packing, sample preparation and size, elution, etc) 
to ensure good chromatographic separation were undertaken, 
one may only conclude that the albumins are so similar as 
to escape separation under these conditions.
The only instance where insignificant separation 
was achieved was on a DEAE-Sephacel column equilibrated 
with tris-HCl buffer (pH 8.8, 0.1 M). The elution profile 
is shown on Fig. 4.5.
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Fig. 4.5 Elution pattern of double albumins on DEAE- 
Sephacel
C o lu m n : 1 0 0  x  3 cm . E l u e n t :  t r i S - H C l  ( 0 . 1  M, pH 8 .8 )
w it h  l i n e a r  N a C l  g r a d i e n t  t o  0 . 5  M. E a c h  f r a c t i o n :
1 0  m l .
The minor peaks 1 and 2 consisted of pure Albumin Mundey 
while the mixture of albumins was detected in the major 
peak 3. Peak 4 also consisted of double albumins but 
contained a slightly lesser quantity of the abnormal 
moiety. Therefore, ion-exchange chromatography was 
generally an ineffective method in the preparative 
isolation of Albumin Mundey.
Fig. 4.6 shows the positions of the albumins 
after electrofocusing in a granulated gel medium. The 
albumins were focused as two prominent peaks (A and B) 
of approximate isoelectric points (ple), 5.0 and 5.6. 
Peak A actually consists of two minor peaks (i and ii) 
of approximate ple of 4.8 and 5.0.
Fig. 4.6 Preparative isoelectric focusing of the 
double albumins in the pH range 4-6.5
In Section 3.2, the defatted double albumins 
were determined to be isoelectric at pH 5.70 and 5.71. 
Therefore they were expected to be focused around the 
region of peak B. Analysis of various fractions of 
peaks A and B by ultrathin isoelectric focusing between 
pH 4 and 6.5 showed that separation was not effected.
p
H
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It was not possible to explain why the albumins 
focused at two vastly different pi's. The possibility 
that incomplete electrofocusing may be a factor can be 
discounted, since a pH gradient (about 3.5 to 6.8) was 
established as shown on Fig. 4.6. The measured pH at the 
extremities of the gel bed was slightly below and above 
the focusing range of pH 4 to 6.5 due to the effect of 
the electrolytes located at these positions.
Although Albumin Mundey was obtained by prepara­
tive isoelectric focusing on polyacrylamide, the percentage 
recovery of albumins obtained by free diffusion of the 
albumins from homogenised gels was very low. Only about 10% 
of the proteins were recovered. Another source of loss 
was the removal of Pharmalyte carriers by gel filtration.
If the double albumins were separated by 
chromatofocusing, Albumin Mundey should be eluted before 
normal albumin since the ple of Albumin Mundey is the 
higher of the two albumins. Therefore, it is fractionated 
as the leading band in a decreasing pH gradient.
Chromatofocusing of the double albumins in 
the narrow pH gradient (5 to 4) and the wide pH gradient 
(6 to 4) are shown on Figs. 4.7 and 4.8, respectively.
Better resolution was obtained in the wide pH range.
The elution profile of the albumins between 
pH 6 to 4 (Fig. 4.8) shows two main peaks numbered 2 and 3. 
Peak 1 is a poorly resolved peak at the shoulder of peak 2. 
When fractions of these peaks were analysed by thin layer 
isoelectric focusing, Albumin Mundey was eluted first, 
as expected (peak 1). Peak 2 consisted of mixed albumins
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as did peak 3. The latter consisted of a slightly lesser 
quantity of Albumin Mundey.
It appeared that rechromatography of peak 2, 
consisting of double albumins^ under identical conditions 
to the first should fractionate more pure Albumin Mundey. 
Recycling of peak 2 confirmed this expectation. Although 
repetitive recycling of the second peak from each successive 
chromatofocusing should collectively produce pure Albumin 
Mundey, heavy losses in material can be expected due to 
successive rechromatofocusing and also to the intermediate 
process of removing the Polybuffer by gel filtration. As 
this study was actually performed simultaneously with 
preparative PAGE, this latter method proved to be faster, 
inexpensive and more productive.
The chromatographic behaviour of Albumin Mundey 
on 65 dye-affinity columns was monitored for two factors. 
The first factor was the binding affinity of the double 
albumins for the immobilised dye. The second was the 
differential binding of the albumins, that is, the 
quantity of albumin, (as measured by absorbance at 280 nm) 
eluted before and during block elution with buffers contain­
ing sodium thiocyanate (0.2 M) and potassium chloride 
(1 M) to desorb the albumins. Dyes that were considered 
to be useful in the separation of the albumins would 
desorb half of the total quantity of albumin before the 
block elution and the remaining half during this process. 
Dyes that manifested this behaviour are listed on 
Table 4.1. The analysis of these two fractions obtained 
from each of the dyes listed on this table showed the 
unseparated double albumins.
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Table 4.1 Immobilised dyes that selectively bound 
the double albumins
Procion Red MX-5B, H-8BN, 
MX-G, H-3BN
H-3B, HE-3B,
Procion Blue H-B-3R, H-5R, 
HE-RD, MX-4GD
MX-G, MX-2G,
Procion Yellow H-5G, HE-3G, MX-GR, H-3R
Procion Green HE-4BD
Procion Brown H-2G, MX-3BR, H-5BR
Procion Rubine MX-B
Procion Scarlet MX-G
Procion Turquoise H-7G
Procion Olive H-7G
Procion Orange MX-2R
Procion Navy MX-RB, H-4R
Cibacron Olive G-P
Cibacron Brilliant Green 4G-A
Cibacron Brilliant Yellow 3G-P
Cibacron Brilliant Blue BRP
Cibacron Black BGA
Bromosulphthalein binds serum albumin with 
high affinity in free solution11. However, when this 
dye was bound onto an insoluble matrix, it did not bind 
normal albumin which was used as a test sample. The 
reason may be that steric hindrance prevented binding.
The last point in this Chapter is the report 
of the successful separation and isolation of Albumin 
Mundey in high quantitative yields. This isolation of
■
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14Fig. 4.9 Analytical disc-PAGE on albumins obtained 
by preparative PAGE** «14
S a m p le  ( 1 )  A lb u m in  M u n d e y , ( 2 )  n o r m a l a lb u m in ,
( 3 , 4 )  u n s e p a r a t e d  A lb u m in  M u n d ey a n d  n o r m a l a lb u m in .  
S a m p le  l o a d in g  ( 1 )  2 0  y g ,  ( 2 )  10  y g ,  (3 )  5 0  y g ,
(4 )  30  y g .
Albumin Mundey in a pure, homogenous form as shown on 
Fig. 4.9, facilitated progression of this study to the 
third stage, namely fragmentation studies to detect 
the mutant peptide.
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third stage, namely fragmentation studies to detect 
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CHAPTER V
STAGE 3: FRAGMENTATION STUDIES
ON ALBUMIN MUNDEY
The last chapter described the preparative isola­
tion of Albumin Mundey in a highly purified form. This 
chapter describes methods used in end group determinations 
and chemical fragmentations of Albumin Mundey at the 
methionines and tryptophan residues.
The N-terminal residue was determined by label- 
4 11ling with DABITC and dansylchloride . The C-terminal residue 
was identified by reaction with carboxypeptidase Y1 .^
The methionine-specific reagent CNBr* and the 
tryptophan-specific reagents, NBS+, NCS^ and o-iodosoben- 
zoic acid, were used to fragment the albumin into relatively 
large peptides.
The products of these fragmentations were carefully 
monitored over numerous experiments, under standardised 
experimental conditions, for consistency in the fragmenta­
tion patterns (number of peptides produced). Cleavages 
at tryptophan were abandoned in the later stages of sequenc­
ing because of the lack of specificity. Instead CNBr was 
used because of its unequalled high specificity, quantita­
tive efficiency and reproducibility. Amino acid modifications 
of proteins purified by chromatography are known to occur
*CNBr = Cyanogen bromide 
^NBS = N-bromosuccinimide 
'NCS = N-chlorosuccinimide
/
as described in Section 6.1. With this possibility in mind 
both Albumin Mundey, processed by chromatography and PAGE, 
and the albumins in serum were subjected to cleavage.
Their fragmentation patternson PAGE were analysed for 
differences.
The control, normal HSA, was isolated from serum 
in an ultrapure form by a triple chromatographic process. 
Before subjection to fragmentations all the albumins were 
defatted6, reduced and S-carboxymethylated6, except for 
reaction with o-iodosobenzoic acid where S-pyridylethyla- 
tion16 was used.
5.1 REDUCTION AND S-CARBOXYMETHYLATION OF ALBUMIN6
The seventeen disulphide bridges of albumin 
were reduced with dithiothreitol in the presence of a 
denaturant (8 M urea) and EDTA. The sulphydryl groups 
formed were alkylated by o-iodoacetic acid to the anionic 
S-carboxymethyl cysteine residue (Scheme 5.1). The 
reaction of this halogen with the thiol group is a
Protein-SH +  I-CH2COOH----- ► Protein-S-CH2COOH +  HI .
Scheme 5.1
bimolecular nucleophilic substitution reaction where the
2highly reactive mercaptide ion is the nucleophilic reagent 
EDTA was required to chelate heavy metal ions so that the 
catalytic reoxidation of the sulphydryl group was prevented
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5.2 PERFORMIC ACID OXIDATION
Initially performic acid oxidation of cystines
27and cysteines to cysteic acid was used . However, this
process destroyed tryptophan and methionine residues 
which were essential for the chemical cleavage of albumin. 
Performic acid rendered albumin resistant to degradation 
by CNBr by oxidising methionine to the stable sulphone 
as shown in Scheme 5.2. Tryptophan was converted to 
N ' —formylkynurenine and other degradation products.
determination is based on the introduction of a marker
group (fluorescent, coloured or UV absorbing) onto the
amino function followed by characterisation of the
derivatised amino acid. This N-terminal residue could
have been determined by several methods. These are
reactions with dinitrofluorobenzene26, dansyl chloride14,
*44-N,N-dimethylaminoazobenzene-4'-isothiocyanate , or by 
31the cyanate method *
*4-N,N-dimethylaminoazobenzene-4'-isothiocyanate = DABITC
HI 0 H
c h 3- s - c m 2- c h 2 - c - c o o h
p e r f o r m i c  a c i d
C H 3 - S - C H 2 - C H 2 - C - C O O H
I
Scheme 5.2
5.3 N-TERMINAL RESIDUE DETERMINATION OF 
ALBUMIN MUNDEY
The general principle of N-terminal residue
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The N-terminal residue of Albumin Mundey was
11 4eventually determined by the dansyl chloride and DABITC
methods. These methods were chosen because of their 
simplicity in methodology and high sensitivity at the 
nanomole and picomole level respectively. This determination 
was also used to detect the presence of any non-albumin proteins, 
but not of normal albumin since these residues may be 
identical.
5.3.1 Labelling with dansyl chloride
aminonaphthalene-5-sulphonyl chloride) gives a strong yellow 
fluorescence when it forms a sulphonamide with the amino groups 
of amino acids and N-terminal residues. This is described 
on Scheme 5.3. The optimum molar ratio of N-terminal
The non-fluorescent dansyl chloride (1-dimethyl-
♦ N il,  • C lin , • CO-NH • CHR, • C O - 9.7
N
o * s * oI
NH • CHR, • CO-NH • CHR, • C O -
N
♦ NH, CHR,- COOH ♦
o *s « oI
N il - CHR, • COOH
Scheme 5.3
residue to dansyl chloride for efficient labelling is 1:5 
at pH 9.7 and 37°C. Dansyl chloride is hydrolysed to
£
hk
t
i
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DNS-OH* by water and by hydroxyl ions. It is easily 
identified as a large blue spot. In the presence of 
excess reagent, DNS-NH2** is probably produced as shown 
in Scheme 5.4.
OH9
DNS-NH • CHR • COO9 +  DNS-C1 — DNS-NH • CHR • COO-DNS----- ►
DNS-NHj +  RCHO +  C 02 + DNS-OH
Scheme 5.4
5.3.2 Labelling with DABITC
DABITC couples with the amino-group of the 
N-terminal residue in alkaline solution to form the 
DABTC***-peptide (Scheme 5.5). This moiety then cyclises 
to form the red DABTH****-amino acid in aqueous solution. 
This amino acid derivative is easily detectable on 
chromatograms as a coloured moiety.
DABTC -A.A- ( blu«) 
MV HjO
M
Scheme 5.5
*DNS-OH = 
**DNS-NH2 = 
* * *DABTC 
****DABTH =
l-dimethylaminonaphthalene-5-sulphonic acid 
l-dimethylaminonaphthalene-5-sulphonamide 
4-N,N-dimethylaminoazobenzene-4'-thiocarbamoyl 
4-N,N-dimethylaminoazobenzene-4'-thiohydantoin
5.4 C-TERMINAL RESIDUE DETERMINATION
The choice of chemical methods for C-terminal 
analysis is more limited than for N-terminal analysis.
Instead the endopeptidases, carboxypeptidase A, B, C and 
Y, are a popular choice.
Some chemical methods involve selectively labelling
20 1the C-terminal residue with tritium or by hydrazinolysis . 
The latter method was initially chosen but was later 
abandoned because of explosive side-reactions. Anhydrous 
hydrazine is used in rocket propulsion fluid! During 
hydrazinolysis, amino acid hydrazides are released from the 
C-terminal of the protein, but only the C-terminal residue is 
liberated as the free amino acid. These moieties are released 
when the protein is heated with anhydrous hydrazine at 100°C.
anhydrous
n 2h4
........ -N H  • CHRm- C O -N H  • CHRn • C O O H --------- .
100 cc
........+  NH2 • CHRm • CO • NH • NH2 +  NH, • CHRn • COOH
Scheme 5.6
Carboxypeptidase Y (EC 3.4.12.-) an exopeptidase 
of the 'serine' and 'acid' class, was used to determine 
the C-terminal residue of Albumin Mundey. This enzyme has 
a broad specificity and releases amino acids sequentially 
from the C-terminus of proteins and peptides. The C-terminal 
residue was then identified by TLC.
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5.5 SPECIFIC CLEAVAGE AT METHIONINE BY CNBr12
CNBr cleaves the C-terminal bond of methionine 
by reacting specifically with the sulphur on the thioester 
side chain of methionine. A mixture of homoserine, 
homoserine lactone and methylthiocyanate is formed. 
Therefore, the C-terminal residues of all fragments 
produced will be homoserine or its lactone except of 
course, when methionine is C-terminal (Scheme 5.7).
Side reactions that can occur in acidic 
conditions include:
(i) The attack of cysteinyl side chains without bond
o o o o
R -N H -C H -C -N H -C H -C -
CH
CH
R
S
CH
R 0
H 0 o  h 20 H ♦NH-CH-C-. H
R -N H -C -C , R - N H - C - C v' ,0 0r
h 2c - c h 2R
C H -S-C ÏN
R - N H - C H - C 0 0 H
l
CH.
OH Scheme 5.7
cleavage. Carboxymethylation of the cysteinyl 
side chain to S-carboxymethyl-cysteine (^ 0) 
prevented this.
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S-CHjCOOH
I
CHj
I
HjN-CH-COOH
(ii) Methionyl side chains can be oxidised to the
sulphoxide or sulphone (Scheme 5.8). But this 
effect was checked by maintaining the reaction 
mixture in an oxygen-free atmosphere.
c h 3 - s - c m 2 - c h 2 - c - c o o h
n h ;
( 0 )
0  HIl I
c h 3 - s - c h 2 - c h 2 - c - c o o h  
0  n h 3
methionine sulphone
Scheme 5.8
CNBr cleavage of HSA at the six methionines 
should produce seven peptides if all the bonds were equally 
susceptible to cleavage. However, methionine-123 is only 
partially susceptible to cleavage. When cleavage at this
7residue does not occur, methionine is converted to homoserine . 
When this factor was taken into account in this cleavage, 
eight peptides were expected as cleavage products (Table 5.1).
5.6 CLEAVAGE AT TRYPTOPHAN
HSA only has one tryptophan residue at position 
214. Therefore, specific cleavage at this residue should, 
ideally, produce two fragments of quite distinct sizes 
and character. It was originally hoped that if the appro-
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TABLE 5.1 Fragmentation Products of HSA by CNBr
CNBr
Fragment Number N-terminal Residues Residue Number
I Aspartic acid 1-87
II + Alanine 88-123
II + III+ Alanine 88-298
III Cysteine 123-298
IV Proline 299-329
V Phenylalanine 330-446
VI Proline 447-548
VII Aspartic acid 549-585
23♦Primary sequence of HSA according to Meloun 
’'Fragments produced by partial cleavage at Met-123
priate half of Albumin Mundey could be identified by 
electrophoresis to contain the mutation(s), it could 
then be isolated and then specifically degraded again 
into smaller fragments (e.g. by trypsin and/or CNBr). By 
this second cleavage, smaller mutant fragment(s) could 
then be identified. The identification of the small 
fragment(s) could be done by realignment of the peptides 
by overlapping sequences followed by determination of 
the N-terminal residues.
The reagents used (NBS, NCS and o-iodosobenzoic 
acid) were found generally to lack specificity, gave low 
cleavage yields and were accompanied by undesirable side 
reaction, unless performed under very stringent conditions. 
Albumin Mundey unseparated from normal albumin was subjected 
to tryptophan-cleaving reagents since these experiments
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were performed before their very difficult separation had 
been achieved.
5.6.1 With NBS and NCS
The mechanisms of cleavage by NBS and NCS (Scheme 
24 275.9) are similar at low pH ' , whereby they halogenate
Scheme 5.9
the indole nucleus. The halogenated indole moiety then 
undergoes spontaneous dehalogenation to form the oxindole 
derivatives through a series of oxidation and hydrolysis. 
The oxindole derivative then promotes the cleavage 
reaction.
Side reactions that can occur with NBS cleavage
are (i) oxidations of sulphydryl groups and disulphide
bonds, which can result in cleavage of cysteinyl bonds'^;
and (ii) the increased susceptibility of tyrosyl and
25histidyl bondsto cleavage in larger excess of NBS
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5.6.2 With o-iodosobenzoic acid
The proposed mechanism of cleavage by o-iodoso- 
benzoic acid is generally similar to that of NBS and NCS25
except that a halogenated intermediate is not formed.
The mechanism on Scheme 5.10 consists of four
separate steps. The first oxidation step produces the
produces an iminospirolactone formed by cyclisation of 
the carbonyl carbon on the oxidised indole nucleus. This 
step is probably the rate-determining step. The last 
step is the hydrolysis of the iminolactone to form 
N-acyldioxindolyalanine (21) resulting in peptide bond 
cleavage.
H H
5-iOOOSOBENZOiC
ACID
H
Scheme 5.10
2 8oxindolyl derivative . The following oxidation step
HO _.CHo—CH
N
H
(*i)
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Oxidation of tyrosyl residues by o-iodoxybenzoic 
acid, which is the disproportionate product of o-iodoso- 
benzoic acid (Scheme 5.11), can presumably be reduced by
preincubation with p-cresol. p-Cresol reacts with the
+ 19released I or I2 •
I N M
Disproportionation of two molecules of o-iodosobcnzoic 
acid (I) produces one molecule of o-iodoxybenzoic acid (II) and one 
molecule of o-iodobenzoic acid (III).
Scheme 5.11
5.7 Preparation of chromatographic ally pure
normal albumin
Normal HSA was used as a control in all these
experiments. The successive methods used to obtain
chromatographically pure normal HSA from pooled serum
22were: ammonium sulphate precipitation , ion exchange
chromatography, affinity chromatography and gel filtration.
Precipitation of albumins from serum by ammonium
21sulphate rather than dextran sulphate or polyethylene 
glycol1(^ was chosen because of the great ease of removal 
of the precipitating agent16. Contaminants such as 
y-globulins and bilirubin-bound albumin were removed by 
ion-exchange chromatography on QAE-Sephadex. Affinity 
chromatography on Sepharose CL6B (22) removed the last 
traces of non-albumin proteins. Albumin dimers and 
oligomers were removed by gel filtration on Sephadex 
G-100. The resulting yield of ultrapure albumin was 
30%. This albumin was then defatted by the method of
15 7
Chen5. The purity of the albumin was determined by SDS- 
34PAGE and conventional thin layer PAGE.
5.8 EXPERIMENTAL
5.8.1 Preparation of chromatographically pure normal
HSA
5.8.1.1 Ammonium Sulphate Precipitation
22Method modified from McMenamy . Ammonium 
sulphate (2.77 g) was added slowly with mixing to serum 
(10 ml) contained in a centrifuge tube to form a 45% 
saturated solution. The pH was adjusted to 6.5. After 
standing at 4°C for 5 min., the proteins were precipitated 
by centrifugation on a bench top centrifuge. The 
supernatant was removed into another centrifuge tube to 
which ammonium sulphate (2.10 g) was slowly added to 
form a 75% solution. The albumins were pelleted by 
centrifugation and then semi-dried by inversion of the 
tube on a piece of filter paper. The albumin was 
solubilised in water (about 10 ml) and the pH adjusted 
to 6.5. It was then dialysed against tris-HCl (pH 7.0, 
0.01 M) at 4°C by ultrafiltration at a pressure of 15 psi 
in a magnetically-stirred cell fitted with an Amicon PM-10
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filter. The albumin was then subjected to ion exchange 
chromatography.
5.8.1.2 Ion-Exchange Chromatography
The ammonium sulphate-precipitated albumin was 
subjected to continuous gradient elution ion-exchange 
chromatography on a QAE-Sephadex column. The column 
(40 x 2 cm i.d.) was equilibrated with tris-HC1 (pH 7.0,
0.1 M). Initially the flow rate of the column was 
adjusted to near zero for half an hour. It was then washed 
with five column volumes of loading buffer until the 
absorbance of the eluate at 280 nm was near zero.
Desorption of the albumin was by a continuous linear gradient 
of NaCl (0-0.5 M) . The albumin peaks were then dialysed 
against iris-HCL (pH 7.0, 0.05 M) and then applied to 
affinity chromatography.
5.8.1.3 Affinity Chromatography
The albumins were applied to a water-jacketed Blue Sepharose 
CL6B affinity column (10 x 1.5 cm i.d.) equilibrated with 
tris-HC1 (pH 7.0, 0.05 M) at a very slow flow rate. After 
zero flow rate for about half an hour, the unabsorped 
proteins were eluted off. The chromatographically pure 
albumin was desorbed by block elution with the eluting 
buffer containing KC1 (1.5 M).
5.8.1.4 Gel Filtration 
Gel filtration of the albumin was on a Sephadex
G-100 (100 x 1.5 cm i.d.) column eluted with water. The 
albumin peaks were dialysed against water (1.5 1) and then 
lyophilised.
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5.8.1.5 Defatting and Removal of Bound Ligands 
on Albumin
The method of Chen3 was followed exactly as
published.
5.9 DETERMINATION OF PURITY OF ALBUMINS
5.9.1 By SDS-PAGE
The purity of albumin was determined by slight 
overloading of the proteins on SDS-PAGE34.
5.9.2 By conventional thin-layer PAGE 
(LKB application note 306)
Large numbers of albumin
samples were screened by horizontal thin layer PAGE (26 x
11.5 cm). This consisted of a tris-glycine buffer (75.1 g 
glycine and 2.5 g sodium azide dissolved in 3 1 water, then 
titrated to pH 8.9 with trisma base) in polyacrylamide
(T = 7.7%, C = 2.6%). Pre-electrophoresis was at 50 mA 
for 30 min. at 10°C on LKB Multiphor 2117. Albumin samples 
(15 mg/ml) were applied onto the gel via filter paper 
sample holders. Electrophoresis was at 15 V/cm for
2.5 h. The albumins were fixed in TCA (57.0 g)/sulpho- 
salicyclic acid (17.0 g) in methanol/water (500 ml, 3:7 v/v) 
for 1 h at room temperature. The gel was stained in Coomassie 
Blue R-250 (0.1%) in methanol/acetic acid/ water (5:1:5 v/v/v) 
and then destained in ethanol/acetic acid/water (3:10:6 
v/v/v).
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5.10 END GROUP DETERMINATION
5.10.1 Reduction and S-carboxymethylation6
Deionised, cyanide ion free urea (3.60 g) and 
EDTA (15 mg) in tris-HC1 (12 ml, pH 8.4, 1 M) were 
rendered oxygen-free by bubbling in oxygen-free nitrogen 
(having passed through alkaline pyrogallol) for about 
30 min. in a screw-cap vial. Pure normal or abnormal 
albumin (25 mg) was added. Water (2 ml) and urea 
[4.5 ml, 8 M in 0.2% (w/v) EDTA] were added to fill the 
tube completely. 6-mercaptoethanol (100 ul) was added 
for reduction at room temperature for 4 h.
The albumins were S-carboxymethylated by drop- 
wise addition of iodoacetamide (0.268 g) in NaOH (1 ml,
1 M). The sample was then dialysed against deionised 
water containing thiodiglycol (0.2%) and EDTA (0.02%).
5.10.2 Dansyl chloride method11
The reduced and S-carboxymethylated albumin 
(50 yg) , was dissolved in SDS (1%, 50 yl) in a test 
tube (0.4 x 5 cm) by immersion in a boiling water bath 
for 5 min. N-ethylmorphorline (50 yl) was added to the 
cooled mixture followed by dansyl chloride (75 yl,
25 mg/ml) in anhydrous dimethylformamide to label the 
N-terminal residue. Dansylation was achieved by letting 
the reaction mixture stand at room temperature for 3 h, 
after which dry acetone (500 yl) was added to precipitate 
the protein.
After about 30 min., the mixture was centrifuged
and the pellet obtained redissolved and washed in dry
acetone (80%, 500 pi), and then dried in vacuo.
The product was hydrolysed by heating in 5.7 M
hydrochloric acid at 105°C for 18 h. in the flame - sealed
tube. After drying in vacuo at 40°C, dry pyridine was
added (50%, 10 pi) to the sample. The labelled N-terminal
residue was determined by two-dimensional ascending TLC
on micropolyamide plates. The solvent systems used
[1.5% formic acid and benzene/acetic acid (4.5:1 v/v)] were 
1 8 1 *3by Lee and Safille or Hartley . Fluorescence of the dansylated 
derivatives under UV light (365 nm) could be enhanced by 
exposure to concentrated ammonia fumes. The controls were 
normal HSA with and without added dansyl chloride. Dansyl 
derivatives with close proximity to dansyl-L-aspartic acid 
(dansyl-L-arginine, -e-lysine, -serine and -glutamic acid) 
were used as markers on the chromatogram.
5.10.3 By DABITC method4
Albumin (1 nmol) was dissolved in 50% aqueous 
pyridine (80 pi) in a small test tube (0.4 x 5 cm). A 
freshly prepared solution of DABITC (40 pi, 4 mg/ml in 
pyridine) was then added. The ensureing coupling reaction 
was performed in a flame-sealed glass tube at 52°C for 2.5 h, 
after which the excess reagent and by-products were extracted 
with 3 portions of heptane/ethyl acetate (500 pi, 2:1 v/v) 
by vortexing and centrifugation. The organic layer was 
carefully removed and the remaining aqueous layer dried
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in a vacuum over P2O5. The dried sample was redissolved in 
water (40 pi) and acetic acid-saturated hydrochloric acid 
(80 pi). Cleavage of this labelled N-terminal residue 
was at 52°C for 50 min.
The DABITC-derivatives were identified by two 
dimensional ascending TLC on micro-polyamide plates.
Solvent systems were water/acetic acid (2:1 v/v) and 
toluene/n-hexane/acetic acid (2:1:1 v/v/v). To develop 
the red colour of the DABTH-amino acid, the dried chromato­
grams were exposed to HC1 vapour. A control, normal HSA, 
was also used.
5.10.4 Synthesis of control DABITC-derivatives3
L-amino acids (0.5 pmol) were dissolved in buffer 
[100 pi, acetone (25 ml), triethylamine (1.2 ml) and water 
(20 ml) titrated to pH 10.1 with acetic acid. The volume 
was made up to 50 ml with water] and incubation lasted 
1 h at 30°C. The solution was then dried in vacuo over 
P20jj. The dried compound was then redissolved in water (200 pi) 
and hydrochloric acid-saturated acetic acid (400 pi).
Incubation was for a further 50 min. at 50°C. After 
drying in vacuo again, ethanol (400 pi) was added to 
extract residue. Synthesised derivatives were L-glycine, 
L-arginine, L-aspartic acid, L-asparagine, and L-glutamine.
5.10.5 C-terminal determination by cleavage with
carboxypeptidase Yi
The full enzymatic activity of the lyophilised 
carboxypeptidase Y (5 pg) (specific activity: 55 pmol/
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min/mg against acetyl-tyrosine-ethyl ester) was initially 
restored by incubation with water (1 yl) at 0°C overnight.
The activity of the contaminant, yeast proteinase A, in 
the preparation was inhibited by preincubation with a 
solution (10 yl) of pepstatin A (1 mM) in MES buffer 
(10 mM, pH 6.8) for 2 min. at room temperature.
The reduced and S-carboxymethylated albumin 
(50 yg) was dissolved in MES buffer (20 yl, 10 mM, pH 6.8). 
This sample was then added to the activated carboxypeptidase. 
Incubation was at 37°C for 10 min. The reaction was stopped 
by freezing and the mixture lyophilised. The controls 
used were: normal albumin with and without added 
carboxypeptidase Y, L-leucine and L-glycine. These two 
amino acids are the last and penultimate amino acid 
residues of normal HSA. The C-terminal residue was 
identified by ascending TLC on silica gel G plates 
(without fluorescence). The solvent system was chloroform/ 
methanol/30% ammonia (2:2:1 v/v/v). Spots were visualised 
by spraying with ninhydrin (0.5%) in acetic acid/l-butanol 
(1:20 v/v) and then incubated at 110°C for 10 min.
5.11 SPECIFIC CLEAVAGE AT METHIONINE
5.11.1 Cleavage of Albumin Mundey
The normal albumin was dissolved in 70% formic 
acid to a concentration of 3 mg/ml. CNBr (50-fold molar 
excess) was added and the reaction allowed to proceed for 
20 h at room temperature in a tightly stoppered flask.
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Water (10 ml) was added to the reaction mixture and the 
resulting solution lyophilised to remove volatile reactants. 
This procedure was repeated. Thiodiglycol (2%) was added 
to all solutions used after cleavage. The control was 
Albumin Mundey without any added CNBr.
5.11.2 Cleavage of double albumins in serum
This cleavage was performed according to the method 
□of Franklin . A corresponding control serum containing no 
CNBr was also set up.
Fragmentation analysis was on the polyacrylamide 
(12%) slab gel containing urea (5 M)/Triton X-100 (6 mM)/ 
acetic acid (5%)^ ~*.
5.12 CLEAVAGE OF DOUBLE ALBUMINS AT TRYPTOPHAN
5.12.1 Cleavage by NBS8
The double albumins (0.5 mg) were dissolved in 
8 M urea/2 M acetic acid (90 yl). A twenty fold molar 
excess of NBS (26 mg) in the same buffer (10 yl) was 
added to the albumins, followed by incubation at room 
temperature for 20 min. The reaction was terminated with 
a ten molar excess of tryptophan (10 mg). The cleavage 
products were then separated on a Sephadex G-10 column 
(14 x 0.5 cm i.d.) eluted with 8 M urea. The eluate was 
monitored at 280 nm. The control consisted of double 
albumins without any NBS.
I
5.12.2 Cleavage by NCS29
The double albumins (2 ymol) were dissolved in 
50% acetic acid (3 ml) and NCS (10 fold molar excess) in 
dimethylformamide (0.3 mmol/ml) added. The reaction 
mixture was stirred for 40 min. at room temperature 
after which methionine was added to destroy excess CNBr.
The solvents were then removed in vacuo and the precipitate 
redissolved in acetic acid (0.1 M, 800 pi). The fragments 
were desalted on a column of Biogel P-Z (90 x 1.5 cm i.d.) 
eluted with acetic acid (0.1 M). The control double albumin 
contained all the reagents except NCS.
5.12.3 Cleavage by o-iodosobenzoic acid1^
The reduced double albumins were first reacted 
with 4-vinyl-pyridine and then subjected to cleavage 
by o-iodosobenzoic acid.
Double albumins (0.9 ymol) dissolved in 
guanidine-hydrochloride (6 M)/tris (0.13 M)-EDTA (0.1 mg/ml)
(pH 7.6, 3 ml) were reduced with dithioerythritol (52 ymol) 
for 3 h at room temperature. After reduction, the albumins 
were reacted with 4-vinyl-pyridine (156 ymol) for 90 min.
The reaction solution was then acidified to pH 2.0 with 
88% formic acid and then desalted by exhaustive dialysis in 
88% formic acid^.
The specificity of o-iodosobenzoic acid for 
tryptophanyl bonds was improved by decreasing the activity 
of o-iodoxybenzoic, a contaminant which modifies tyrosyl groups.
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This was achieved by preincubating o-iodosobenzoic acid 
(37 ymol) with p-cresol in 80% acetic acid/guanidine 
hydrochloride (4 M) for 2.5 h at room temperature.
Double albumins (0.075 ymol) were added and 
the reaction mixture allowed to proceed at room temperature 
for 24 h in the dark. Dithioerythritol (5 mg) was 
added to stop the reaction.
Exhaustive dialysis in 10% acetic acid in the 
dark at 4°C was followed by lyophilisation. Two controls 
were also set up - double albumins and normal HSA, to 
which no o-iodosobenzoic acid was added.
5.13 RESULTS AND DISCUSSION
Monomeric normal HSA was eluted in peaks 2 and 4 
(Fig. 5.1). The first peak represents immunoglobin G 
and dimeric albumins were found in peak 3, which is the 
shoulder of peak 2.
Fig. 5.1 Continuous gradient elution of ammonium 
sulphate - precipitated normal albumins 
on QAE-Sephadex A-25. Bed dimensions:
40 x 1.5 cm. Eluent: Tris-HCl (pH 7.0, 
0.1 M). Each fraction: 2 ml.
Fig. 5.2 shows the elution profile of normal 
albumin on Blue Sepharose CL6B. The slight shoulder
at the start of the albumin peak may be due to bilirubin- 
bound albumin that escaped fractionation on the previous 
chromatographic column.
Fig. 5.2 Chromatography of purified normal albumin on 
Blue Sepharose CL6B. Bed dimensions: (10 x 
1.5 cm). Temperature 10°C. Eluent: tris-HC1 
(pH 7.0, 0.05 M). Albumins desorped by block 
elution with eluent containing KCl (1.5 M).
After gel filtration, to remove aggregates of 
albumin, and defatting the albumins were judged to be pure 
by SDS-PAGE and conventional thin-layer PAGE. Fig. 3.4 
illustrates its purity on an isoelectric focusing gel 
(pH 4-6.5).
The N-terminal residue of Albumin Mundey is L- 
aspartic acid. The two dimensional chromatogram (Fig. 5.3) 
shows an overlap of this residue with that of normal 
albumin and dansyl-L-aspartic acid. They are distinctly 
separated from other dansyl derivatives with close 
proximity to dansyl-L-aspartic acid. DNS-OH was recognised 
as a large blue fluorescent spot.
Labelling of the N-terminal residue of Albumin 
Mundey with DABITC produced inconclusive identification. 
Actually, the red DABTH-aspartic acid of normal HSA is 
near that of Albumin Mundey (Fig. 5.4(f)), but not to
^
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Fig. 5.3 Two dimensional chromatogram of the dansylated 
N-terminal residues of Albumin Mundey, the 
control normal HSA and other reference L-amino 
acids.
=  A lb u m in  M u nd ey Q  =  n o r m a l HSA
that of the synthesised control, DABTH-aspartic acid 
(Fig. 5.4(c)). This latter observation may be attributed 
to the effect of different solvent systems used in the 
synthesis of the DABTH-amino acids and the labelling 
procedure. On Fig. 5.4(a) lysine was identified as three 
different moieties.
On Fig. 5.4 the red a-DABTH-e-lys,(a)iii, with 
its close proximity to the N-terminal residue of Albumin 
Mundey, was initially thought to be the residue of interest. 
However, the use of the more established procedure, 
dansylation, disproved this without any doubt. The other 
two incompletely converted lysyl derivatives were 
identified by their colour. These are a-DABTH-e-DABTC- 
lysine,(a)i,which was purple-blue and the blue a-PTH-e- 
DABTC-lys,(a)ii.
Partial deamination of the asparaginyl side 
chain by the synthetic process resulted in the simultaneous
production of DABTH-aspartic acid. A similar partial 
deamination of glutamyl side chain to glutamic acid was 
not observed in Fig. 5.4(e).
The C-terminal residue of Albumin Mundey released 
by carboxypeptidase Y is L-leucine (Fig. 5.5(c). Its 
mobility is identical to the C-terminal residue of normal 
HSA (Fig. 5.5(c)) and L-leucine (Fig. 5.5(d)).
* t • t •
« « X X Xa b e d «
Fig. 5.5 Silica gel chromatogram showing the C-terminal
residues cleaved by carboxypeptidase and controls, 
(a  = n o r m a l H S A  w it h o u t  c a r b o x y p e p t id a s e )  b =  n o r m a l HSA 
w it h  c a r b o x y p e p t i d a s e )  c  =  A lb u m in  M u n d ey w it h  c a r b o x y ­
p e p t id a s e ;  d  =  L - l e u c i n e ;  e = L - g l y c i n e )
Therefore, the N-terminal residue of albumin 
Mundey is L-aspartic acid while L-leucine is C-terminal.
Analysis of the fragmentation products of 
Albumin Mundey by the methionine-specific and tryptophan- 
specific reagents are discussed separately in the next 
chapter.
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CHAPTER VI
STAGE 4: PEPTIDE MAPPING
This chapter deals with methods used to examine 
the products of chemical fragmentation of Albumin Mundey.
A method for the preparative isolation of the mutant 
peptides is also described and the binding of bilirubin to 
Albumin Mundey studied by the fluorescence.-quenching method.
CNBr fragments were analysed on 12% polyacrylamide 
gel containing 5 M urea, 6 mM Triton X-100 and 5% acetic 
acid^. This procedure was found to have a high degree 
of reproducibility and sensitivity to small changes in 
ionic charge of the peptides. This charge, which determines 
the electrophoretic mobility of the peptide, is due to 
differential micelle formation of this detergent with the
non-polar regions of the peptide. These regions of the
19peptide are generally of high helical content . Unlike 
most conventional gel systems, it is also able to resolve 
neutral amino acid substitutions. When long gels (48 cm) 
were used, a higher degree of resolution and clarity of 
the peptide maps were obtained as opposed to conventional 
gels of length 16 cm.
Fragmentation products of the tryptophan-specific
8 16cleavages were resolved on SDS-PAGE ' or by SDS-gradient 12
12PAGE (12-25%). However, no distinctive advantage was
achieved by the use of the latter gel system.
In the initial stages of peptide mapping a highly 
11 18sensitive silver stain ' was used to detect peptides
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that were below the sensitivity of the organic stain, 
Coomassie Blue. This stain is 100-fold more sensitive 
than Coomassie Blue. Protein bands are detected by a 
process analogous to the photographic printing process 
whereby ionic silver is reduced to the metallic form. 
However, it was found to be too sensitive to be of 
practical use as numerous artefactual bands were produced.
6.1 PREPARATIVE ISOLATION OF PEPTIDES
The same polyacrylamide gel system as in peptide 
mapping was used in the preparative isolation of the 
peptides. The peptides were extracted from the excised 
gel slices by reverse polarity electrophoretic elution10 
or by free diffusion from homogenised gels5. The identities 
of the peptides were established by use of dansyl chloride 
to label the N-terminal residue15 and by molecular weight 
determination5.
This preparative method, which entailed the excision 
of the peptide-containing gel immediately after rapid 
staining with Coomassie, was chosen against other methods 
such as chromatography for the following reasons.
(i) Positive identification of the mutant peptides 
was guaranteed.
(ii) The expected difficulty in identification of the 
mutant peptides by chromatographic fractionation 
as they are physiochemically very similar to their 
normal analogues.
(iii) Amino acid modifications occur in the peptides 
fractionated by chromatography.
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Scheme 6.2
These reasons justified the preparative method used.
The extracted peptides were identified by 
determination of their N-terminal residue by dansylation1^
Oand by molecular weight determination by SDS-PAGE .
The binding of bilirubin to Albumin Mundey was
determined by fluorescence-quenching studies. Albumin,
like most proteins, exhibit ultraviolet fluorescence which
can be quenched by binding of ligands. This quenching
2only occurs with binding and the binding of bilirubin 
causes such quenching1. Therefore, with this technique 
both the capacity and affinity of albumin for bilirubin 
could be determined.
6.2 OTHER PREPARATIVE TECHNIQUES
C-NH-
* h n /C H \ : h  I I/ ^ r/ s O c  
H,
This section describes two methods commonly 
used in fractionation of peptides. They are chromato­
graphy and HPLC.
6.2.1 Chromatography
Chromatographic separation of peptides are usually 
achieved by a combination of several techniques. These
i t*- .. JHgÌKL.
are ion exchange chromatography, gel permeation chromato­
graphy and paper electrophoresis. In one variation, the 
mixture of peptides is initially fractionated on a 
cationic exchanger. The resulting impure fractions are 
rechromatographed on an anionic exchanger. Finally, the 
remaining unresolved peptides can then be fractionated 
by gel filtration or paper electrophoresis. Alternatively, 
the sequence of the above processes can be reversed, i.e. 
an initial resolution by gel filtration followed by fractiona­
tion by ion-exchange chromatography.
6 . 2 . 2 HPLC
6.3 EXPERIMENTAL
Fullmer and WassermanJ described the use of a 
combination of solvents coupled with gradient elution 
from reversed phase support media in analytical and prepara­
tive peptide mapping. The solvent system was orthophosphoric 
acid-acetonitrile. Wilson^, in a recent series of papers
described the implementation of HPLC in the fractionation of
4 6peptides. Acetonitrile ' and the hydrophilic ion-pairing 
solvent, orthophosphoric acid*’, were also used in the rapid 
and effective separation of peptides.
6.3.1 Peptide Mapping
The peptides were resolved on polyacrylamide gel 
(12%) containing the gel buffer, 5 M urea/6 mM Triton-XlOO
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in 5% acetic acid. The initial fractionation was on short 
vertical slab gels (17 cm) but the resolution was vastly 
improved on gels of longer lengths (48 cm).
The gel was initially subjected to pre-electro- 
phoresis at 360 V for 36 h after which constant wattage 
was obtained. It was then overlayered with a solution of 
the above gel buffer containing a reducing agent, dithio- 
threitol (0.5 M) to maintain the gel in a reduced state.
This precaution reduced or prevented the oxidation of 
amino acids as described in Section 6.1. Similarly, all 
glassware was washed in thiodiglycol (0.1%) and all buffers 
used contained this agent in similar concentrations. 
Electrophoresis was carried out at 300 V until the 
Fuchsin Red marker was eluted out of the gel.
After electrophoresis the peptides were fixed in 
10% TCA, stained in 0.1% Coomassie Blue in destaining solution, 
acetic acid/methanol/water 10:45:35 (v/v/v). The gel was 
then destained at room temperature.
6.3.2 Preparative isolation of peptides
The preparative gel, which was of similar 
composition to the analytical gel, was of dimensions 
48 x 23 x 3 cm. Immediately after electrophoresis, the 
gel was rapidly stained (about three-quarters to one hour) 
in Coomassie Blue (0.2% w/v) dissolved in water. This 
process avoided amino acid modifications that could be 
acquired during prolonged staining in conventional 
solutions containing organic solvents. The lightly-stained
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gel was then rinsed in water.
In the method of Gibson and Gracey8, the peptide 
band was excised from the gel. It was finely homogenised in 
formic acid (60%) to form a gel/supernation suspension of 
proportions 1:1 (v/v). Peptides were eluted from the gel 
by magnetic stirring for 6 h at 4°C. The supernatant 
obtained by centrifugation was then removed. The homogenised 
gel was washed twice with formic acid (60%) to increase 
recovery of the gel. All the supernatants were combined 
and lyophilised.
To extract the dye, equal volumes of HC1 (5.7 M) 
and n-octanol were added to the lyophilised peptide. After 
thorough mixing, the solutions were centrifuged and the 
dark blue organic layer removed. This extraction was 
repeated twice. The final acid phase was diluted with 
water and the formic acid removed by lyophilisation, 
resulting in pure peptides.
The electrophoretic elution of peptides by the 
method of Mendel-Hartig10 was found to be more effective 
with SDS-PAGE8,16 than with Triton-urea gels20.
6.3.3 N-terminal determination of peptides
Modification of the method by Tamura18. The 
peptides (1 nmol) were dissolved in cold triethylamine 
(0.1 M, 10 pi). Cold dansyl chloride (0.5% w/v, 10 ul)
in dry acetone was added and the reactants refrigerated 
for 16 h. The solvents were then removed at 40°C 
in vacuo.
Hydrochloric acid (5.7 M, 50 ul) was added and 
hydrolysis carried out in flame-sealed tubes for 18 h at 
105°C. After drying again in vacuo at 40°C, the dansyl 
amino acid was identified by two dimentional TLC on 
micro-polyamide plates using the solvent system of 
Hartley^.
6.3.4 Gradient gel 12
A gradient gel was cast by magnetically mixing 
two polyacrylamide solutions of different cross-linkings 
and then introducing this polymerisation solution into the 
polymerising chamber at a steady rate (about 10 ml/min).
This gradient gel was tris-HCl (pH 8.8, 36.6% 
w/v) containing SDS (0.1% w/v) in polyacrylamide (12-25%). 
The electrolyte was tris-glycine [pH 8.3, trisma base 
(30.2 g) and glycine (144 g) dissolved to 1 litre water].
The stacking gel was tris-HC1 (pH 6.8, 6%) in polyacrylamide 
(1 0 %).
After electrophoresis, for about 7 h, the gel 
was stained overnight in Coomassie Blue R-250 (0.02%) in 
acetic acid (7%). The gel was then destained in methanol/ 
acetic acid/water 5:2:13 (v/v/v).
6.3.5 Laemmli gel
3The method was modified from Laemli . The 
glass tube was pretreated with dimethyldichlorosilane to 
prevent adhesion of the gel to the tube and so ease removal
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of the gel after electrophoresis. The gel (0.6 x 15 cm) 
was tris-HC1 (pH 8.8, 0.375 M) in polyacrylamide (12.6%).
The electrophoresis buffer was tris (0.5 M)/glycine (0.384 M) 
(pH 8.3). The gel and electrophoresis buffer both contained 
SDS (0.1% w/v and 1% w/v respectively).
Electrophoresis was carried out at 120 V, after 
which, the gel was fixed in isopropanol/acetic acid/water 
5:2:13 (v/v/v). The stain was Coomassie Blue R-250 
(0.1%) in methanol/acetic acid/water 5:2:13 (v/v/v).
Destaining was also in this solution without the added dye.
The standard markers used were of molecular weight 
2,512-16,949 and 12,300-78,000 obtained from BDH.
6.3.6 Silver stain14
The peptides in the gel were fixed in methanol/acetic 
acid/water 25:6:19 (v/v/v) for 1 h, followed by rinsing in 
ethanol/acetic acid/water 2:1:17 (v/v/v) for 20 min. The 
gel was rinsed again in water (1 litre) for 20 min., 
glutaraldehyde (1., 500 ml), followed by three rinses in 
water (1 litre) for 20 min each.
A freshly made silver stain was made by adding 
silver nitrate (20 ml, 3.88 g silver nitrate in 20 ml 
water) slowly but with rapid mixing to this solution (95 ml 
water, 9.2 ml 1 M NaOH and 7.0 ml 35% NH^OH). Water was 
then added to the resulting concoction until the 500 ml 
mark. After staining the gel in this solution for 20 min., 
the gel was washed in water (1 litre) for 15 min. The 
silver ions were reduced in a Switzer Reducer (100 ml
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ethanol, 60 mg citric acid and 0.25 ml 37% formaldehyde 
made up to 1 litre water). The final stages consisted 
of washing the gel in three washes of water (1 litre).
A number of precautions had to be observed with 
this staining process. These are
(i) all vessels must be very clean,
(ii) the gel must be agitated intermittently during 
all steps,
(iii) the gel must be handled with gloves since 
fingerprints are also stained!! and
(iv) the gel must be removed immediately from the 
Switzer Reducer when the bands are stained.
Any prolonged immersion will result in very 
dark backgrounds. This background can, 
however, be decreased with commercial 
photographic fixer (1:9 v/v).
6.3.7 Bilirubin binding9
The binding of bilirubin was studied by the 
fluorescence-quenching method. The fluorescence of 
albumin (1.04 pmol/lit, 3 ml, pH 7.4) in a far UV-quartz 
cuvette was measured by adding portions of bilirubin 
(20 pmol/lit). After mixing, the fluorescence was measured 
using a Perkin-Elmer Fluorescence Spectrophotometer MPF-3 
where the excitation filter had a maximal transmission at 
294 nm with a half band width of 13 nm, while the emission 
maximum was 343 nm with half band width of 12 nm.
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6.4 RESULTS AND DISCUSSION
Non-specific cleavages at tryptophan-214 by 
NBS, NCS and o-iodosobenzoic acid (Table 6.1) were attested 
by examination of the fragmentation products on SDS-PAGE6. 
Highly specific cleavage at this residue should produce 
three peptides. These are the uncleaved albumin, N-terminal 
fragment (residue 1-214) and the C-terminal fragment 
(residue 215-585).
Table 6.1 Fragments obtained by the cleavage of 
o-iodosobenzoic acid on albumins
Sample o-Iodosobenzoicacid
R.M.* Of 
protein band
Identity of 
protein band
Normal HSA X 0.25 Uncleaved HSA
Normal HSA / 0.25 Uncleaved HSA 1 H '  !
0.29 t
0.35 Unknown
0.44 t
Double albumins X 0.26 Uncleaved albumins
Double albumins / 0.25 Uncleaved albumins
0.30 t
0.37 Unknown
' 0.42 Unknown § ■  " |
0.45 t
1
R.M.* = relative mobility
d i s t a n c e  m ig r a t e d  b y  p r o t e i n  l e n g t h  o f  g e l  b e f o r e  s t a i n i n g
d i s t a n c e  m ig r a t e d  b y  t r a c k in g  l e n g t h  o f  g e l  a f t e r  s t a i n i n g  
d y e
C-terminal fragment (residue 215-585)
N-terminal fragment (residue 1-214)
The results on Table 6.1 show that o-iodosobenzoic 
acid released an extra fragment from normal HSA while under 
identical experimental conditions, two extra fragments were
■ ■ 1
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released. The identities of these extra fragments were 
not pursued further since the objective of this study was 
only to test the specificity of this reagent.
Examination of the fragmentation products of 
NBS and NCS cleavage also deviated from the expected quantity. 
Inconsistent numbers of extra fragments were produced under 
similar experimental conditions and it was difficult to 
characterise a typical cleavage. The extra fragments may 
arise from non-specific cleavages at tyrosyl and histidyl 
residues as described in Section 5.6.1.
On the contrary, the fragmentation patterns of 
CNBr cleavage, shown on Fig. 6.1 (a) and (b), were highly 
reproducible. They show the presence of two faster-migrating 
peptides, labelled (F) and (L), in Albumin Mundey that 
were not found in the control, normal HSA. Another 
observation is that each of the fragments (A-L) is present 
as two bands. The different form of the fragment is probably 
due to oxidation of the unreacted cysteinyl residues during 
reduction and alkylation as described in Section 5.1.
The eluted peptides were identified by N-terminal 
and molecular weight determination. Fig. 6.3(a) shows the 
dansylated N-terminals of the unseparated CNBr fragments 
of Albumin Mundey. The detected residues are L-aspartic 
acid, L-cysteine, L-alanine, L-proline and L-phenylalanine.
It shows that the partially resistant bond at methionine-123 
was cleaved since L-cysteine was detected. Only one 
cysteinyl residue (cysteine-214) was expected, as explained 
on Table 5.1. A quantitative estimation of this cleavage
was unnecessary.
(a) (b)
F i g .  6 . 1  R e s o l u t i o n  o f  C N B r  f r a g m e n t s  o f  i s o l a t e d  a l b u m i n s  
T r a c k  ( 1 )  A lb u m in  M u nd ey T r a c k s  ( 1 , 2  a n d  4)  N o rm a l HSA 
T r a c k s  ( 2 , 3 ) N o r m a l  HSA T r a c k  (3) A lb u m in  M undey
L e n g t h  o f  g e l  =  48 cm .
Fig. 6.3(b) shows the N-terminal residues of the 
extracted CNBr peptides of Albumin Mundey. The same five 
residues, as in the unseparated fragments [Fig. 6.1(a)], 
were observed. However, it was relatively more difficult 
to interpret this chromatogram, as the mobility of these 
residues were altered by the polarity of the solvents used 
in the extraction process. Therefore, they were identified 
by their relative positions to each other on the 
chromatograms rather than with the standard dansyl-L-amino
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were observed. However, it was relatively more difficult 
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Fig. 6.2 Chromatograms of DNS-amino acids on micro­
polyamide plates 
(a) CNBr fragments of 
Albumin Mundey 
0 = standard amino 
acids
0 = dansylated amino 
acids of Albumin 
Mundey fragments 
fl> = DNS-NHj.
• = INS-Ort
(b) iso\ctte.<A CN-Br fraarnent 
of albumin Mundey
CNBr fragments 
gr = d n s- nh2 
•  = I n s- oh
acids, which were not exposed to these solvents. A further 
positive identification was made by molecular weight 
determination on SDS-PAGE. These results are summarised 
on Table 6.2.
In conclusion, the two mutant peptides (F and L) 
in Albumin Mundey correspond to CNBr fragments I (res.
1-87) and VI (res. 447-548).
Since one of the sites of mutation in Albumin 
Mundey is between residues 447-548, defective binding of 
bilirubin and palmitate are expected. The secondary 
binding site of bilirubin is between residues 446-547 
(Section 1.5.2.3) and the primary binding site for 
palmitate is between residues 377-582. Also the mutation 
in the N-terminal (between residues 1-87) may impair
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Table 6.2 The CNBr peptides of Albumin Mundey
Peptide N-terminalresidue
Approximate 
mol. wt. 
lO^daltons
Residue number
CNBr
fragment
number
A ala 4,21 88-123,88-298 II,II+III
B cys 18 18 III
C cys 18 124-298 III
D asp 9 1-87 I
E asp 9 1-87 I
F asp 9 1-87 I
G phe 12 330-446 V
H phe 12 330-446 V
J pro 11 447-548 VI
K pro 11 447-548 VI
L pro 11 447-548 VI
M ND ND ND
ND = not determined
binding of copper and nickel (Section 1.5.4.2).
A preliminary study using the fluorescence-quenching 
technique to study the binding of bilirubin to albumin 
shows that Albumin Mundey has both a slight decreased 
capacity and affinity for this ligand.
Fig. 6.2 shows a comparison of the fluorescence­
quenching of Albumin Mundey and the control, normal HSA.
It shows that the bilirubin binding site of Albumin Mundey 
is saturated at a slightly lower concentration than 
normal albumin and threfore has a decreased affinity for 
bilirubin.
\
1.0 K
0.6 -
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Fig. 6.2 Fluorescence-quenching titration of albumin, 
1.64 ymol/lit with bilirubin 
X = normal HSA O = Albumin Mundey
Since the sites of mutation on Albumin Mundey 
are now known, further studies on the binding studies of 
Albumin Mundey should include the estimation of binding 
affinity (K^ ) of this ligand; palmitate, possibly by use 
of ^H-palmitate and of copper and nickel.
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CHAPTER VII
STAGE 5: AMINO ACID ANALYSIS OF THE MUTANT PEPTIDE
This was the last experimental stage in quest 
of identification of the mutant amino acids in Albumin 
Mundey. It was unfortunate that this objective was not 
fulfilled due to insufficient time. However, in this 
chapter, some classical peptide/protein sequencing techniques 
are contrasted. These are the well known Edman degradation 
reaction, column chromatography and tryptic digestion. 
Operations of the Edman degradation in the manual, automated, 
solid phase and microsequencing mode are described. The 
phenylisothiocyanate amino acids, produced by this degradation, 
are analysed by high pressure liquid chromatography (HPLC), 
mass spectrometry and gas-liquid chromatography (GLC) .
7.1 EDMAN DEGRADATION
This is a classical technique for determining
the primary structure of proteins and peptides. It was
formulated over 25 years ago and still remains a popular
15method. In this reaction , successive N-terminal amino 
acid residues of the protein or peptide react with 
phenylisothiocyanate* to form the phenylthiohydantoin+ - 
amino acids. Each degradation step consists of three operations: 
coupling, cleavage and conversion.
‘Phenylisothiocyanate
+Phenylthiohydantoin
PITC
PTH
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7.1.1 Coupling1^
In this reaction the free a-amino group of the 
N-terminal amino acid couples with phenylisothiocyanate to 
form the phenylthiocarbamyl^-peptide (Scheme 7.1).
C6H5-NCS + NH2-CHR-CONH-X C6H5-NH-CS-NH.CHR-CO-NH-X
Scheme 7.1
The rate of reaction is dependent on the pK of the amino 
group. The usual reaction conditions are pH 9 and tempera­
ture 4 0°C.
A side reaction that can occur is the oxidative 
desulphuration of the phenylthiocarbamyl group. This 
prevents the formation of the thiazolinone and so blocks 
any further degradation"^.
207.1.2 Cleavage
The peptide bond nearest the PTC-substituent is 
rapidly cleaved in a strong acidic medium to produce the 
2-anilino-5-thiazolinone derivative (I) (Scheme 7.2).
The new peptide is shorter by one amino acid residue and 
the free a-amino group can undergo another cycle of 
degradation.
^Phenylthiocarbamyl = PTC
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11 + +
C»H5 NH CS NH CHR CO NH X ------*  C,Hj-NH-C---- -N H  + NH3 X
S\ C/ CHR
Scheme 7.2
Under severe experimental conditions some 
side-reactions can occur.
(i) An N-terminal glutamic acid can cyclise 
to form a pyroglutamic acid (Scheme 7.3). This stops any 
further degradation^1 by blocking the a-amino group. (i)
o o1 11+x __CH-C-NH-I I V.-iN 11 — 1
C H ,1
‘l 1 
o' NC
C H ,| H ,
o/ \ n i i , Scheme 7.3
NH,
(ii) The a -*• 6 interconversion of aspartyl 
residues and asparagine residues^1, can occur even under 
mild conditions. The B-aspartyl bond is not cleaved so 
further degradation is halted (Scheme 7.4).
-HN-CH-C-NH- -
I
CH.
I
COOH
-NH-CH—C
/°
H.C- V
N-
-HN-CH-COOH
I
CHj
Ic-o
Scheme 7.4 HN-
(iii) When the degradation involves a histidine
group, both this residue and the one adjacent to it are
6 6simultaneously released
7.1.3 Conversion
Conversion of the unstable thiazolinone derivative 
to the isomeric stable 3-phenyl-2-thiohydantoin (II) 
actually consists of two steps,hydrolysis and cyclisation.
The first step (Scheme 7.5) is the hydrolysis 
of the thiazolinone to the PTC-amino acid. This reaction
in acidic aqueous medium is much faster than the second 
one (Scheme 7.6), where the PTC-amino acid cyclises to form
Some side reactions can easily occur at this stage. 
These are (i) the decomposition of PTH-serine by 6-elimina-
(ii) partial hydrolysis of the amide groups of PTH-asparagine 
and PTH-glutamine. Their respective PTH-aspartic acid and 
PTH-glutamic acid are formed; (iii) desulphurisation of
+
CtHs-NH-C------- NH + HjO CjHj-NHCSNH-CHR-COOH + H+
Scheme 7.5o
the corresponding PTH-amino acid^.
H+
C.H, • NH • CS • NH • CHR • COOH SC---- NH + H,0
C6Hs Nv  /CHR
Il IIScheme 7.6 o
tion which is followed by a possible polymerisation reaction1
35the phenylthiocarbamyl group by oxidation which also can 
occur in the coupling reaction (Section 7.1.1).
7.2 MODES OF OPERATION
7.2.1 Automated Edman Degradation
The invention of the automated protein sequenator 
by Edman and Begg^ revolutionised the field of protein 
sequencing. This instrument only performs the coupling 
and cleavage reactions. The conversion reaction is left 
to conventional methods. The two steps are completed in 
about 95 min. Therefore 15 cycles can be achieved in a 
day compared to one cycle by manual methods.
The principle of the sequenator is that intact 
proteins or long peptides are repetitively sequenced 
(coupling and cleavage) inside a spinning cylindrical 
glass cup. The proteins/peptides react with phenylisothiocyanate 
(in n-hexane or heptane) and the coupling medium (Quadrol - 
trifluoroacetic acid (pH 9.0). These reagents form a thin 
spinning film. By sliding another thin film of benzene 
and ethylacetate, excess PITC, Quadrol and side products 
are removed. In the cleavage reaction, a short exposure 
of the PTC-peptide to anhydrous heptafluorobutyric acid 
forms anilinothiazolinone. The thiazolinone is then 
extracted with 1-chlorobutane.
The yield of this repetitive operation is about 
98%. Losses in material occur during washings in the 
last stages of degradation. The shortened peptide is 
easily removed together with the thiazolinone during 
cleavage.
Some steps to minimise losses are: (i) not
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repeating the cleavage process and (ii) the use of 
4 5Braunitzer reagents ' (4-sulphobenzeneisothiocyanate,
3,5-disulphobenzeneisothiocyanate and 4,6,8-trisulpho- 
naphthalene-2-isothiocyanate). These highly polar reagents 
couple with the lysine and S-aminoethyl cysteine residues 
of a peptide. Hydrophilic moieties are formed with 
reduced solubility in organic solvents.
7.2.2 Solid-phase Edman Degradation
This is the repetitive isothiocyanate degradation
38 39of short peptides anchored to insoluble supports '
8 38 12such as resins, polyamides , polystyrenes or glass .
This technique is ideal for sequence determination of CNBr 
32fragments and tryptic peptides with lysine or ornithine
39as C-terminal residues . The advantages of solid phase 
degradations are that peptide losses through extractions 
are minimised (contrast Section 7.2.1) and that the coupling 
and cleavage processes can be accomplished simply by 
elution of the reaction buffers into the column.
Most of the problems associated with solid-phase 
degradation are concerned with support methods and increasing 
the yield of peptides attached to solid supports. Ideally, 
the C-terminal carboxy group on the bridgehead of the peptide 
should be attached to the insoluble support.
Edman degradation can then proceed from the 
unattached N-terminal end. However, this is not always 
possible, especially with carboxyl groups of glutamic and 
aspartic acids. This is due to similar reactivities 
of their C-terminal carboxyl groups. However, selective
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attachment of the aspartyl residue can apparently be achieved
52by modification of the carboxyl group activation procedure
A variation of solid-phase degradation is
carboxyl-terminal sequencing. It uses di-p-nitrophenyl-
phosphoryl azide to form an acyl azide with the peptide
carboxyl terminus. The carboxyl terminus is released as
46an aldehyde derivative by thermolysis of the acyl azide ,
to form a peptide-amide. The product formed by reaction
of the peptide amide with 1,l-bis (trifluoroacetoxy)iodobenzene
47produces an aldehyde and a new peptide amide
In the reverse principle of the solid support, the 
isothiocyanate groups are attached to the support instead 
of the peptide13.
7.2.3 Manual Edman Degradation
This manual degradation of a peptide can be from
the conventional N-terminal end (Section 7.3.1) or from 
57the C-terminal
In degradation from the C-terminal end, the thio­
cyanate reacts with the C-terminal residue of the peptide 
(Scheme 7.7). The acy lisothiocyanate (I) spontaneously 
rearranges to the l-acyl-2-thiohydantoin derivative (II).
X CO NH CHR CO N C S ------>• X CO N-------CHR
I I
I SCV /CO
HScheme 7.7 M
The acyl group is then hydrolysed to form 2-thiohydantoin 
(Scheme 7.8) which creates a new C-terminal available for
another degradation cycle.
X • CO • N ------ CHR + H.O XCOOH + HN-
SCN /CO SCX /CO
Scheme 7.8
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Analysis of amino acids released by the Edman
degradation as their highly sensitive dansyl derivatives
23were pioneered by Gray and Hartley . Repetitive analysis
can be 'subtractive' where the cleaved N-terminal residue
is identified after the cleavage and conversion steps'^,
59or by hydrolysis of the PTH-derivatives to regenerate 
the amino acids.
7.2.4 Microsequencing
Chang et at. reports the microsequencing of a 
peptide by a double coupling method using organic isothio­
cyanates. The first coupling is with 4-N,N-dimethylamino- 
azobenzene-4'-isothiocyanate and the second with the 
Edman reagent, phenylisothiocyanate. The resulting coloured 
thiohydantoins are easily detectable on chromatograms.
7.3 ANALYSIS OF PTH-AMINO ACIDS
PTH-amino acids may be separated and identified 
by chromatographic methods such as paper‘d, thin layer1 ,^ 
gas-liquid (GLC)^1, high pressure liquid chromatography 
(HPLC) or by mass spectrometry (MS).
1* \ 1
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In all these systems the PTH-amino acids can be
identified by a direct or an indirect method. The direct
method relies on the positive identification of the
released moiety19'^  ^ . In the indirect method,
identification depends on a difference in analysis of the
peptide before and after a degradation step.
Two techniques of the indirect method exist. In the 
30method of Hirs et at. , quantitative amino acid analysis
of the peptide is made before and after a degradation
21cycle. In the method of Gray and Hartley , only the N- 
terminal amino acid is determined before and after a 
degradation cycle. This latter technique is less ambiguous 
than the former method.
In the following sections, analysis of PTH-amino 
acids by HPLC, GLC and MS are discussed.
7.3.1 High Performance Liquid Chromatography (HPLC)
The separation of PTH-amino acid by HPLC is 
usually by adsorption chromatography. Here the mobile 
phase is liquid and the stationary phase is solid. The 
solid particles are very fine (3-10 u in diameter).
The two modes of adsorption chromatography to accomplish 
separation can be ordinary adsorption or reverse-phase 
chromatography.
Ordinary adsorption chromatography has a polar 
stationary phase (e.g. silica gel, porous glass beads or 
alumina) and the mobile phase is relatively non-polar 
(e.g. hexane or chloroform29). Therefore, PTH-amino acids
r 1 m y c
201
have to compete with the mobile liquid phase for adsorption. 
Their retention onto the stationary phase is dependent on 
their basicity. The order of elution of these moieties 
is such that non-polar substances are followed by those of 
increasing polarity. The last group of PTH-amino acids, 
highly charged derivatives, is very difficult to elute 
because of strong adhesion. Therefore, reverse phase 
chromatography coupled to gradient elution or to ion pair 
chromatography is advisable.
Ion pair chromatography is a special form of 
liquid-liquid chromatography (liquid stationary and 
mobile phases) which, when used in the reverse-phase 
mode with a hydrocarbon bonded stationary phase, can be 
used for the separation of polar amino acid derivatives.
One of the explanations for their retention 
onto the hydrophobic stationary phase is that the ionic 
amino acid forms an ion pair with a suitable counter-ion 
in the mobile phase that increase its lipophilic 
character^.
In reverse phase chromatography, the stationary
phase is non-polar (e.g. polymer beads) but the mobile phase
29is polar (e.g. water or ethanol ). The order of elution
of PTH-amino acids is the reverse from that in ordinary
chromatography. The polar derivatives are eluted first
followed by those of decreasing polarity. Recently, Black 
2and Coon reported the separation of PTH-amino acids 
with wide polarity difference by the application of a 
step-gradient.
The choice of either ordinary adsorption or 
reverse phase chromatography is, as stated, dependent on
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the chemical character of the heterogenous pool of 
PTH-amino acids. These chemical characteristics can be 
divided into three classes: non-polar, relatively polar 
or highly polar6. The non-polar PTH-amino acids (pro, 
leu, ile, val, phe, met and ala) can be separated under
mild lipophilic solvent conditions on highly efficient 
columns, since their common structural differences are 
in the length and branching of their aliphatic side chains.
The second group, relatively polar derivatives, try, gly, 
lys, tyr, thr, ser, asn and gin), must be separated by 
gradient elution because of the wide variety in polarity of 
their functional groups.
The last group of highly charged acids and bases 
(glu, asp, cyn, his and arg) poses the largest problem in 
separation and identification due to their strong adhesion 
to the stationary phase. Ion pair chromatography or adsorption 
chromatographycoupled to reverse phase chromatography may 
solve this problem.
7.3.2 Gas-liquid Chromatography (GLC)
The PTH-amino acids are very diverse in their 
chemical and chromatographic properties, with respect to 
GLC. They can be classed into three groups, volatile, 
less volatile and involatile561.
Group I PTH-derivatives (ala, gly, val, leu, ile, 
met, pro, phe) are the most volatile and their presence are 
recorded as symmetrical peaks. Group II derivatives (gin, 
asn, tyr, his, and tryptophan) are less volatile. All,
except tryptophan, adsorb strongly onto the chromatographic
particles. They are recorded as trailing peaks. Group III
derivatives are unstable and involatile (asp, glu, lys, ser,
thr, cys) and must first be converted to their volatile
24 48trimethylsilyl derivatives before analysis '
The general procedure in gas-liquid chromatography
is that PTH-amino acids are first volatised or converted to
their more volatile form by, for example, silylation. They
are then introduced into the stationary liquid phase of a
high melting polymer-coated particle (e.g. chromasorb W)
packed in a long glass column (PTH-amino acids are
33destroyed by contact with metals) . They are then heated
at an optimised temperature ranging from 160-290°C. An 
4 9inert gas, helium , or nitrogen, is used as the moving 
phase and the vapourised derivatives partition themselves 
between the stationary liquid phase and moving gas phase 
according to their individual gas-liquid coefficients.
The current generated by the flow of the ionised fragments 
of the PTH-derivatives in a hydrogen flame defector 
(300°C) is monitored and recorded as separate peaks.
7.3.3 Mass Spectrometry (MS)
This is another valuable method for analysis 
19 42 55of PTH-amino acids ' ' . The chemical ionisation
method (Cl) is usually preferred over the more common 
electron ionisation (El) mode since it is more sensitive
21and spectral bands are fewer which eases their interpretation 
A unique feature of MS is that it is possible
'-Vi f :JF ' .
to analyse samples after cleavage without prior conversion
5  6to the thiohydantoin . This is because thiohydantoins 
are formed from a thiocarbamyl peptide4  ^or a thiazoline^0 
by the heat of the probe.
7.4 COLUMN CHROMATOGRAPHY
The principle involved in column chromatography 
is the resolution of a mixture of amino acids into 
individual amino acids on an ion exchange column consisting 
of very fine and homogenous particles. This technique is 
the prototype of HPLC.
Factors that determine the sensitivity, reproducibility 
and resolution are (i) sample preparation, (ii) particle size, 
homogeneity and degree of cross-linking in the ion exchange 
resin, (iii) ionic compositions, ionic strengths, pH 
and temperatures of the eluting buffer, (iv) flow rate 
and pressure of the eluting buffer and finally (v) 
dimensions (length and diameter) of the chromatographic 
column.
Examples of careful sample preparation are as 
follows: (i) Hydrolysis of the pure peptide under oxygen-free 
conditions to minimise destruction of amino acids by 
oxidation. The extent of amino acid destruction is also 
dependent on the character of the peptide, time and 
temperature of hydrolysis. The most labile amino acids 
are tryptophan, cysteine, cystine, serine, threonine and 
tyrosine40. (ii)Incomplete hydrolysis of some peptides can 
occur between resistant bonds, e.g. between sterically
20 5
hindered amino acids. (iii)Also,amino acids are released 
at different rates during hydrolysis. The result is 
that the total concentration of amino acids may not 
necessarily correlate with that of the original peptide.
Like all column chromatographic techniques, the 
sample volume should not be more than 10% of total column 
volume. The sample should have a low salt concentration and 
be free of contaminants such as air borne and particulate
substances. Amino acids were found in air borne
53 45particles and even finger prints
The features of a good chromatographic column of
high resolving power are that it should be properly packed 
25with very fine homogenous and uniformly cross-linked 
2 8(usually 4-12%) ion exchange resin.
6 2The citrate buffer systems formulated by Spackman
in 1958 are used today even in amino acid analysers. Acidic
and neutral amino acids are separated by citrate buffers of
pH 3.25 and 4.25 respectively. The basic and very strongly adsorped
6 2amino acids are eluted with buffers of pH 5.25 and 10.1 .
Delivery of the buffers is at a constant rate at high 
26,43pressure
Decreasing the column diameter increases the
sensitivity proportionately. A decrease in the column
length increases the speed and sensitivity but decreases 
2 7the resolution . The average column is of dimensions 
4 40.9 x 150 cm , but a twenty-fold increase in sensitivity 
can be achieved on a 0.28 x 60 cm column. A microbore 
column of 0.05 cm diameter increases the sensitivity 
even further by 300 times'^.
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The eluted amino acids are detected by reaction 
with ninhydrin^1 or fluorescamine^. Ninhydrin forms a 
purple colour with most amino acids or a yellow colour 
with proline or hydroxyproline. Fluorescamine reacts 
almost instantaneously with primary amines at pH 9 at 
room temperature. It forms a highly fluorescent product. 
However, proline and hydroxy proline must first be 
oxidised to primary amines by N-chlorosuccinimide before 
reaction with fluorescamine.
7.5 DIGESTION BY TRYPSIN
Treatment of the mutant peptide with trypsin, 
the most specific of the endopeptidases, result 
in cleavage at lysyl and arginyl residues. Under careful 
optimised conditions, the extent of fragmentation can be 
controlled.
Slow albumin mutants usually arise from basic 
to acidic amino acid substitutions (the other possibility 
being neutral to acidic substitutions). The involvement of 
a lysyl residue in this mutation can be proven by 
selectively modifying the lysyl residues in the mutant 
peptide by chemical means.
Analytical comparison of this digest against a 
corresponding normal peptide by finger printing methods on, 
for example, two dimensional Cleveland gels11, should 
reveal a peptide map of the mutant moiety with one less 
peptide than the total in the corresponding normal peptide.
The sequence of the small fragment in the larger
.. ■ I ' 1 II
mutant peptide is deduced by realignment of the tryptic 
fragments. The identities of the peptides can be confirmed 
by determining their N-terminal and C-terminal residues. 
Since the mutant tryptic peptide is now sufficiently 
small, manual Edman degradation (Section 7.2.3) can 
successfully reveal its sequence.
The rates of tryptic cleavage of the susceptible 
bonds in this peptide are influenced by the chemical 
characters of the side chains of the amino acids in the 
susceptible bonds. Slower rates in hydrolysis occur 
when the susceptible bond is adjacent to an acidic amino 
acid1 and consist of repetitive sequences of arginine 
and/or lysine. The imino nitrogen of proline renders the 
bond practically resistant to cleavage60.
As mentioned, chemical modification of the
e-amino group of lysine restricts hydrolysis specifically
2 2at arginyl residues. Trifluoroacetylation (Scheme 7.9)
and maleylation"^ (Scheme 7.10) are the two most popular
o o
pl I 10, 25 T .
FjC-C-S-C.Hs - Protcin-NMj------------ "  ^Protein-N'-C-C-Fj + C;Hs-SH
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O
y O  pl I 9
Protcin-NHj + HC—C, ------—
1 > 0  2*
i
* Protcin-NH-Cv
N
HC—C' 
No
- o o c
o
1 11,0 +
Protein-Nil j +
'CH
1
✓ CH
H O O C '
CH vi
CH
IHC.
Scheme 7.10
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methods because of the ease in their removal under mild 
conditions to regenerate the unmodified amine functions 
and also their high specificity for the a- and e-amino 
groups of proteins.
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CHAPTER VIII
STUDY ON THE PHOTOINDUCED ISOMERISATION 
OF BILIRUBIN-IXa IN DETERGENTS
8 . 1 INTRODUCTION
The end product of haeme degradation (Scheme 8.1) 
is the linear tetrapyrrole, bilirubin-IXa (2^ 4). This
functionless and toxic end product is removed from the
circulation by an essential esterification of its two
propionyl side chains with carbohydrates (eg, glucuronic
acid glucose and xylose) to form mono- or diester. This
reaction is catalysed by glucuronyl-, glycosyl- and
7 12 29xylosyl-transferases in the liver ' ' . Bilirubin
diglucuronide is shown on (23).
.N m /  -----------------------► Excreteduu1' \
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A failure in this detoxification system can lead 
to hyperbilirubinemia, which manifests itself by a yellow 
colouration of the skin. Even in early civilisation, 
Hippocrates expounded its prognosis and diagnosis1 and 
the intricate chemistry of this waste product of haeme 
catabolism has continued to fuel the researches of photo-, 
analytical-, organic- and physio-chemists.
8.2 PHOTOTHERAPY OF NEO-NATAL JAUNDICE
The widely-used therapy for neo-natal jaundice
is photo-irradiation of the skin with blue and white light
27from luminescent sources . Maximum effect in phototherapy 
is experienced in light of approximate wavelength, 550 nm. 
This coincides with the bilirubin absorption maximum of 450- 
600 nm28.
During phototherapy, the bilirubin concentration
is decreased by both photochemical decomposition and elimina-
19tion of undecomposed bilirubin
The photochemical decomposition of bilirubin
occurs in the surface layers of the skin and not in the 
2vessels . Furthermore, these oxidation products, which
are absorbed by the skin by binding to collagen and lipids,
are unlike those produced in aqueous solution17.
The undecomposed bilirubin (mainly ois-trans
isomers) is eliminated from the organism in the unbound
state. This is unlike the conventional method of elimination
18as conjugated bilirubin
8.3 STRUCTURE OF BILIRUBIN
Bilirubin-IXa (24) consists of four pyrrole rings
linked by three carbon bridges. The side chains consist
of two vinyl, four methyls and two propionic acid moieties.
This naturally occurring isomer is derived from the
scission of the photoporphyrin IXa ring [Scheme 8.1(1)]
at the a-carbon bridge. It exists predominantly in the
lactam form (NH-C=0) rather than the corresponding
14tautomeric lactim (N=C-OH) form 
8.4 ISOMERS OF BILIRUBIN
Modification of the basic structure of bilirubin- 
IXa can give rise to structural and geometrical (ois-trans) 
isomers.
Structural isomers can be induced in vitro or
produced in vivo. In vitro reversible isomerisation can
2 6be catalysed by strong non-oxidising acids , by aerobic
24incubation in the dark or anaerobic irradiation with 
visible light.
The latter two mechanisms appear to be catalysed 
21by a free radical process . In all three cases, random 
recombination of the dipyrroles (formed by cleavage at
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the central methylene bridge) results in a mixture of
the bilirubin-XIIIa (2^5) , -IXa and -Ilia (^ 6) isomers in
25an approximate molar ratio of 1:2:1
These isomers are also found in the serum of
jaundiced new-borns where the Ilia and Xllla isomers are in
near equal proportion. Collectively, they constitute
27between 30-40% of the total bilirubin concentration
Geometrical isomers of bilirubin arise from 
the different positions (Z or E) of substituents relative 
to the two enamide C=C bond. The possible permutations, 
are shown below (27) .
N* M
(27)
Naturally occurring bilirubin-IXa has a ridge- 
tile configuration (^ 8) • Rings A and B are coplanar and 
are at right angles to the coplanar rings, C and D. This 
contortion, due to the Z,Z configuration at C^-C^ and
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C^-C^g, is maintained by six strong intramolecular 
hydrogen bonds formed along the ridge of c8“c12 '
These bonds are formed between the amide and carboxyl 
moieties of the carboxylic acid groups, pyrrole-imino 
hydrogens and the terminal lactam system^.
8.5 CHEMICAL PROPERTIES
The chemical properties of bilirubin are
predictable from its chemical structure. The central
methylene bridge, which separates the dipyrrole segments,
is especially prone to attack by electrophiles, oxidative
22dehydrogenation and cleavage . However, the outer 
dipyrrylmethane bridges are more stable.
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Bilirubin has two weakly acidic carboxylic acid 
side chains (propionic acid) which readily form esters. 
Esterification with alcohols renders the molecule 
susceptible to autoxidation since the central methylene 
bridge becomes exposed. This results in an unstable 
molecule11. Its acidic properties can also be increased 
in an alkaline medium by the tautomeric transition to 
the bislactim form.
The basicity of bilirubin is conferred by the 
nitrogen atoms of the central pyrrole rings. The double 
bonds on these rings are, however, more resistant to 
reduction than those in the outer rings and side chains.
8.6 PHOTOCHEMICAL ISOMERISATION OF BILIRUBIN
The photoisomerisation of bilirubin-IXa to its
21structural isomers, Ilia and Xllla, occurs frequently 
and is the cause of contamination in commercial bilirubin.
A proposed mechanism (Scheme 8.2) involves a 
free radical, R°, which may be bilirubin or any component 
of this system. The free radical attacks bilirubin-IXa
Me Vin Me P P Me Me Vin
\  /  \ _ /  + \ _ /
0 / ^ N/ S / ^ N/ \ R  C H , ^  N °
H H H H
Scheme 8.2
at Cg or C1X to form tetrapyrrole free radicals. These 
then decompose into two dipyrrole fragments. In the 
following chain propagation reaction, the radical fragment
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can attack an unreacted molecule of bilirubin at Cg or
Cj^. A hexapyrrole free radical is then formed from which
another free radical dipyrrole fragment is split off. The
end result of this chain reaction is the production of bili-
rubin-IIIa and -Xllla in place of the original -IXa 
27molecule . The absorption of light also converts bilirubin-IXa 
to a probable mixture of cis-trans (Z,E) geometric isomers 
about C4~Cg and c15-c1g bonds in the tetrapyrroles.
8.7 AIMS OF THIS STUDY
Detergents greatly enhance the activity of 'native' 
glucuronyltransferase in hepatic microsomal membrane 
preparations (Section 8.9). The aim of this study was
to investigate the possibility that detergent micelles 
may also catalyse the photo-isomerisation of bilirubin-IXa. 
These detergent-water systems are analogous to the behaviour 
of naturally occurring lipids^, therefore, the ionic 
characters of the detergents used were chosen to mimic that 
of the phospholipids of membranes. Also, the disproportiona­
tion of bilirubin monoglucuronide into unconjugated bilirubin 
and bilirubin diglucuronide on photoirradiation in micelles 
was also studied.
The following sections discuss micellar catalysis 
and the two opposing theories on the conjugation of 
bilirubin prior to excretion.
221
8.8 MICELLAR CATALYSIS
In dilute solutions, detergents will specifically 
orientate to form high molecular weight aggregates or 
micelles. They consist of a hydrophobic core surrounded 
by a hydrophilic coat.
The narrow range at which micelles are formed is 
determined by the critical micellar concentration (CMC).
[  d e t e r g e n t ]
Fig. 8.1 Changes in a physical property as a function 
of detergent concentration.
This value for detergents with long aliphatic chain
-4 -2is usually between 10 and 10 M. For non-ionic micelles, 
this concentration is 100-fold smaller than for ionic 
micelles with comparable hydrophobic groups. The positive 
charge of anionic detergents is less exposed than the
negative charge of anionic micelles and they are more
9compact in structure .
The cationic detergent, cetyltrimethylammonium 
bromide [CH3 (CH2)35N+(CH3)3Br ] was used to mimic the
am
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naturally occurring phosphoglyceride, phosphatidylcholine 
(lecithin) with -CH2~CH2-N+ (CH^)3 as a functional group. 
Also used were the neutral and anionic detergents,
Tween 20 and sodium dodecyl sulphate.
8.9 CONJUGATION OF BILIRUBIN
In humans and most mammals, bilirubin is
conjugated as the diglucuronide in a reaction catalysed
by glucuronyltransferase. In hepatic microsomal membrane
preparations, the activity of this enzyme is greatly
enhanced by agents that agitate the membrane. They
probably relax the constrains which an intact membrane
imposes on the enzyme. These agents may be high pH,
detergent, ultrasonication, several glucuronides or brief
5 8 13treatment with phospholipase A ' '
Formation of Bilirubin Diglucuronide
Bilirubin monoglucuronide (BMG) is formed from 
bilirubin-IXa in a well-established reaction, catalysed by 
UDP-glucuronosyltransferase. However, the ensuing 
mechanism resulting in formation of bilirubin diglucuronide 
(BDG) is subject to controversy.
Two different mechanisms have been proposed. The
13first mechanism, proposed by Heirwegh is generally accepted, 
where the diglucuronide is formed by a sequential mechanism. 
The glucuronosyl residue is transferred from UDP-glucuronic 
acid to the unesterified propionic acid side-chain of BMG 
in a reaction catalysed by UDP-glucuronosyltransferase.
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The second opposing mechanism, proposed by Jansen1  ^
is based on a transesterification reaction. This reaction 
involves the transfer of a glucuronosyl group from one BMG 
molecule to another (transglucuronidation), resulting in 
equimolar concentrations of BMG and unconjugated 
bilirubin. This mechanism differs from the former in 
several factors. These are:
(i) The enzyme is located in the liver plasma membrane 
instead of the microsomes.
(ii) The formation of BDG from BMG is catalysed by 
BMG- and not BDG-glucuronosyltransferase.
(iii) This transglucuronidation reaction does not 
require UDP-glucuronic acid as sugar donor.
8.10 EXPERIMENTAL
All operations involving bilirubin were carried
out in subdued light
8.10.1 Purification of bilirubin
The method of Fog10 was used to remove
contaminants from commercial bilirubin-IXa
8.10.2 Photoisomerisation of bilirubin in detergent 
solution
All solutions used were thoroughly degassed before
use. Bilirubin (2 mg, 3.33 mmol) was dissolved in dilute 
KOH (0.1 M, 9 ml) and phosphate buffer (0.1 M, 10 ml)
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containing detergent (1 mM) was immediately added.
Detergents used were cetyltrimethylammonium bromide 
(CTAB), sodium dodecyl sulphate and poly(oxyethylene) sorbitan 
mono-oleate (Tween 20). These respective detergents are 
cationic, anionic and neutral in character.
The solutions were then placed in test-tubes open 
to the air in a water bath at 20 + 0.5°C and irradiated 
by a 60 W tungsten lamp placed perpendicularly 8 cm 
away from the tubes. At appropriate time intervals, portions 
(1 ml) were removed and added to glycine/HCl buffer (1 ml, 0.4 
M-HC1 adjusted to pH 2.75 with solid glycine). The bilirubin 
was then extracted with chloroform (1 m) and a sample 
(300 yl) was applied to a TLC plate (5 x 20 cm). The plates 
were developed in glacial acetic acid in chloroform (0.58% 
v/v). The experiment was repeated, in the absence of 
detergent, at pH 6.5 and with all three detergents in the 
pH range 5-8. In the control experiments solutions of 
bilirubin in cetyltrimethylammonium bromide buffer were 
kept in the dark for 30 min. before chromatography and 
assay. Merck silica gel 60 glass-backed TLC plates were 
activated at 120°C for 18 h and then cooled in a desiccator 
before use.
8.10.3 Formation of ethyl anthranilate pigments
Method modified from Blanckaert3. The pigments 
separated by thin-layer plate, were scraped off and powders 
transferred to centrifuge tubes containing diazotised 
ethyl anthranilate (1 ml). This prevented the rapid
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oxidation of pigments. Formamide (2 ml) and ethanol (2 ml) 
were immediately added followed by vigorous mixing every 
0.5 min. for 5 min. Glycine-HCl (pH 2.7, 2.5 ml) and 
pentan-2-one (1.5 ml) was added and shaken vigorously to 
extract the ethyl anthranilate azopigments. The UV 
absorbance of the pigment at 530 nm was recorded using a 
Cecil 505 Mk II spectrophotometer.
Pentan-3-one can be substituted for pentan-2-one 
without any change in extraction value.
In quantitative experiments, the rapid decomposition 
of bilirubin on dried developed chromatograms could be 
inhibited by spraying the chromatograms with a dilute 
solution (1% w/v) of ascorbic acid in water. However, 
the bilirubin treated in this manner could not be 
diazotised and estimated in the normal manner. Otherwise, 
a clean glass plate was placed on top of the chromatogram to 
prevent decomposition of bilirubin.
8.10.4 Infra-red spectroscopy of isomers
The pigments separated by TLC were scraped off 
into a centrifuge tube. Bilirubin was dissolved in 
chloroform. After centrifugation at 2,000 rpm for 1 min., 
the supernatant was transferred to a round bottomed flask 
and chloroform removed in vacuo at 50°C. The pigment so 
obtained was ground with spectral grade KBr (1% mixture) 
and a wafer was formed by compression at 7.5 tons. Spectra 
were obtained with a Perkin Elmer 580B IR spectrophotometer.
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8.10.5 Formation of isomers under aerobic and anaerobic 
conditions
30 min.
CTAB-phosphate solution (pH 6.5) was purged for 
with gaseous oxygen or nitrogen before use. A
freshly prepared solution of bilirubin (2 mg, 0.33 mmol) 
in KOH (0.1 M, 1 ml) was added to the solution followed 
by irradiation with visible light.
8.10.6 Effect of free-radical inhibitions on 
photoisomerisation
N-tert-butyl-a-phenylnitrone (1 mg) was added to
the isomerisation cocktail of bilirubin. The reducing 
agent, L-ascorbic acid, was also used.
8.10.7 Dehydrogenation with 2,3-dichloro-5,6-dicyano 
p-benzoquinoneJU
This mild oxidising agent dehydrogenates the
pigment at the central methylene bridge to produce the fully 
conjugated biliverdin-IXa. The pigments separated by TLC 
were scraped off the plate into individual test-tubes and 
then dissolved in dimethyl sulphoxide. Drops of a freshly 
prepared solution of 2,3-dichloro-5,6-dicyano-p-benzoquinone 
in dimethyl sulphoxide (1 mg/ml) was added to the pigment until 
no further colour change.
8.10.8 Electron spin resonance of bilirubin
Visible light was shone on an ESR tube containing
bilirubin (3 mg, 3.33 mmol) in CTAB-phosphate (10 ml, pH 6.5)
The tube was cooled to sub-zero temperature by liquid 
nitrogen and dry ice. The ESR of bilirubin was obtained 
at 30, 120 and 150 min. of irradiation.
8.10.9 Effect of irradiation of bilirubin monoglucuronide
in a solution of cationic detergent
This experiment was performed by Dr. D.W. Hutchinson 
in the laboratory of Professor K. P. Heirwegh. Unconjugated 
bilirubin and bilirubin diglucuronide was removed from 
bilirubin monoglucuronide (2.3 A454 units) by TLC on silica 
with chloroform/methanol/water (10:5:1 v/v/v). The 
purified bilirubin monoglucuronide was dissolved in 
cetyltrimethylammonium bromide/phosphate buffer (20 yl, 
pH 6.5) and irradiated as described in Section 8.10.2. 
Glycine/HCl buffer saturated with NaCl (pH 1.8, 500 yl) 
was added and the solution extracted with chloroform/ 
methanol (2:1 v/v, 500 yl). TLC of the non-aqueous 
extract (1.6 A4^4 units) on silica developed with chloroform/ 
methanol/water as in Section 8.10.2 showed the presence 
of bilirubin diglucuronide (19%), unconjugated bilirubin 
(16%) and bilirubin monoglucuronide (65%) , as estimated 
after spraying with ascorbate, with a Flying Spot TLD 100 
densitometer (Vitatron, Dieren, The Netherlands).
8.11 RESULTS AND DISCUSSION
Irradiation of bilirubin-IXa in a neutral buffered 
solution containing a cationic detergent resulted in a 
rapid isomerisation to the -Ilia and -XIII isomers. The
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proportion of the bilirubin-IIIa, IXa and XIII«. isomers in the 
equilibrium mixture was 1:2:1. Within the pH range 5-8, 
the maximum rate of isomerisation occurred at pH 6.5 
(Fig. 8.2) with a half-life for the isomerisation reaction 
of 10 min.
Fig. 8.2 Photoisomerisation of bilirubin-IXg in cetyl- 
trimethylammonium bromide/phosphate buffer at 
different pH values.
The ordinate represents the total percentage 
of bilirubin-IIIa and-XIIIa after 10 min. 
irradiation corrected for the value of controls 
kept in the dark for the same period.
X = cetyltrimethylammonium bromide,
O = sodium dodecyl sulphate 
□ = Tween 20
isomerisation was undetectable in the dark after 
30 min. in the absence of detergent or with neutral or 
anionic detergents in the pH range 5-8.
This difference in reactivity may be due to a 
difference in charge distribution of the detergent micelles. 
Presumably bilirubin is embedded in the cetyltrimethyl­
ammonium bromide micelles so that propionic acid groups 
are close to the positive charges on the exterior of
229
the micelles. The methylene bridge where bond fission 
must occur for isomerisation to take place is therefore 
in a non-aqueous environment.
This photoinduced rearrangement involves free 
radicals as an ESR study showed the formation of a free- 
radical during photoisomerisation. Also it is totally 
inhibited by L-ascorbic acid (1 mg/10 ml of buffer) or 
N-benzylidene-1,1-dimethylamine-N-oxide (1 mg/10 ml) of 
buffer. The latter is an efficient free radical trap1*’.
Flushing the reaction with nitrogen before and during 
the irradiation had little effect on the rate of isomerisa­
tion since the reaction was carried out under anaerobic 
conditions.
The mild oxidising agent, 2,3-dichloro-5,6- 
dicyano-p-benzoquinone in dimethylsulphoxide dehydrogenated 
the isomers to biliverdin. This was evident from the 
resulting green colouration of the pigments (*max 390 nm) .
The bilirubin-IIIa, -IXa and Xllla had the same polarity 
on TLC as the starting material. Therefore, the irradiation 
products did not contain appreciable quantities of the 
(Z,E)- or (E,E)-isomers. Their IR and UV spectra were 
also essentially identical to the original material. The 
diazopigments derived from these isomers were identical to 
those from the starting material.
Preliminary experiments by Dr. D. W. Hutchinson showed 
that bilirubin monoglucuronide disproportionates rapidly into 
the diglucuronide and unconjugated bilirubin when solution 
of the monoglucuronide in buffered cetyltrimethylammonium 
bromide at pH 6.5 were irradiated with visible light.
V
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In conclusion, when bilirubin-IXa in a 
buffered aqueous cationic detergent at near neutral pH is 
irradiated with visible light it rapidly isomerised to 
an equilibrium mixture of the -Ilia and -Xllla isomers.
Bilirubin monoglucuronide rapidly disproportionated into 
unconjugated bilirubin and bilirubin diglucuronide on irradiation 
in a solution of the cationic detergent.
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